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This thesis follows standard scientific nomenclature for genes, proteins, and conditions. 
Genes are specified in italics and proteins are in standard text. Where a gene and its 
protein are discussed jointly, the one with the main focus takes precedence in terms of 






The metanephric kidney consists of two types of epithelia; the Wolffian duct-derived 
ureteric bud and the nephrogenic components that originate from mesenchymal-to-
epithelial transitions in the metanephric mesenchyme. The ureteric bud forms when 
inductive signals from the metanephric mesenchyme stimulates the evagination of an 
epithelial tube from the Wolffian duct into the mesenchyme. Reciprocal signalling 
between the ureteric bud and the metanephric mesenchyme regulates the branching of 
the ureteric bud and the induction of nephron formation. Inductive and inhibitory 
signalling of ureteric bud growth and branching has been shown by several protein 
families, however, the mechanical aspects of ureteric bud branching and nephrogenesis 
are largely unknown.  
 
I investigated the roles of Rac1-GTPase and Rho-kinase during kidney development. 
These proteins are important regulators of the cytoskeleton where Rac1 is a promoter of 
actin filament polymerisation and Rho-kinase directly stimulates the formation and 
contraction of actin-myosin stress fibres. Using a cell-permeable inhibitor, Rac1 was 
inhibited with no effects on nephron formation or subsequent segmentation and 
patterning. Inhibition of active Rac1 significantly reduced the level of ureteric bud 
branching and also resulted in lower proliferation rates.  
 
Rho-kinase was similarly targeted using two inhibitors. Rho-kinase inhibition had 
important effects on nephron formation and nephron maturation. Inhibition of Rho-
kinase resulted in decreased levels of nephron formation and severely morphologically 
abnormal nephrons. The formation of apical-basal polarity was disturbed as was the 
development of the visceral and parietal epithelia; precursors of the renal corpuscle. 
Inhibition of Rho-kinase led to abnormal formation of the proximal-distal axis and 
abnormal segmentation of the nephron. 
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The effects of Rho-kinase inhibition were partially mimicked by direct targeting of 
actin-myosin contractions using a myosin-ATPase inhibitor. This demonstrated that 
Rho-kinase is necessary during multiple stages of nephrogenesis and maturation, at least 
in part, as a result of its ability to regulate actin-myosin contraction. 
 
These results show that Rac1 and Rho-kinase play important roles during several aspects 
of kidney development and highlights the significance of further investigating the 











Introduction to mechanisms of kidney development, nephron 





The focus of this thesis is on the development of the metanephric kidney and 
specifically the roles of Rac1-GTPase and Rho-kinase. These proteins have each 
been implicated as necessary components of normal kidney development (Michael, 
Sweeney, and Davies 2005; Meyer et al 2006; Osafune et al 2006). Rac1-GTPase 
(Rac1) and Rho-kinase (ROCK) are both integral for the regulation of planar cell 
polarity and for the control of actin and actin-myosin cytoskeletal components. In 
this thesis I present data indicating that normal kidney growth, ureteric bud 
branching, and proliferation are processes dependent on Rac1 activity. Nephron 
formation, apicobasal polarity formation, glomerular cleft development and 
proximal-distal nephron patterning show a requirement for ROCK. 
 
The development of the kidney, like all other organs, can be discussed at different 
levels of resolution. The complexity of the kidney renders it impossible to cover 
completely in a single piece of work, thus various efforts have been made in order to 
describe the kidney in detail from several different points of view. From an 
anatomical/physiological point of view, Brenner & Rector’s, The Kidney, 6
th
 Ed. 
(Brenner 1999) covers the human kidney in great detail. From an 
anatomical/developmental perspective, the work Organogenesis of the Kidney 
(Saxen 1987) discusses normal kidney development and The Kidney: From Normal 
Development to Congenital Disease (Vize, Woolf, and Bard 2003) provides excellent 
insights into the development and the abnormalities found in the mouse kidney. For 
an ontology of the kidney from development through to adulthood, Little et al 2007 
offers a detailed, up-to-date description of all known components in the kidney 
(Little et al 2007). 
 In order to introduce the topic of kidney development efficiently, I will discuss the 
mechanisms of morphogenesis under several sub-headings, each with the appropriate 
level of detail. This has been done because there are several different compartments 
within the kidney that not only represent different cellular lineages, such as the 
metanephric mesenchyme and the ureteric bud, but they also differ in the processes 
that take place within them. This chapter will start by introducing the kidney in terms 
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of its importance for homeostasis I will then cover the origin of its compartments 
where the development of the ureteric bud and the nephrons will be discussed in 
detail. Particular focus will be placed on the stages and mechanisms of ureteric bud 
branching, nephrogenesis and nephron maturation. Where appropriate, Rac1 and 
ROCK will be discussed in terms of their possible, proven or closely linked roles to 
kidney development. However, as they carry out important functions in a large 
number of systems, the importance of each protein will be discussed mainly within 
the results chapters as the relevance of their functions appear. 
 
 
1.2 The kidney and its origins 
 
1.2.1 The functional importance of the kidney 
 
The kidney performs three main functions: (i) to separate wanted and unwanted 
compounds carried by the blood and (ii) to regulate the removal of excess water from 
the blood, and (iii) to recapture water from the urine (Dickinson et al 2007). The 
kidney performs its roles by acting as a filtration apparatus between the visceral 
components (blood vessels) and the tubular systems (nephrons/collecting ducts in the 
kidney) and by being highly capable of reabsorbing selected ions and small solutes. 
The actual filtration unit of the kidney is the renal corpuscle, which is a small 
capsule-like portion of the nephron. The renal corpuscle permits the very close 
interaction between a double-layered and complex basement membrane and the 
blood. This basement membrane, together with a highly adapted and unique cell type 
(the podocytes), makes up the filter that separates the blood from the epithelial 
tubule’s lumen, which eventually leads to the bladder and away from the body. The 
blood is supplied to the kidney from the aorta via the renal artery which through a 
series of subdivisions becomes the afferent arteriole which enters the glomerulus in 
the renal corpuscle (Brenner 1999).  Although the flow of metabolites and fluid from 
the blood through the glomerulus is effective, the filtration is somewhat non-
selective in that some desired molecules such as salts and water are also permitted to 
pass through the filtration. The kidney’s ability to reabsorb such molecules is 
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adjustable and thus provides it with the means to regulate salt concentrations and 
water excretion for homeostatic purposes. 
 
 
1.2.2 The origin of the kidney 
  
The epithelial components within the metanephric kidney, the collecting duct system 
and the nephrons, both originate from the intermediate mesoderm, as do all the 
epithelial kidney structures. The developmental stages that occur between the 
specification of the lineages in the intermediate mesoderm and the final stage when 
the kidney is formed, differ for the two types of epithelia. The collecting duct 
epithelium in the kidney originates from the nephric duct/Wolffian duct whereas the 
nephrons originate from the most caudal part of the nephric cord, the metanephric 
mesenchyme, reviewed by Saxen 1987. During development, the Wolffian duct 
grows in a rostral to caudal direction, adjacent to the nephric cord where it, together 
with the nephric cord, forms three sets of kidneys. Prior to the development of the 
metanephric/permanent kidney, two sets of transient kidney structures are formed, 
the pronephric kidney around embryonic day 8 (E8) and the mesonephric kidney at 
E9.5, reviewed by Saxen 1987. The pronephric and the mesonephric kidney are 
ephemeral structures in the mouse although the mesonephric kidney contributes to 
the efferent ducts and the vas deference in male animals, discussed in Saxen 1987. 
The pronephric and the mesonephric kidneys do not contribute to the final structures 
for blood filtration and excretion which is carried out by the metanephric kidney. The 
metanephric kidney forms when the Wolffian duct has elongated to a point 
perpendicular to the dorsal hind limbs at around E10-E10.5. Inductive signalling by 
glial cell-line derived neurotrophic factor (GDNF), from the adjacent medial 
metanephric mesenchyme, results in a small ureteric bud evaginating, elongating, 
penetrating and branching within the metanephric mesenchyme (Vega et al 1996; 
Sanchez et al 1996; Pichel et al 1996; Sainio et al 1997). Other genes such as 
transcription factors Sal-like 1 (Sall1) and Wilms’ Tumour 1 homologue (WT1) are 
also necessary for ureteric bud invasion and in knockouts this process fails to occur 
(Kreidberg et al 1993; Nishinakamura et al 2001). Through reciprocal signalling, the 
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ureteric bud activates the canonical Wnt-signalling pathway in the metanephric 
mesenchyme, possibly by secretion of Wingless/Ints 9b (Wnt9b), which has been 
shown to stimulate nephron formation (Carroll et al 2005; Park, Valerius, and 
McMahon 2007). These processes set the stage for the main epithelial morphogenetic 
processes that take place during kidney development and each process will be 
discussed in further detail below.  
 
 
1.3 The collecting duct system in the kidney  
 
1.3.1 The ureteric bud 
 
The collecting duct system is the mature structure that is derived from the embryonic 
ureteric bud which, as previously mentioned, forms by evagination from the 
Wolffian duct. This form of epitheliogenesis, where new epithelia forms by 
outgrowth from already existing epithelia, is relatively common during development 
and can be seen for example in the lung, prostate, and mammary glands; for reviews 
of their development see Warburton and colleagues, Timms, and Watson and Khaled 
(Warburton et al 2000; Timms 2008; Watson and Khaled 2008). The mechanisms 
that regulate the formation and the branching of the ureteric bud are largely unknown 
but some circumstantial evidence is beginning to emerge. The initial consideration is 
to understand whether the mode of ureteric bud branching lies towards producing a 
stereotypically branched structure or if the branching is a more plastic and inducible 
process. In the extreme sense this can be considered as the divide between an 
autonomous genetically stereotyped programme, versus branching morphogenesis 
that would result from the induction and inhibition by environmental factors. Early 
lung development, for example, produces a relatively stereotypic left-right 
asymmetrical pattern which is a result of the early development of the left-right body 
axis programming, as reviewed by Cardoso and Lu (Cardoso and Lu 2006). 
Drosophila tracheal development has also been shown to be regulated by several 
genes that produce a highly replicable branching pattern through time and space 
where tubule diameter, length, and branching are all determined by a genetic 
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programme, as shown and discussed by Beitel and Krasnow (Beitel and Krasnow 
2000). Superficially, normal ureteric bud formation and early development also 
follows what appears to be a fairly reproducible pattern. Ureteric bud evagination 
occurs at a highly replicable location just before E11 and forms the characteristic, 
single-branched, t-bud stage at E11.5 (Saxen 1987). However, the induction and 
branching of the ureteric bud is dependent on signalling molecules such as GDNF 
that are expressed in the metanephric mesenchyme and which are detected by 
receptors expressed by the ureteric bud, as shown and discussed by Sainio and 
colleagues (Sainio et al 1997). Growth factors can both increase (e.g. FGF7) (Qiao et 
al 1999) and decrease (e.g. BMP2) (Piscione et al 1997) branching as well as 
produce ectopic bud formation or branching in regions normally unbranched (e.g. 
GDNF) (Sainio et al 1997). This suggests that the branching morphogenesis of the 
ureteric bud is strongly modulated by its environment perhaps suggesting that the 
emphasis lies towards providing a mechanism of branching that is highly plastic. 
Some components of ureteric bud branching can however be considered as adhering 
to a genetic programme in the sense that the ureteric bud is a result of a number of 
events that predispose it to behave in a certain manner. 
 
 
1.3.2 Mechanisms of branching in the ureteric bud 
 
Several different mechanisms could act alone, or in unison, to regulate the 
development of the collecting duct system. It is important to understand how 
branching of the ureteric bud occurs since it will produce the shape of the mature 
collecting duct and also because of its close interaction with, and ability to induce, 
the metanephric mesenchyme. The pattern of ureteric bud branching ultimately leads 
to the pattern by which the nephrons will form. In this section I review some of the 
processes that are known, or considered likely, to be involved in the regulation of the 
ureteric bud morphogenesis. 
 
The evagination of the ureteric bud from the Wolffian duct represents the first of 
many branching events that the ureteric bud undergoes to create the final collecting 
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duct system. As discussed, numerous proteins have been shown to be part of the 
branching regulatory pathway in the ureteric bud. Extracellular signalling proteins 
FGF7 and FGF10, reviewed by Bates (Bates 2007), GDNF (Vega et al 1996), and 
Pleiotrophin (Sakural, Bush, and Nigam 2001), and the intracellular signalling 
protein Sprouty (Chi et al 2004) are examples of such proteins. The discovery of 
growth factors that stimulate or inhibit growth has shown a lot about how the ureteric 
bud develops but it has shown significantly less about what mechanisms produce the 
branching and growth. Trying to elucidate how the ureteric bud branch is a typical 
trap-door problem (Davies 2005). Like a trap-door, the development of a shape or a 
cell lineage is mainly unidirectional. The main type of data that can be obtained from 
a standard experiment will represent the kidney at that time-point, and it is tricky to 
determine how a branch came to be or how a nephron shape formed, as discussed by 
Srinivas and colleagues (Srinivas et al 1999). The development of a homeobox gene 
family 7b (Hox7b)-GFP mouse solved the problem to determine the mode of how the 
ureteric bud branches, at least on a macroscopic level (Srinivas et al 1999). Using 
Hoxb7-GFP mice allowed for detailed time-lapse video recording of branching 
ureteric buds in cultures (Watanabe and Costantini 2004). The authors showed that 
75% of all branching during the first 7 set of branching events occur by terminal 
bifurcations of the ureteric bud. That means that the vast majority of branching 
occurs at the most terminal points of the ureteric bud and each ureteric bud divides 
into two sub-branches. The remaining 25% of branching events took place by either 
terminal trifurcations (dividing into three), 18%, or by lateral branching, 6% 
(Watanabe and Costantini 2004). It worthwhile to keep in mind that it is possible that 
the mode of ureteric branching could change after the first 7 branch generations 
which is how long the authors investigated ureteric bud branching. In addition, the 
mode of branching that was detected in the culture conditions used by the authors 
could differ from how the ureteric bud normally branches in vivo. In the mammalian 
lung, the mode of branching alters after around 2 generations in order to continue by 
the process of clefting, as reviewed by Warburton (Warburton et al 2000).  
 
One possible mechanism for the growth of the ureteric bud, as well as for its 
branching, is proliferation. The growth of the ureteric bud has been suggested to 
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occur by the relatively rapid proliferation rates seen in the ureteric bud tips (Michael 
and Davies 2004). The mammary glands, another highly branched epithelial 
structure, have been shown to be dependent on proliferation for normal duct 
initiation (Ewald et al 2008), as has the ureteric bud (Michael and Davies 2004). 
Other recent evidence now adds additional support to the hypothesis that 
proliferation might be important for branching as was shown using mice mosaic for 
c-Ret
-/-
/Hoxb7-GFP cells and wild type cells (Shakya, Watanabe, and Costantini 
2005). C-ret, the GDNF receptor, is normally detected expressed in the ureteric bud 
tips, where one of the GDNF/c-ret functions appears to be the regulation of 
proliferation (Michael and Davies 2004; Shakya, Watanabe, and Costantini 2005). In 
the mosaic mice, c-ret deficient GFP labelled cells failed to contribute to the ureteric 
bud tips and displayed gradually reducing numbers towards branches formed during 
later generations of branching events. This inability of c-ret deficient cells to 
contribute to the tip regions might have resulted from them not expressing tip-like 
proliferation rates and therefore becoming a gradually smaller fraction of the total 
number of cells in the ureteric bud (Shakya, Watanabe, and Costantini 2005). This 
reinforces the suggestion that the majority of proliferation occurs in the ureteric bud 
tips and that this is accountable for the main proportion of growth displayed by the 
ureteric bud. However, this does not prove that proliferation rates are directly linked 
to the process of branching although the inhibition of proliferation results in reduced 
ureteric bud emergence and reduced branching (Michael and Davies 2004) and (this 
work).  
 
Cellular migration is another important process during embryogenesis. The 
possibility of motility acting as a morphogenetic mechanism in the ureteric bud 
would be attractive as it could provide insights into how tubular branching occurs. If 
cells at the ureteric bud tips are subjected to and are responsive to chemotactic 
signals then individual cells, or cells moving as a sheet or in a group, could force 
morphological changes in the epithelium which could lead to new branches forming. 
In addition, as motility can be both rapidly induced and inhibited this could provide a 
mechanism for how the spatial patterning of the ureteric bud tree is regulated. This 
would have to be highly regulated in order to affect only those regions of the ureteric 
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bud tips that are required to produce new branches. The directed migration of a 
single cell or a sheet of epithelial cells have been shown to be potent mechanisms for 
epithelial reorganisation in for example wound healing (Desai et al 2004) as well as 
during mammary gland branching (Ewald et al 2008). The metanephric mesenchyme 
is known to express Hepatocyte growth factor/Scatter factor (HGF/SF) (Woolf et al 
1995), where the HGF protein is a potent motogenic factor for epithelial cells in vitro 
(Stoker et al 1987; Weidner et al 1991). The HGF receptor, c-met has also been 
shown to be expressed by the ureteric bud (Woolf et al 1995). Interestingly, studies 
of HGF in the kidney have resulted in contradicting conclusions. Using an HGF 
antibody-inhibitor approach, Woolf and colleagues showed that kidney rudiment 
cultures exhibited reduced branching and nephrogenesis as well as increased 
apoptosis (Woolf et al 1995). In the HGF null mutant mouse on the other hand, the 
kidneys developed normally (Schmidt et al 1995). 
More direct evidence has also suggested that epithelial cells in the ureteric bud tips 
are motile. Using the Hoxb7-GFP reporter mice previously described, Watanabe and 
Costantini showed that cells in the ureteric bud tips display changes in shape and 
orientation in a very dynamic manner that is reminiscent of motile cells (Watanabe 
and Costantini 2004). Not only do the cells appear to be motile but a study looking at 
the importance of the cytoskeleton in the kidney showed that the mild disruption of 
actin filaments results in morphologically aberrant ureteric bud tips displaying what 
appears as scattering of epithelial cells from the ureteric bud tips (Michael, Sweeney, 
and Davies 2005). This was suggested to perhaps reflect a motogenic mechanism in 
the ureteric bud tips. The authors speculated that the disruption of actin might result 
primarily in the weakening of already-loose cellular junctions in the ureteric bud tips 
and that the mechanisms of motility, which demand only very short-lived and short 
actin strands, remained functional (Michael, Sweeney, and Davies 2005).  
Kim and Dressler directly claimed that cellular motility is involved during renal 
branching morphogenesis (Kim and Dressler 2007). The authors studied the protein 
Phosphatase and tensin homolog (PTEN). PTEN has been shown to be a negative 
regulator of cell motility which by reciprocal actions and localisation pattern 
counteracts the motogenic effects of Phosphatidylinositol 3-kinase (PI3K), as was 
studied in Dictyostelium (Funamoto et al 2002). PI3K phosphorylates 
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phosphatidylinositol (3,4)-diphosphate (PIP2) into the motogenic form, 
phosphatidylinosotol (3,4,5)-triphosphate (PIP3), whereas PTEN acts as a PIP3 
phosphatase, as reviewed by both Funamoto and colleagues, and  Kim and Dressler 
(Funamoto et al 2002; Kim and Dressler 2007). Firstly, Kim and Dressler  illustrated 
that Madin-Darby Canine Kidney (MDCK) cells, expressing a mutant form of the 
pten gene, showed increased chemotactic responsiveness to GDNF, whereas cells 
over expressing the wild type pten gene exhibited no chemotactic response to GDNF 
(Kim and Dressler 2007). Secondly, the authors combined the floxed mutant pten 
gene with a hoxb7-Cre gene with the result of producing mice with pten negative 
ureteric buds. The resulting ureteric buds displayed abnormally shaped tips with 
irregular basement membranes. Due to the results obtained from the MDCK cells, 
the authors interpreted these results as evidence that a mechanism of cell migration is 
present during ureteric bud branching morphogenesis and the disruption of this, leads 
to the aberrant ureteric bud tips. However in an earlier publication, Martin-Belmonte 
and colleagues revealed an alternative explanation for the abnormal phenotype 
observed in the pten negative ureteric buds (Martin-Belmonte et al 2007). Martin-
Belmonte and colleagues used MDCK cysts to study the development of polarity 
during cyst development. Their findings show that repressing PTEN production or 
inhibiting existing PTEN resulted in abnormal formation of the apical surface of 
MDCK cysts (Martin-Belmonte et al 2007). The same result could be achieved by 
interfering with Annexin 2, cell division cycle 42 (Cdc42) and atypical protein kinase 
C (aPKC) (Martin-Belmonte et al 2007). It was thus speculated that the localisation 
of PTEN to the apical surface of cells during cystogenesis, results in an apical 
accumulation of PIP2, which results in the recruitment of PIP2 binding protein 
Cdc42 (Martin-Belmonte et al 2007). Cdc42 binds aPKC/Par6, proteins known to be 
involved in the production of polarity (Martin-Belmonte et al 2007). Importantly, 
Rac1, a central protein in motility, regulation did not localise in a manner similar to 
Cdc42 which could suggest that their roles are different (Martin-Belmonte et al 
2007). These results provide an interesting interpretation to the results obtained by 
Kim and Dressler in 2007 and demonstrates the importance to further elucidate 
whether motility plays a role during branching morphogenesis. 
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Epithelial morphogenesis can also be regulated by the contraction of actin-bands 
through processes that are not necessarily connected to migration. Actin-myosin 
contraction can lead to large-scale epithelial changes, as for example during 
Drosophila ventral furrow invagination (Nikolaidou and Barrett 2004; Fox and Peifer 
2007). Another example of this type of morphogenesis can be found during the 
initiation of sea urchin gastrulation, where RhoA has been shown to be essential for 
the initial stages of invagination during archenteron formation (Beane, Gross, and 
Mcclay 2006). High amounts of apical actin have been demonstrated in the ureteric 
bud tips (Fisher et al 2001; Michael, Sweeney, and Davies 2005) as well as apical 
localisation of myosin (Meyer et al 2006). Interestingly, these actin bands disappear 
as a result of inhibition of both GDNF (Michael, Sweeney, and Davies 2005) as well 
as direct inhibition of the Erk/MAPK pathway (Fisher et al 2001). Branching 
morphogenesis in the kidney is highly disrupted by both the inhibition of actin-
myosin contraction via inhibition of Rho-kinase as well as by direct inhibition of 
actin polymerisation (Michael, Sweeney, and Davies 2005). It is has not yet been 
determined whether these effects are a result of abnormal actin-myosin function in 
the ureteric bud tips.  
 
Proliferation, migration and cytoskeletal rearrangements are some of the most 
favoured models for ureteric bud branching morphogenesis. There are other possible 
mechanisms such as, clefting and convergent extension, that could regulate 
branching and elongation. This is an area of kidney development that needs 
significantly more investment in terms of time and effort in order to provide a clearer 
picture of the machinery involved.  
 
 
1.3.3 Ureteric bud branching and cellular differentiation 
 
The branching of the ureteric bud occurs mainly by terminal bifurcation (Watanabe 
and Costantini 2004). The preference to branch at the ureteric bud tips does not 
necessarily mean that the ability to branch is restricted to these areas of the ureteric 
bud; it just shows where branching occurs. The ureteric bud tips express genes that 
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display a strongly tip-restricted expression pattern, c-ret (Pachnis, Mankoo, and 
Costantini 1993) as well as Wnt11 and sex-determining region Y (SRY) box 9 (Sox9) 
are good examples, as reviewed by Michael, Sweeney and Davies (Michael, 
Sweeney, and Davies 2007). This regionalised expression of specific genes in the 
ureteric bud tips has previously been suggested to indicate that this is the region 
where the capability to branch is maintained (Michael, Sweeney, and Davies 2007). 
Significantly, this region correlates with the area previously defined to display 
elevated proliferation rates (Michael and Davies 2004; Michael, Sweeney, and 
Davies 2007). Recently a study was carried out to determine whether β-catenin might 
be important for the ureteric bud, considering the expression of numerous Wnts in 
the kidney. The ureteric bud expresses and is subjected to several Wnt proteins that 
could potentially signal through the canonical Wnt-signalling pathway, thus 
regulating the transduction of β-catenin signalling. The Wnt-signalling pathways will 
be described in further detail in this chapter in relation to nephron induction. This 
study crossed conditional β-catenin mutant mice with mice carrying the Hoxb7-Cre, 
thus removing β-catenin from the Wolffian duct and the ureteric bud (Marose et al 
2008). These mice displayed some interesting phenotypes. The authors showed that 
the ureteric buds that invaded the metanephric mesenchyme failed to branch properly 
(Marose et al 2008). β-catenin mutant ureteric buds lost the expression of ureteric 
bud tip markers such as Wnt11, Sox9 and c-Ret, and prematurely initiated expression 
of collecting duct/stalk maturation markers such as zona occludens α1+ (ZO1α1+) 
and Aquaporin 3 (Marose et al 2008). In addition, the expression of a non-degradable 
and stable form of β-catenin protein, in the ureteric bud, resulted in the failure of the 
ureteric buds to express maturation markers such as Aquaporin 2 and 3 (Marose et al 
2008). The authors thus accredited the abnormal branching to be a result of a failure 
in the ureteric bud to maintain the undifferentiated cell identity normally found in the 
ureteric bud tips (Marose et al 2008). Exactly which molecular mechanism it is that 
drives this tip-concentrated β-catenin signalling, is yet to be determined, however 
Wnt11 is known to display tip-specific expression (Kispert et al 1996) and could be a 
potential regulator of β-catenin degradation. Wnt11 mutants have been shown to have 
a disrupted branching morphology, although this has partially been attributed to 
reduced GDNF/c-ret signalling (Majumdar et al 2003).  
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A somewhat neglected, but equally possible, scenario is that a mutation of β-catenin 
might affect cell-cell junctions. β-catenin protein was originally considered, solely to 
be a component of adherens junctions where it forms a complex with α-catenin and 
E-cadherin and links the junctions to the cytoskeleton, reviewed by Niessen and 
Gottardi (Niessen and Gottardi 2008). It was only when it was discovered to be 
involved in Wnt-signalling that the focus somewhat shifted, as reviewed by Gavard 
and Mège (Gavard and Mege 2005). A loss of β-catenin protein could result in 
abnormal or failure of adherens junction formation since β-catenin has been shown 
not only to shield cadherins from degradation but also to provide stability through 
cytoskeleton linkage, reviewed by Niessen and Gottardi (Niessen and Gottardi 2008). 
 
Interestingly, the ability of tip cells to differentiate in a tip-to-stalk direction has been 
shown to be bidirectional by demonstrating the ability of stalk cell to revert towards 
a tip cell identity (Sweeney, Lindström, and Davies 2008). These data are briefly 
explained here and a copy of the publication has been included in Appendix 1. These 
data are not presented as a results chapter since its focus is not directly in line with 
the theme of this thesis and because the data does not stand as a story without the 
data contributed by the other authors. In this article we have demonstrated that stalk 
regions of the ureteric bud, which have lost the expression of tip markers and 
differentiated into a stalk state, as shown by the gain of stalk markers, are capable of 
reverting from a ureteric bud stalk identity to the ureteric bud tip identity (Sweeney, 
Lindström, and Davies 2008). These reverted cells produce new tips that regain the 
expression of Wnt11 were are able to undergo branching morphogenesis and induce 
nephron formation in a typical fashion (Sweeney, Lindström, and Davies 2008). The 
work by Marose and colleagues could provide a possible molecular mechanism for 
how the identity-reversal works (Marose et al 2008). A possibility is that β-catenin 
signalling might be important for the stalk-to-tip identity reversal as well as for the 
maintenance of the tip-identity. Future experiments should aim at determining 
whether the β-catenin signalling plays a role during the reversal of stalk cells into tip 
cells or if the β-catenin signalling is only initiated at a stage when this process has 
already begun. This would establish whether β-catenin signalling is a primary 
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regulator of tip-identity of if it is a downstream effector initiated as a response by the 
acquisition of a tip-identity.   
 
 
1.4 The Nephrons 
 
1.4.1 Nephron development: major stages and processes 
 
The formation of nephrons occurs by a very different mechanism compared to that 
regulating ureteric bud induction. Nephrons form by the process of mesenchymal-to-
epithelial transition. Mesenchymal-to-epithelial transitions are a rarer form of 
epitheliogenesis compared to that used for the formation of the ureteric bud, although 
they are seen in for example somitogenesis where each somite develops clear 
boundaries by a layer of cells transiting from a mesenchymal to epithelial state, as 
reviewed by Takahashi and colleagues (Takahashi et al 2005). A mesenchymal-to-
epithelial transition entails a more fundamental reorganisation of the cells, compared 
to the evagination of a bud from already existing epithelia. The transiting 
mesenchymal cells are required to acquire an apicobasal polarity as well as to 
express new genes such as the structurally important protein cytokeratin and to 
develop junctional adhesion complexes. In addition, as a result of becoming 
epithelial, the cells deposit a basement membrane.  
 
In this thesis, the development of the nephron is discussed in the order of the main 
structural stages through which each nephron progresses during development. 
Nephron formation is a sequential process and as a result, during development, new 
nephrons are continuously induced to form and mature. This means that, at any given 
time-point subsequent to the initial nephron induction, the kidney consists of an 
ordered pattern of nephrons at different developmental stages. The detail in which 
nephron induction and development is discussed herein is necessary because a large 




1.4.2 Stage 1: Cap Mesenchyme 
 
The cap mesenchyme is the structure containing the nephron progenitor cells. The 
nephron progenitor cells are nephron stem cells that possess the potential for self 
renewal as well as being able to produce a large number of different types of cells 
within the adult nephron (Kobayashi 2008). It is not clear when the progenitor cell 
population is defined and whether there can be recruitment from the metanephric 
mesenchyme into the cap mesenchyme once this population has formed. It is also not 
known if the cap mesenchyme is a homogenous population of cells of if sub-
populations exist which might already be programmed for the specific contribution to 
particular nephron segments. 
 
The term ‘cap mesenchyme’ refers to the mesenchymal cells directly surrounding the 
ureteric bud tips. The cap mesenchyme is characterised by the presence of several 
proteins, for example Neural Cell Adhesion Molecule (NCAM), Sine oculis-related 
homeobox 2 (Six2), Wilms’ tumour 1 homologue (WT1) and Paired box 2 (Pax2) 
(Klein et al 1988a; Plachov et al 1990; Armstrong et al 1993; Self et al 2006). 
Structurally, the cap mesenchyme appears almost columnar and somewhat epithelial 
as is shown by the cells ‘polarisation’ towards the ureteric bud tips (see Fig.3.3 in 
Chapter 3). This might be a manifestation of the high amounts of adhesion molecules 
expressed by these cells such as NCAM (Klein et al 1988a). The cap mesenchyme 
contains nephron progenitor cells. Six2 expression has been closely linked to this 
population of progenitors, as knockouts of Six2 appear to result in the loss of the 
progenitor cell’s ability to self-renew and the cells start to differentiate (Self et al 
2006). Such Six2 deficient progenitor cells do however maintain their ability to 
become induced and form nephrons and, in fact, ectopic nephron formation occurs 
surrounding the ureteric bud tips, which  suggests that all the progenitor cells 
proceed toward a nephron fate (Self et al 2006). The closeness of the cap 
mesenchyme to the ureteric bud tips ensures that this population of mesenchymal 
cells is subjected to nephron inducing signalling molecules secreted by the ureteric 
bud, for example Wnt9b (Carroll et al 2005). Several key components have been 
identified that are important for the induction of nephron formation, for example, 
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Wnt4 and WT1 (Stark et al 1994; Davies et al 2004), also discussed by Park, 
Valerius and McMahon (Park, Valerius, and McMahon 2007). The first aspect of 
nephron induction that will be discussed, here is Wnt signalling, which in recent 
years has been shown to be essential for the initial steps of nephrogenesis. 
 
 
1.4.3 Wnt signalling in the kidney 
 
A large number of Wnt genes are expressed during kidney development, as shown 
below in Table 1.1. and in Diagram1.1 Wnt signalling can be divided into two main 
fractions: (1) the canonical/β-catenin-dependent pathway; (2) the non-canonical/β-
catenin-independent pathway, as reviewed by Slusarski and Pelegri (Slusarski and 
Pelegri 2007), see Diagram1.2. Perhaps most important for this thesis, is the planar 
cell polarity which has been shown to act via Rho-kinase (Habas, Dawid, and He 
2003). The importance of Wnt signalling for the kidney has been emerging for a long 
period of time and it appears that they play a pivotal role during kidney development 
and thus deserve a fairly detailed introduction. 
 
Wnt Expression Function Reference 
Wnt2b Stroma Ureteric bud branching (Lin et al 2001) 
Wnt4 Nephrons Nephron formation (Stark et al 1994) 
Wnt6 Ureteric bud stalk Nephron induction (Itaranta et al 2002) 
Wnt7b Mature collecting duct Unknown  (Kispert et al 1996) 
Wnt9b Ureteric bud stalk Nephron induction (Carroll et al 2005) 
Wnt11 Ureteric bud tip Ureteric bud branching (Kispert et al 1996; Majumdar et al 
2003) 
Table 1.1 Important Wnt genes expressed in the metanephric kidney. 
 
A number of papers have begun to dissect out how the Wnt signalling pathways 
regulate kidney development (Park, Valerius, and McMahon 2007; Kuure et al 2007; 
Schmidt-Ott et al 2007; Schmidt-Ott and Barasch 2008; Marose et al 2008). The Wnt 
signalling pathways share a common element in that they all act through the trans-
membrane receptor Frizzled. This is also where a divergence is seen. Through 
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activation of Frizzled, the canonical pathway continues by activating Dishevelled and 
inhibiting the β-catenin degradation complex; the non-canonical pathway splits into 
the Dishevelled-dependent activation of Rho pathways and Rac1-Jun N-terminal 
Kinase (JNK) pathways that regulate planar cell polarity as well as the Dishevelled-
independent pathway that regulates calcium release and activates calcium dependent 
processes in addition to protein kinase C. For further information, see the reviews by 
Clevers for a description of the canonical pathway (Clevers 2006), Wang and 
Nathans for the planar cell polarity (Wang and Nathans 2007) and Slusarski and 

















Diagram1.1 Wnt expression in relation to the embryonic kidney structures.  



























1.4.4 Canonical Wnt signalling: the β-catenin pathway in the kidney. 
 
The Wnt/β-catenin signalling pathway is known to regulate many cellular processes 
including, proliferation, cell survival and adhesion, as discussed by Marose and 
colleagues (Marose et al 2008). In the canonical Wnt pathway, Wnt binds to Frizzled 
and phosphorylated Dishevelled which in turn phosphorylates glycogen synthase 
kinase 3 Beta (GSK3β); this process leads to the recruitment of Axin to the 
Frizzled/low density lipoprotein receptor-related protein 5/6 (LRP5/6) membrane 
complex and as a result the disruption of the β-catenin destruction complex, as 
reviewed by Clevers, and by Schmidt-Ott and Barasch (Clevers 2006; Schmidt-Ott 
and Barasch 2008) The inhibition of the β-catenin degradation complex means that 
stable β-catenin can translocate to the nucleus and bind to members of the 
transcription factor family TCF/LEF, which regulates the cellular processes 
described here. 
The β-catenin pathway has long been proposed to function in the kidney. Initial 
research showed that mimicry of Wnt signalling using GSK3β-inhibiting lithium 
ions, can drive nephron induction in culture (Davies and Garrod 1995). Since then, 
three major papers have demonstrated that the β-catenin signalling pathway is 
necessary and sufficient for nephron induction (Park, Valerius, and McMahon 2007; 
Kuure et al 2007; Schmidt-Ott et al 2007). These investigations demonstrated three 
major things. Firstly, the specific activation of β-catenin signalling using the 
expression of a stable mutant form of β-catenin in the nephron progenitor population 
of cells, as defined by Six2 expression (Self et al 2006), results in the induction of 
these cells to become nephrons (Park, Valerius, and McMahon 2007; Kuure et al 
2007). Secondly, the specific knockout of β-catenin in the same population of cells 
results in a complete loss of nephron induction (Park, Valerius, and McMahon 2007). 
Thirdly, during the transition period between un-induced cap mesenchyme and 
induced mesenchyme, a set of genes regulated by the β-catenin/TCF/LEF pathway is 
activated; a process that can be interrupted by the expression of a dominant negative 
form of TCF (Schmidt-Ott et al 2007). An interesting effect of the continuous 
activation of β-catenin signalling in the Six2 positive progenitor cells, is that this 
effectively inhibits the transition from a mesenchymal to epithelial state (Park, 
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Valerius, and McMahon 2007). This shows that β-catenin signalling is a necessary 
process during the induction of nephron formation but is required to be reduced for 
the completion of nephron formation. This was previously shown by Davies and 
Garrod who demonstrated that the induction of nephrons using lithium was more 
efficient if lithium was only present during the initial 24 of culturing, although the 
connection with Wnt-signalling was not made (Davies and Garrod 1995). In order to 
further the understanding of β-catenin signalling two questions need immediate 
attention: (1) What activates the β-catenin signalling pathway in the progenitor cells? 
(2) What maintains the progenitor cell population? Likely candidates for the 
induction of the β-catenin signalling are Wnt9b and/or Wnt6 which have been shown 
to be expressed by the ureteric bud and are necessary and sufficient to inducing 
nephron formation (Itaranta et al 2002; Carroll et al 2005), see table 1.1. Not only do 
these Wnts induce nephron formation but their expression starts in the correct 
location on the tip/stalk border where nephron formation normally takes place 
(Itaranta et al 2002; Carroll et al 2005). A large number of Wnts have been 
demonstrated to be sufficient for induction of nephrogenesis. Wnt1, Wnt3a, Wnt4, 
Wnt7a and Wnt7b were all tested and shown to induce nephron formation by co-
culturing of metanephric mesenchyme and Wnt expressing National Institutes of 
Health 3T3 (NIH3T3) cells (Kispert, Vainio, and McMahon 1998). It is noteworthy 
to mention that other proteins such as R-spondins are also capable of inducing the 
canonical β-catenin pathway, reviewed by Clevers (Clevers 2006). R-spondin 1 and 3 
are both present in the metanephric mesenchyme during kidney development (Nam, 
Turcotte, and Yoon 2007). 
 
As previously noted, it is also important to mention that β-catenin can also act as a 
component that is necessary for adherens junctions, reviewed by Gavard and Mège 
(Gavard and Mege 2005). In fact, it has been demonstrated that Wnt signalling can 
regulate a kidney specific cadherin, cadherin-6, in Madin-Darby Canine Kidney 
cells, a property that could have major impacts on nephron behaviour (Stewart, 
Barth, and Nelson 2000). It is possible that the necessity of β-catenin could very well 
be a result of abnormal adherens junctions, in particular since the nephron has been 






























Diagram1.2 Canonical and Non-Canonical Wnt-signalling. 
The diagram is based on references cited in the text. 
 
 
1.4.5 Non-canonical Wnt signalling: the Planar Cell Polarity and the Calcium-
pathways in the kidney 
 
The non-canonical pathways have two major branches: the planar cell polarity 
pathway and the calcium pathway, which are both activated by Wnt binding to 
Frizzled, discussed by Habas, David and He as well as by Slusarski and Pelegri 
(Habas, Dawid, and He 2003; Slusarski and Pelegri 2007). The calcium pathway acts 
via phospholipase C (PLC) which promotes the conversion of phosphatidylinositol-
4,5-biphosphate (PIP2) into inositol-1,4,5-triphosphate (IP3) and diacylglycerol 
which stimulate calcium release and activation of PKC, respectively, reviewed by 
Slusarski and Pelegri (Slusarski and Pelegri 2007). The release of calcium results in 
the activation of calcium-dependent proteins such as calcium/calmodulin-dependent 
kinase II (CamKII) and the activation of nuclear factors of activated T cells (NFATs) 
(Slusarski and Pelegri 2007). Both calcium as well as NFATs are capable of 
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inhibiting the canonical Wnt-signalling pathway (Slusarski and Pelegri 2007). The 
importance of NFATs in the kidneys is currently being investigated in the kidney, as 
so far very little is known (Burn, S. personal communication). As mentioned earlier, 
the planar cell polarity is perhaps more relevant for this work. The planar cell 
polarity is a different type of polarity compared to the apicobasal polarity. Whereas 
apicobasal polarity refers to the polarity across an individual cell, planar polarity is 
the polarity that is found along the axis of the epithelium (Davies and Garrod 1997). 
The majority of molecular components in the planar cell polarity pathways were 
identified in Drosophila, however a recent review by Wang and Nathans gives an 
excellent summary of the vertebrate system (Wang and Nathans 2007). The planar 
cell polarity pathway is not exclusively activated by the Wnt/Frizzled pathway but 
can also be regulated via a set of protocadherins as is discussed below. The 
Wnt/Frizzled planar cell polarity pathway has been shown to work in Human 
Embryonic Kidney 293 (HEK293) cells via the independent activation of both the 
RhoA and Rac1 through Dishevelled, where Rac1 activates Jun N-terminal Kinase 
(JNK) (Habas, Dawid, and He 2003). In vivo experiments have demonstrated that the 
same mechanism is important for Xenopus gastrulation and convergent extension 
(Habas, Dawid, and He 2003). 
 
Evidence is emerging that both of the planar cell polarity pathways affect kidney 
development. Using a kidney progenitor cell culture system, Osafune and colleagues 
demonstrated that inhibition of either JNK1, JNK2 or Rac1 resulted in smaller 
cultures when inhibited in either whole kidney cultures (JNK1 and JNK2 only) or 
nephron progenitor cell cultures (JNK1, JNK2 and Rac1) (Osafune et al 2006). On 
the contrary, activation of Rac1 resulted in large cultures; the same was seen by 
inhibition of Rho-kinase or RhoA (Osafune et al 2006). Interestingly, inhibition of 
JNK1 or JNK2 resulted in a reduction in the number of progenitor cell cultures that 
expressed markers indicative of fully epithelialised cells which suggested that JNK1 
and JNK2 might be important for the transition from a mesenchymal to epithelial 
state (Osafune et al 2006). Inhibition of JNK1 or JNK2 did not however disturb 
ureteric bud morphology, and the kidneys displayed size-wise proportionally normal 
numbers of branches (Osafune et al 2006). The authors concluded that a planar cell 
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polarity pathway is used in the kidney to regulate kidney and nephron size, however, 
the authors unfortunately did not look at effects on nephron size in whole cultures 
nor did they determine whether the planar cell polarity pathway affected proliferation 
rates. This is an important point, as the differences in culture sizes could well be a 
result of cell size rather than cell number.  
 
The protocadherin planar cell polarity pathway, or the Dachsous system, has also 
been observed during kidney development. This pathway functions via the 
protocadherins Fat and Dachsous in addition to a protein Four-jointed, where 
Dachsous is antagonist of Fat, which in turn is an inhibitor of Four-jointed 
transcription (Casal, Lawrence, and Struhl 2006; Wang and Nathans 2007; Saburi et 
al 2008). The protocadherin planar cell polarity pathway appears to function 
independently of the Wnt/Frizzled pathway and its polarity is set up based on cellular 
variations in the concentration of Dachsous and Fat (Casal, Lawrence, and Struhl 
2006). This planar cell polarity pathway has in fact been demonstrated to be an 
important regulator for collecting duct and nephron morphogenesis (Saburi et al 
2008). Mutants of Fat4 display shortened and bloated collecting duct systems as well 
as dilated tubules within the nephron (Saburi et al 2008). Combinations of Fat4 
mutants and mutants of either van Gogh-like 2 (Vangl2) or Four-jointed results in 
more severe but consistent phenotypes (Saburi et al 2008). The formation of dilated 
cystic tubules appears to be a result of a disruption in the mechanism that regulates 
the orientation of cell division (Saburi et al 2008). Normally, in the kidney, the 
majority of cell division are in the plane of the epithelium (Fischer et al 2006). This 
orientation was shown to be disrupted in mice displaying polycystic kidney disease 
(Fischer et al 2006) as well as in the Fat4 mutants (Saburi et al 2008). Significantly, 
the distorted tubule morphology and cystogenesis did not lead to aberrant cellular 
differentiation, suggesting a structural organisational defect rather than a genetic one 
(Saburi et al 2008).  
  
To gain a better understanding of how all types of Wnt signalling might regulate 
nephron induction, it is important to formally show that the β-catenin pathway is 
activated by Wnt signalling. Although, both β-catenin-dependent signalling and 
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planar cell polarity pathways have been shown in the kidney, it is still necessary to 
determine which Wnt signalling molecules activate these cascades since other 
signalling molecules such as R-spondins are also capable of binding and activating 
Frizzled, reviewed by Clevers (Clevers 2006).  
 
 
1.4.6 Stage 2: Pretubular Aggregates towards Renal Vesicles 
 
The pretubular aggregates form as a result of nephron induction (Saxen 1987). The 
pretubular aggregates are small cellular clusters of the cells from the cap 
mesenchyme which have received an inductive signal and are progressing towards a 
nephrogenic fate. A key marker for the pretubular aggregate stage is Wnt4 
expression. Wnt4 has long been known to be a crucial regulator of nephron 
development and Wnt4 mutants arrest their nephrogenic development at around the 
stage of pretubular aggregate formation, which correlates well with the onset of Wnt4 
expression in the nephron (Stark et al 1994). The formation of the pretubular 
aggregates can be seen as the first structurally defined population of cells that will 
contribute to the nephrons; however, it is not known how these cells are selected and 
how they segregate out from the other cells in the cap mesenchyme which also 
receive the inductive signals from the ureteric bud. Recently, large scale microarray 
experiments have been carried out in order to characterise the genes that are 
important during the transition from pretubular aggregate stage to renal vesicle stage 
(Valerius and McMahon 2008). In the analysis by Valerius and McMahon, the 
authors performed microarray analyses of whole kidneys from E14.5 embryos of 
wild type and Wnt4 mutant genotypes (Valerius and McMahon 2008). Unfortunately, 
as the microarray experiments were carried out on E14.5 kidneys, the wild type 
samples contained nephrons far beyond the renal vesicle stage, thus limiting the 
analysis somewhat. Why Wnt4 mutants arrest at the pretubular aggregate stage is not 
known, and it has been suggested that Wnt4 might not be as essential to renal vesicle 
formation as others have reported since a few nephrons are sometimes detected in 
Wnt4 mutant mice (Kobayashi et al 2005). Other genes that are necessary for the 
progression towards the renal vesicle stage are genes coding for structural 
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components such as α6β1 integrin and α-laminin which both have been shown to be 
important for nephron formation (Klein et al 1988b; Sorokin et al 1990). α6β1 
integrin and α-laminin protein are to a large extent similar in their pattern where both 
are detected at a stage preceding the epithelialisation of the mesenchymal cells, 
although whereas α-laminin is exclusively detected on the basal surfaces of 
epithelialising cells, α6-integrin is also found on the lateral and apical surfaces 
(Sorokin et al 1990). Inhibition of α-laminin and/or α6-integrin results in the arrest of 
nephron development at a pretubular aggregates stage and no polarised cells are 
formed (Klein et al 1988b; Sorokin et al 1990). These are interesting results because, 
rather than simply showing the necessity for a particular gene during nephron 
development, these studies determined the need for proteins that are important for 
structural processes such as adhesion, cell-matrix binding and apicobasal polarity 
formation during renal vesicle formation.  
 
The renal vesicle represents the first epithelial structure of the nephrons. The 
formation of the renal vesicle from the pretubular aggregates requires the transition 
from a mesenchymal cell type into an epithelial type. To comprehend the 
mesenchymal-to-epithelial transition during nephrogenesis it is necessary to 
appreciate some of the changes that the cells are required to undergo during this 
transition (Davies and Garrod 1997). In an attempt to define what makes a cell 
epithelial, Davies and Garrod came to the conclusion that no specific gene or protein 
can fully define a single cell as being either epithelial or mesenchymal (Davies and 
Garrod 1997). However, the properties that a set of cells possess as a whole can 
generally be defined as epithelial or mesenchymal (Davies and Garrod 1997). The 
renal vesicle fulfils many of the criteria for being epithelial although a very immature 
epithelium. Of major interest and importance to the nephron is the development of 
three cellular polarities; the apical, basal and lateral. It is not known in what order 
these polarities develop in the nephron, although α-laminin and NCAM demarcates 
the basal surfaces and the lateral sides from a very early stage, respectively (Klein et 
al 1988a; Klein et al 1988b). NCAM is found at high amounts in the renal vesicle 
and in the pretubular aggregates, but it is also found in the condensed mesenchyme at 
levels that are relatively uniform to those in the nephron structures (Klein et al 
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1988a). Knockouts of NCAM are viable and, though they do have non-kidney 
phenotypes, no effects are reported in the kidney (Cremer et al 1994). According to 
electron microscopy studies carried out on rabbit renal vesicles, tight-junctions are 
present from an early stage but are found along the whole of the lateral surface and it 
is only at later time-points that the localisation is restricted towards the apical portion 
of the lateral surface (Minuth, Schiller, and Taugner 1981). In mature epithelia, tight-
junctions are otherwise a good marker for the apical surface (Davies and Garrod 
1997). In terms of cadherins, both E-cadherin and cadherin-6 are detected in the renal 
vesicle (Cho et al 1998), however, the disruption of cadherin-6 results in no major 
phenotypes except that cadherin-6 mutant mice show a slight delay in the 
mesenchymal-to-epithelial conversion and some problems with fusing to the ureteric 
bud (Mah et al 2000). The apical surface of the renal vesicle faces the inside, or 
luminal surface of the cyst and proteins that displays an apically restricted 
localisation in the renal vesicle, such as gp330/α2-macroglobulin receptor associated 
protein (Abbate et al 1994), are rare. Even the gp330/α2-macroglobulin receptor 
associated protein is not an ideal marker as it is also found within the cytoplasm and 
in cytoplasmic vacuoles (Abbate et al 1994). Desmosome components, desmoplakin 
1 and 2, have been shown to present from a very early stage (Garrod and Fleming 
1990). In the renal vesicle, they display a stronger localisation towards the apical 
surface, although they are still present basally (Garrod and Fleming 1990). The 
progression of the nephrons from a mesenchymal to epithelial cell state is gradual as 
has been demonstrated using several epithelial markers (Davies and Garrod 1995). It 
is only to be expected that the acquisition of a properly defined apicobasal axis will 
also be occurring gradually as the cells gain more functions and a greater need for a 
developed polarity. The most developed polarity of the renal vesicle is the basal 
polarity where α-laminin is rapidly deposited during epithelialisation (Klein et al 
1988b). 
 
In order to provide a morphological basis for the introduction to the nephron 
development around and beyond the renal vesicle stage, a series of images show the 
development that a nephron goes through (Fig.1.1). The greyscale images were 
obtained from Potter’s excellent work Normal and Abnormal Development of the 
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Kidney (Potter 1972), p.46-47, and show the early human nephrogenesis from renal 
vesicle stage, through comma-shape body stage and until s-shape body stage. Images 
1-8 are in the order of development and the stage is specified for each image. These 


























Fig.1.1 Human Renal Vesicle to S-shaped Body stage. 
Original greyscale images were obtained and adapted entirely from p.46-47 (Potter 1972). Nephron 
stages are in order and are specified in blue text. The nephron borders are marked with red dashed 
lines. Letters ‘A’, ‘B’, and ‘C’ should be ignored. 
renal vesicle renal vesicle 








The second polarity of the renal vesicle is a planar polarity. It is interesting to note 
that whereas the renal vesicle is immature in terms of its apicobasal axis, the planar 
polarity is already quite defined although not fully developed. The planar polarity of 
the renal vesicle is the same as the proximal-distal polarity of the nephron. The 
proximal-distal axis of the nephron is based on the terms used in the mature nephron 
where the nephron segments are either near or far from to the glomerulus. In the 
renal vesicle this nomenclature is confusing because the glomerulus has not yet 
developed and it is likely that the most important signalling centre for the nephron is 
the ureteric bud since the renal vesicle’s proximal-distal axis is always oriented so 
that the distal nephron portion is nearest to the ureteric bud. Interestingly, nephrons 
can still initiate proximal-distal axis formation if induced by an ectopic source and 
without the orienting guidance of the ureteric bud (Davies and Garrod 1995; Kispert, 
Vainio, and McMahon 1998). In the mature nephron at least 8 molecularly defined 
regions are detectable between the glomerulus and the collecting duct (Raciti et al 
2008). At renal vesicle stage, at least two genetically distinct domains exist; the distal 
domain and the proximal domain which contains glomerular progenitors.  
 
Numerous proteins display entirely restricted or elevated detection in the distal 
domain, for example, E-cadherin (Cho et al 1998), LIM homeobox 1 (Lim1/Lhx1) 
(Kobayashi et al 2005; Cheng et al 2007)  and Brn1/ POU transcription factor class 3 
(Brn1/Pou3f3) (Nakai et al 2003), and several genes have been shown to be 
expressed mainly in the distal regions, for example, Bone morphogenetic protein 2 
(BMP2), Dickkopf homologue 1 (Dkk1), Gene regulated by oestrogen in breast 
cancer protein 1 (Greb1) and Jagged 1 (Jag1) (gudmap.org). A smaller number of 
proteins have so far been shown to be primarily localised to proximal regions 
although WT1 (Huber et al 2000)(gudmap.org) and cadherin-6 (Cho et al 1998) are 
excellent examples. It is possible that the cells within the pretubular aggregates 
already possess some form of polarised pattern and that this only becomes 
sufficiently clear in the renal vesicles when the cells are sufficiently structured. The 
orientation of the proximal-distal axis is likely be a function of the ureteric bud as the 
nephrons align in a stereotyped fashion towards the bud. Knockouts of Six2 display 
ectopic nephron formation on the renal capsule facing side of the ureteric buds and in 
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spite of this the majority of ectopic nephrons display normal proximal-distal axis 
alignment towards the ureteric bud (Self et al 2006), reviewed by Kopan, Cheng and 
Surendran (Kopan, Cheng, and Surendran 2007). The Six2 knockout nephrons do 
however sporadically show a proximal-distal axis confusion, where segment specific 
markers display expanded regions of overlap (Self et al 2006). This does suggest that 
the nephrons themselves also possess a mechanism to arrange their orientation, 
although it could just be a mechanism that responds to cues from the ureteric bud. 
The nephrons are however capable of producing normal proximal-distal axes entirely 
in the absence of the ureteric bud. As previously mentioned, the expression of Wnts 
from NIH3T3 cells can induce the metanephric mesenchyme to generate typically 
patterned nephrons (Kispert, Vainio, and McMahon 1998). This suggests that the 
nephrons are capable of organising their proximal-distal axes, although the ureteric 
bud can probably influence the direction of the axis.  
 
 
1.4.7 Stage 3: Comma-Shaped and S-Shaped Nephrons 
 
In the progression from renal vesicles to comma-shaped bodies, nephrons are 
dependent on different genes to those in earlier stages. Transcription factors Lim1 
(Kobayashi et al 2005) and WT1 (Armstrong et al 1993), extracellular signalling 
protein Wnt4 (Stark et al 1994; Kobayashi et al 2005) and growth factor FGF8 
(Grieshammer et al 2005) are all likely to be important at this stage. Conditional 
Lim1 knockout mice with a deletion of Lim1 in the metanephric mesenchyme have 
been shown to allow nephron development to progress until the renal vesicle stage 
but no further (Kobayashi et al 2005). Lim1 is expressed in the whole of the 
pretubular aggregates and renal vesicles and show restricted expression in the 
comma- and s-shaped bodies and in the immature podocytes (Kobayashi et al 2005). 
Interestingly, in chimaeras of Lim1 knockout cells and wild type cells the Lim
-/-
 cells 
are capable of contributing to the entire pretubular aggregates but not to the distal 
domains of the renal vesicles, nor the maturing podocytes (Kobayashi et al 2005). 
Lim1
-/-
 cells were gradually restricted until they eventually only remained within the 
parietal epithelium (Kobayashi et al 2005). The exclusion of Lim1
-/-
 cells from the 
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distal portion of the renal vesicle corresponds well with the findings that this is the 
nephron stage where Lim1 is initially required since the conditional Lim1
-/-
 mutants 
arrested their nephrogenic development at this stage. Another gene that has been 
shown to be essential for renal vesicle development is fgf8, which is expressed in the 
pretubular aggregates and in the distal portion of the renal vesicles (Grieshammer et 
al 2005). In the s-shaped body, fgf8 expression is detected in the entire tubular region 
of the nephron but is not expressed in the parietal or visceral epithelia (Grieshammer 
et al 2005). Conditional fgf8 mutant mice with no fgf8 expression in the metanephric 
mesenchyme do not express Wnt4 or Lim1 and do not progress beyond the renal 
vesicle stage (Grieshammer et al 2005). Of interest is that these nephrons progress 
until renal vesicle stage despite not expressing Wnt4, which previously has been 
considered essential for the mesenchymal-to-epithelial transition of the nephrons. 
The authors speculate that perhaps FGF8 is required to maintain Wnt4 expression 
and the initial Wnt4 expression comes on at a very low level that only permits the 
transition to take place but subsequent development is halted (Grieshammer et al 
2005). Fgf8 was also shown to be important for the promotion of cell survival in the 
progenitor cell population (Grieshammer et al 2005). Conditional WT1 mutations 
with a deletion of WT1 expression in the metanephric mesenchyme have also been 
made (Hohenstein, P. Unpublished). Interestingly, the deletion of WT1 at an early 
stage of kidney development, using Nestin-Cre, results in the disruption of nephron 
formation (Hohenstein, P. personal communication) a result previously shown using 
siRNA targeting of WT1 in kidney cultures (Davies et al 2004). The deletion of WT1 
using Pax8-Cre, expressed in the condensed mesenchyme, results in malformed 
nephrons with no glomerulus, however, the nephrons are tubular and maintain their 
ability to correctly fuse with the ureteric bud (Hohenstein, P. Personal 
Communication). The transition between the renal vesicle and the comma-shape 
body stage is beginning to become better characterised. The use of microarray 
analyses to compare mice with normal kidneys and mice with mutations that halt 
nephron development at particular stage, e.g. Lim1, are yielding interesting data 
(Potter et al 2007). The genes mentioned above highlight some of the components 
which now have to be connected to actual processes and pathways during nephron 
formation.  
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The formation of the comma-shaped body is characterised by the dramatic 
morphological change that encompasses the development of the glomerular cleft 
(Fig.1.1(3,4)). The formation of the glomerular cleft is rapid and it occurs by a 
portion of the epithelium forming a sickle-shaped invagination through the proximal 
part of the renal vesicle. Some genes have been demonstrated to be necessary for 
proximal nephron development. Conditional knockouts of Notch2 in the metanephric 
mesenchyme resulted in nephrons forming without any proximal portions, such as 
the proximal convoluted tubule or the glomerulus (Cheng et al 2007). The distal 
tubules that formed displayed some normality as they retained their capability to fuse 
with the ureteric bud (Cheng et al 2007). Notch2 expression was shown to be needed 
for normal proliferation rates in proximal portions of the nephron and interestingly, 
over expression of Notch1 resulted in nephrons that were composed entirely of 
proximal-tubule like segments that lacked podocyte differentiation (Cheng et al 
2007). The authors reported that proximal distal polarity appeared to develop 
normally in renal vesicles, as shown with distally restricted detection of Lim1 and 
high levels of Pax2, however proximal marker cadherin-6 was never detected (Cheng 
et al 2007). This suggests that Notch2 expression might be needed around the time 
when the glomerular cleft forms. Perhaps it is misleading to consider that the 
proximal-distal polarity is one polarity. Rather, it might represent two domains that 
display differentiation down diverging pathways and that the differentiation of one 
domain might not necessarily be dependent on the other. In fact the apparently 
normal development of distal tubules in the Notch2 mutant nephrons support that one 
portion can develop normally without the other doing so. However, the continuous 
expression of Notch1 which rescued the Notch2 mutant and induced proximal tubule 
development also appeared to induce the entire nephron to become proximal and this 
inhibited podocyte differentiation (Cheng et al 2007). This could indicate that 
podocyte differentiation is in fact dependent on normal proximal or distal tubule 
development but equally, it could a direct result of Notch1 expression. It is important 
to bear in mind that the proximal and distal domains of the renal vesicle do not 
necessarily correspond to the proximal and distal segments of the mature nephron. 
The distal domain of the renal vesicle might correspond to the entire tubular section 
of the mature nephron and the proximal part, constitute only the glomerulus. To 
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elucidate the fate of cells in the renal vesicle, lineage maps are required. The 
discussion regarding Notch2 was to point out that at least one gene has been shown 
to be important for proximal nephron development around the time of glomerular 
cleft formation. It has not been shown that Notch2 expression is necessary for the 
formation of the glomerular cleft; in fact, no genes have to my knowledge been 
directly linked to glomerular cleft formation.  
The importance of understanding glomerular cleft formation lies in the structure that 
it gives rise to. Glomerular cleft formation is accompanied by the formation and 
differentiation of the parietal and visceral epithelia which gives rise to the cells in the 
Bowman’s capsule and the podocytes, respectively (Saxen 1987). Without these 
structures, no glomerulus will form and the nephron will not be functional. The 
structures in the s-shaped body have been highlighted in (Fig.1.2) and its 
development is shown in (Fig.1.1).  
 
Fig.1.2 Mouse S-Shaped body nephron with labelled structures. 
 
This electron micrograph was obtained and adapted from p.232 (Vize, Woolf, and Bard 2003). (A) 
and (B) shows the same nephron in greyscale. (B) Shows a superimposed coloured overlay to demark 
important structures. The original image annotation describes vc-vascular cleft, ve-visceral 
epithelium, pe-parietal epithelium, BS-Bowman’s space, BC-Bowman’s capsule. Additional 







Several hypotheses could be presented to describe glomerular cleft formation. Saxen 
suggested a model by cell detachment (Saxen 1987), however, invagination as in 
Drosophila ventral furrow formation or during sea urchin gastrulation, might also 
provide a realistic explanation. From observing the detailed images of human 
nephron development by Potter, (Potter 1972) (Fig.1.1) it is relatively clear that the 
cells undergo major morphological changes; in particular those cells producing the 
parietal epithelium.  
 
The s-shaped body contains the majority of building blocks required for the 
subsequent maturation of the nephron into the mature nephron form. The subsequent 
development of the nephron is mainly characterised by its elongation and the 
concurrent segmentation and differentiation. As the nephron elongates it acquires the 
expression of a large number of genes such as the members of the solute carrier 
family which often display segment-specific gene expression (Raciti et al 2008). 
 
 
1.5 Rac1 and Rho-kinase  
 
The paragraphs above introduce the development of the kidney in order to provide a 
background to better understand the analyses carried out to elucidate the roles that 
the Rho-GTPases play during kidney morphogenesis. Briefly, the reason for 
investigating the role of the Rho-GTPases during kidney development is because 
they have been strongly implicated, but not yet shown, to act during this process. 
This makes them an ideal target to both better our understanding of kidney 
organogenesis but also to produce new and exciting data. The following sections, 
aim at providing a general introduction to the Rho-GTPases although each protein 







1.5.1 Introducing the Rho-GTPases 
 
The Rho-GTPases belong to the Ras superfamily of proteins which comprises the 
Ras, Rho, Rab, Arf, Ran, Rheb, Rin/Rit and Rad/Gem subgroups, as reviewed by 
Aznar and Lacal (Aznar and Lacal 2001) and Zohn (Zohn et al 1998). The Rho-
GTPase subgroup consists of at least 14 genes of which the most notable are Rac1, 
Rac2, RhoA and Cdc42, these are presented in full in Table 1.2 (Aznar and Lacal 
2001). Characteristically for the Rho-GTPases is the ability to cycle between being 
bound to guanine diphosphate (GDP) and guanine triphosphate (GTP), which are 
their inactive and active states, respectively (Shih et al 1986).  
 
Gene Mus musculus aliases Homo sapiens aliases 
RhoA Arha, Arha1, Arha2  
RhoB  Arh6, Arhb,   
RhoC Arh9, Arhc  
Cdc42 CDC42Hs G25K 
TC10 Rhoq, Arhq, TC10A  
Rac1 -  
Rac2 -  
Rac3 Rac1B  
Rho6/Rnd1   
Rho7/Rnd2 RhoN ARHN, RHO7, RhoN 
Rho8/Rnd3/RhoE Arhe, RhoE  
RhoD Arhd, Rho, RhoHP1, RhoM  
RhoH Arhh TTF 
RhoG Arhg, Sid10750  
Table 1.2 The Rho-GTPase family 
The genes were compiled from (Zohn et al 1998; Aznar and Lacal 2001). Gene name aliases were 
determined using Entrez Gene (Maglott et al 2007). 
 
The cycling of Rho-GTPases between their active and inactive state is regulated by 
three major classes of proteins, the guanine nucleotide exchange factors (GEFs), 
GTPase activating proteins (GAPs) and guanine nucleotide dissociation inhibitors 
(GDIs). GEFs, increase the exchange of GDP for GTP, GAPs enhance hydrolysis of 
GTP to GDP and GDIs inhibit the exchange of and/or the hydrolysis of GTP, as 
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reviewed by Van Aelst and D’Souza-Schorey (Van Aelst and D'Souza-Schorey 
1997). The regulation of GTPase activity is made additionally complex by several 
processes such as spatiotemporal regulation, multi-protein complexes as well as by 
the sheer number of regulators (Kwan and Kirschner 2005). In a review by 
Buchsbaum, the author states that an excess of 60 GEFs have been identified in the 
mammalian genome (Buchsbaum 2007).  
 
The GTPase family also have the capacity to regulate each other’s activities. It has 
been shown that Cdc42-GTPase activation can result in the activation of Rac1 and 
subsequently RhoA in National Institute of Health 3T3 (NIH3T3) fibroblast cells 
(Nobes and Hall 1995) but evidence presented by (Sander et al 1999) provided 
evidence that active Rac1, induced by platelet-derived growth factor (PDGF), is also 
capable of down-regulating RhoA activity. (Rosenfeldt et al 2006) also found 
negative regulation exerted by Rac1 on Rho. They showed that in constitutively 
active Rac1 mutant cells, stress-fibre formation, which is normally produced via Rho 
activation, was in fact inhibited. The cells that expressed the mutant Rac1, proved to 
be unable to bind p21-activated kinase 1 (PAK1), and through this lost their ability to 
inhibit Rho activation. PAK1 was shown to bind Rho GEF, P115RhoGEF which if 
inhibited results in a loss of Rho-induced stress-fibre formation (Rosenfeldt et al 
2006). The introduction of dominant negative PAK1 resulted in the retardation of the 
ability of Rac to inhibit thrombin-induced stress fibres (Rosenfeldt et al 2006). These 
results suggest an direct relationship between Rac and Rho via PAK1 (Rosenfeldt et 
al 2006).  This is interesting, particularly in light of that the Wnt/Frizzled planar cell 
polarity pathway activates both Rac1 and RhoA in mammalian cells (Habas, Dawid, 
and He 2003).  
 
The examples described above emphasise the versatility in regulation of activation 
and inactivation which is also reflected by the large number of processes where 
GTPases are involved. Cell growth, proliferation, cell cycling, transformation, 
migration and polarity are some of the functions so far found to be controlled by 
Rho-GTPases (Ridley et al 1992; Nobes and Hall 1995; Gu et al 2003; Benitah et al 
2005) and extensively reviewed by Ridley (Ridley 2001). 
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Rac1 has long been known to regulate actin polymerisation via the ‘WASP family 
Verproline homologous’ (WAVE) proteins which activates the Actin related protein 
2/3 (Arp2/3) complex as shown and reviewed by Ridley, Eden and colleagues 
(Ridley et al 1992; Eden et al 2002) and Bompard and Caron (Bompard and Caron 
2005). Rac1 has also been shown to mediate cell-cell adhesion by stabilising 
cadherin-catenins complexes, reviewed by Fukata and colleagues (Fukata et al 1999). 
RhoA is a key regulator for the formation of actin-myosin contractile stress fibres as 
well as for formation of focal adhesion complexes (Ridley and Hall 1992; Fukata et 
al 1999). The close connections which GTPases have to the regulation of cellular 
adhesion and the cytoskeleton, as well as to gene regulation, links them to 
mechanisms that may be fundamental to the morphogenesis of a tissue where cell 
migration, adhesion, cytoskeletal remodelling and cellular differentiation may be 
means of normal morphogenesis.  
 
 
1.6 Aims of thesis 
 
The aim of this thesis is to improve the current understanding of mechanisms 
involved in ureteric bud branching morphogenesis and nephron formation. The focus 
has been on understanding what roles Rac1-GTPase and Rho-kinase might play 
during these processes. This is important because these proteins have been 
implicated, either directly or indirectly, in both nephrogenesis and in ureteric bud 
branching. Rac1 and Rho-kinase are both central proteins in the Wnt/Frizzled planar 
cell polarity pathways, cellular migration regulation and organising actin and actin-




1.7 Main findings of the thesis 
 
The significant data described herein show that Rac1 regulates the size and 
branching of kidneys in culture via cell proliferation but Rac1 does not control 
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nephron formation or maturation, nor ureteric bud differentiation. Rho-kinase is an 
important protein during nephron formation, nephron apicobasal polarity formation, 
glomerular cleft formation and for proximal-distal nephron patterning. Rho-kinase 











Materials and Methods 
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2.1 Dissections and organ culture 
 
2.1.1 Mouse strains 
 
Pregnant CD1 mice were obtained from BRR-BRF-Phase II Little France, Edinburgh 
EH16 4SB. Mice were sacrificed by cervical dislocation. The lower abdomen was 
cut and the uterus removed.    
 
 
2.1.2 Dissection of E11.5 kidneys 
 
Using forceps and handheld surgical blades E11.5 CD1 uteri were dissected in 
Minimum Essential Medium Eagle’s (M5650/SIGMA) in 90mm petri dishes 
(633185/Greiner Bio-One). Embryos, within their amniotic sacs, were removed. The 
embryos were immediately beheaded using 25gauge needles (300600/BD 
Microlance 3) attached to 1mL syringes (300013/BD Plasipak). This type of needle 
setup was used for all dissections on the embryos. All further directions will 
described with regards to one embryo and the same procedures were carried out on 
all embryos. Two incisions were carried out on the embryo to isolate the region 
where the kidneys are located. The first incision was made rostral to the developing 
hind legs and the second incision was made caudal to the developing hind legs. To 
expose the kidneys for dissection, the embryo was placed with its ventral side facing 
down and one needle was used to penetrate the embryo from the dorsal side through 
the developing spinal cord all the way through. In this manner the embryo was 
pinned to the petri dish. A second needle was used to cut through the embryo in a 
dorsal to ventral motion and sequentially in a rostral to caudal direction to make a cut 
through the most medial region. The left hand and right hand sides were separated 
and placed with their lateral surfaces facing down. At this stage the embryonic 
kidneys were fully visible and were carefully dissected out from the rest of the 
embryo. Using a glass pipette the kidneys were transferred to complete kidney 
culture medium (CKCM) (Minimum Essential Medium Eagle’s with 10% calf serum 
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(Biosera), 100units Penicillin + 100µg/mL Streptomycin (P4333/SIGMA) and placed 
at 37°C in the culture hood. 
 
 
2.1.3 Dissection of E11.5 spinal cord 
 
The section of the embryo caudal to the brainstem and rostral to the forelimbs was 
used for this dissection. The same setup was used to dissect the spinal cord as was 
used for the kidneys. The regions lateral to the spinal cord were removed to leave the 
spinal cord. A cut was made through the most dorsal part of the spinal cord in a 
rostral to ventral direction. The ventral part of the spinal cord was not cut through. 
The spinal cord was unfolded outwards with the most dorsal parts being on the 
opposite sides of the roughly rectangular tissue and the ventral parts being in the 
centre. Cuts were made halfway between the most dorsal part and the most ventral 
part of the spinal cord on each side to produce two strips of dorsal spinal cord. The 
ventral parts were discarded. All dorsal ganglion remnants were removed and the 
remaining tissue was cut into small rectangular pieces.  
 
 
2.1.4 Separation of ureteric bud and metanephric mesenchyme 
 
Dissected kidneys were transferred from complete culture medium to Minimum 
Essential Medium Eagle’s containing Trypsin EDTA (T4174/SIGMA) to a final 
concentration of 1x (1/10 dilution of 5g/L porcine trypsin and 2g/L EDTA 4Na in 
0.9% NaCl as specified by SIGMA). The kidneys were incubate for 10min at 37°C 
for dissections aimed at ureteric bud isolation or 5min at 37°C for dissections aimed 
at metanephric mesenchyme isolation. Following incubation, rudiments were 
transferred to CKCM where the metanephric mesenchyme was separated from the 





2.1.5 Surface-medium interface kidney cultures 
 
Trowell grids were placed in 35mm petri dishes (627160/Greiner Cell Star). Isopore 
membrane filters (TMTP02500/MILLIPORE) cut to appropriate sizes ca 1 cm2 were 
placed upon the Trowell grid. Sufficient CKCM was added to the petri dish in order 
for the medium to reach the membrane filter without submerging it. Dissected 
kidneys were placed on the membrane filters and the whole culture dish placed in the 
incubator at 37°C with 5% CO2.  
 
 
2.1.6 Metanephric mesenchyme induction with spinal cord 
 
Metanephric mesenchyme was dissected from the ureteric bud as described above. 
Spinal cord was dissected as described above. Surface-medium interface kidney 
cultures were set up as described above. Spinal cord rudiments were placed on the 
membrane filter and the metanephric mesenchyme placed upon the spinal cord. 
Cultures were incubated at 37°C with 5% CO2. Trans-filter setups were also carried 
out where three isopore filters were placed on top of each other with the spinal cord 
between the bottom two and the metanephric mesenchyme on the top filter. For these 
setups, the bottom two filters were removed after 24hrs of induction leaving the 





2.2.1 Sandwich Mount for Confocal Scanning 
 
A large rectangular coverslip 22mm x 64mm (VWR INTERNATIONAL) was 
placed upon a glass slide (Blue Star/CHANCE PROPPER). Two small coverslips 
22mm x 22mm (No.1½/CHANCE PROPPER) were attached on opposite sides of the 
larger coverslip using nail varnish (PrettyinPink/LIZZIE). The fixed and stained 
sample was placed in the empty space between the two smaller coverslips and 
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immersed in a 1:1 (1xPBS:Glycerol) solution. A second large rectangular coverslip 
was placed on top and as such enclosing the sample. For long term storage the sides 
were sealed with nail varnish to prevent drying. 
 
 
2.2.2 Confocal microscopy 
 
The majority of samples scanned with a confocal microscope were scanned on a 
Leica TCS-NT laser scanning confocal microscope. A small portion of samples were 
scanned on a Zeiss LSM510 CLSM. Leica lenses used were: 5x HC PL FLUOTAR 
5x/0.15; 10x HC PL FLUOTAR 10x/0.30 PH1; 20x HC PL FLUOTAR 20x/0.50 
PH2; 40x PL FLUOTAR 40x/1.00 OIL PH3; PL APO 63x/1.32 OIL. Imersol 





2.3.1 General protocol for fluorescent immunohistochemistry in kidney cultures 
 
(1) 10 min. fixation in −20°C methanol (M/4000/17/Fisher Scientific) at room 
temperature (RT.) 
(2) 30 min. wash in 1x Phosphate Buffer Saline (1xPBS) (0.01M phosphate buffer, 
0.0027M KCl, 0.137M NaCl, in dH2O, pH 7.4 specified by SIGMA) (P4417/Sigma) 
at RT.  
(3) 24 hrs. Primary antibody incubation at 4ºC.  
(4) 30 min. wash in 1xPBS.  
(5) 24 hrs. Secondary antibody incubation in 1xPBS at 4ºC.  
(6) 30 min. wash in 1xPBS at RT.  





2.3.2 Antibody-specific alterations to the general protocol for immunostaining 
 
For Phospho-Histone 3-(Ser10) (9701/CELL SIGNALLING), all steps using 1xPBS 
were modified so that the PBS was substituted for 1x Tris Buffered Saline (0.05M 
Tris and 0.15M NaCl, in dH2O, pH 7.6 specified by SIGMA) (T5030/SIGMA). The 
1x Tris Buffered Saline solution contained 5% goat serum (G9023/SIGMA). Each 
washing step was extended with 30min. 
 
For staining with Dolichos biflorus Lectin-FITC conjugated (L2785/SIGMA), the 
lectin was diluted in 5% milk (Dried Skimmed Milk/MARVEL) in 1xPBS. 
 
 
2.3.3 Primary and secondary antibodies 
 
Mouse IgG anti-Calbindin D-28K (ab9481/ABCAM), 1:100. Rabbit IgG anti-
Calbindin D-28K (ab1778/CHEMICON), 1:100. Rabbit IgG anti-Laminin 
(L9393/SIGMA), 1:100. Mouse IgG anti-NCAM (C9672/SIGMA), 1:100. Mouse 
IgM anti-CD15 (C7798/SIGMA), 1:100. Mouse IgG anti-E-cadherin (610181/BD), 
1:100. Mouse IgG anti-Cytokeratin (C2562/SIGMA), 1:100. Mouse IgG anti-WT1 
(sc-192 /SANTA CRUZ), 1:400. Rabbit IgG anti-Phospho-Histone 3-(Ser10) 
(9701/CELL SIGNALLING), 1:100. Rat IgG anti-L1 (MAB5272/Chemicon), 1:100. 
Mouse IgG Anti-BrdU (B2531/SIGMA), 1:50. Mouse IgG anti-ROCK-II 
(610623/BD Transduction Labs), 1:100. TO-PRO-3 Iodide (T3605/MOLECULAR 
PROBES), 1:250. Propidium Iodide (P3566/MOLECULAR PROBES), 1:1000. 
Phalloidin FITC-conjugated (P5282/SIGMA), 1:100. Dolichos biflorus Lectin FITC-
conjugated (L2785/SIGMA), 1:100) Anti-mouse-IgG-FITC (F0257/SIGMA), 1:200. 
Anti-mouse-IgG-TRITC (T5393/SIGMA), 1:200. Anti-mouse-IgM-FITC 
(M9259/SIGMA), 1:100. Anti-rabbit-FITC (F9887/SIGMA), 1:200. Anti-rabbit-
TRITC (T5268/SIGMA), 1:200. Anti-rat-IgG-Alexa Fluor 647 
(A21472/MOLECULAR PROBES), 1:100. Anti-mouse-IgG-Alexa Fluor 647 
(A31571/MOLECULAR PROBES), 1:100.   
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2.3.4 Testing of antibodies for kidney fluorescent immunohistochemistry 
 
All new antibodies were controlled as follows: (a) Primary antibody only; (b) 
Secondary antibody only; (c) Primary and Secondary antibodies. Kidneys were 
scanned using confocal microscopy or imaged on the fluorescent microscope to test 
for fluorescence by the primary antibody and for non-specific binding of the 
secondary antibody. For some antibodies (e.g. anti-L1), additional tests had to be 
carried out to ensure specificity of binding. 
 
 
2.4 Protein inhibitors 
 
Protein inhibitors were added directly to the kidney cultures by adding the 
reconstituted inhibitor solutions to the kidney culture medium. NSC23766 
(553502/CALBIOCHEM) was reconstituted in dH2O to a stock concentration of 
10mM. NSC23766 was used at a maximum concentration of 100µM. Y-27632 
(Y0503/SIGMA) was reconstituted in dH2O to a stock concentration of 5mM. Y-
27632 was used at a maximum concentration of 20µM. Glycyl-H1152 
dihydrochloride (2485/TOCRIS) was reconstituted in dH2O to a stock concentration 
of 5mM. Glycyl-H1152 dihydrochloride was used at a maximum concentration of 
2.5µM. 2,3-Butanedione monoxime (203984/CALBIOCHEM) was reconstituted in 
DMSO to a stock concentration of 5M. 2,3-Butanedione monoxime was used at a 
maximum concentration of 10mM. Methotrexate (M8407/SIGMA) was reconstituted 
in 1M NaOH to a stock concentration of 50mM. Methotrexate was used at a 
maximum concentration of 500nM. 
For experiments where inhibitors were added, the control conditions, denoted as 
CKCM (Complete Kidney Culture Medium) or “controls/control conditions”, 






2.5 Proliferation assay using 5-bromo-2-deoxyuridine 
 
2.5.1 Marking Proliferating Cells in Kidneys using BrdU 
 
E11.5 CD1 embryos were dissected as described above and cultured as described in 
using surface-medium interface kidney cultures. Experimental kidneys were cultured 
in CKCM with 75µM NSC23766 (553502/Calbiochem). Control kidneys were 
cultured in CKCM without any added NSC23766. At t=30hrs 5-bromo-2-
deoxyuridine (BrdU) (B9285/Sigma) was added to make a final working 
concentration of 100µM. Kidneys were exposed to BrdU for 16hrs.  
 
 
2.5.2 Immunohistochemistry for 5-bromo-2-deoxyuridine  
 
At t=46hrs kidneys on filters were treated according to the following protocol:  
(1) 10 min. fixation in −20°C methanol (M/4000/17/Fisher Scientific) at RT.  
(2) 30 min. wash in 1xPBS (P4417/Sigma, 0.01M phosphate buffer, 0.0027M KCl, 
0.137M NaCl, in dH2O, pH 7.4 specified by SIGMA) at RT.  
(3) 30 min. fixation in 4% paraformaldehyde (PFA) (15,812-7/Sigma) in 1xPBS at 
RT.  
(4) 30 min. wash in 1xPBS at RT.  
(5) 7 min. wash in 0.5 mg/mL trypsin (T4174/SIGMA) at 37ºC.  
(6) 1.5 hrs. fixation in 4% PFA in 1xPBS at RT.  
(7) 30 min. wash in 1xPBS at RT.  
(8) 60min DNA-denaturing in (95% formamide (F7503/Sigma), 5% 0.15M 
trisodiumcitrate (10242/BDH)) at 70ºC.  
(9) 30 min. wash in 1xPBS at RT.  
(10) 24 hrs. Primary antibody incubation (1:200 anti-calbindin D28k-rabbit 
(Ab1778/Chemicon) and 1:50 anti-BrdU-mouse (B2531/Sigma) in 1xPBS) at 4ºC.  
(11) 30 min. wash in 1xPBS at RT.  
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(12) 24 hrs. Secondary antibody incubation (1:100 FITC-conjugated anti-rabbit IgG 
(F0382/Sigma) and 1:100 TRITC-conjugated anti-mouse IgG (T5393/SIGMA) in 
1xPBS) at 4ºC.  
(13) 30 min. wash in 1xPBS at RT. 
 
Kidneys on filters were mounted on Sandwich Mount slides and scanned using a 
Leica TCS-NT confocal microscope. FITC and TRITC channels were scanned 
sequentially to ensure minimal levels of cross-talk. Images were captured at 3µm 
intervals through the whole kidneys. 
 
 
2.5.3 Quantification of cell proliferation 
 
The quantification of BrdU positive nuclei within the tips was difficult and required 
the strict adherence to a relatively complicated but necessary protocol. In order to 
make the measurements unambiguous and replicable, the protocol is described in full 
detail. All lines and points discussed below are shown in (Fig.2.1) p66. 
 
For each confocal stack, every tip within each stack was analysed. All sections of 
each stack were viewed and ever tip was identified. For each tip, it was determined 
which image within the stack it was where the tip was at its widest. This was 
identified by eye and for each tip, this image was considered to be the “middle 
section” of that tip. 
Each stack was opened using Scion Image Alpha 4.0.3.2 and calibrated to a scale of 
1024pixels:500µm using the Set scale function. This calibration was applicable to all 
images as they were all captured using the 20x lens (HC PL FLUOTAR 20x/0.50 
PH2/Leica) with the same Leica TCS-NT confocal microscope. All images were 
converted to greyscale using the Greyscale function.  For area measurements, the 
image that had been captured using the FITC-channel, thus showing the Calbindin D-
28K protein distribution, was opened and for the BrdU nuclei counts, the image 
captured using the TRITC-channel was opened.  
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The following protocol was used to (i) determine the tip boundaries, (ii) measure the 
tip area in µm
2
 and (iii) count BrdU positive nuclei.  
 
i) Determining tip boundaries 
 
In order to determine whether a ‘tip’ should be considered as one or two tips the 
following screen was carried out. The middle section image showing the Calbindin 
D-28K protein localisation was opened and the two points furthest apart in the tip 
were identified and a 100µm line was drawn from each point towards the other point. 
For illustrative/explanatory purposes these lines were named “Line 1” and “Line 2” 
and they are depicted as dashed double-headed arrows and the points are termed 
“Widest point 1” and “Widest point 2” and are shown as blue circular marks. If the 
lines overlap by >25% the tip was considered to be one tip and if they overlapped by 
<25% the tip was separated into two tips. To determine the end of the tip and the 
beginning of the stalk a point was identified approximately equidistant to the two 
widest points that is the furthest away from the stalk. This point shall be considered 
as “Alternative point 1” and was here shown using a purple circular mark. A 100µm 
line was drawn from this point towards the stalk to a point medial to the ureteric bud 
edges where that point was located in the stalk region or in a region directly 
neighbouring the stalk (this will depend on the size of the tip). This line was named 
“Line 3” and it is represented by a solid double-headed arrow. The point shall be 
named “Alternative point 2” and it was marked with a yellow circular mark. Draw a 
line through alternative point 2 that was perpendicular to line 3 so that the line 
intercepts the ureteric bud edges. In the case where that line would not immediately 
connect with the ureteric bud edges the line or lines should be drawn to ureteric bud 
margins that are nearest to the alternative point 2. This line shall be named “Line 
4”and it was shown as a dashed white line that intercepts alternative point 2. This 
protocol allowed for the consistent specification of the ureteric bud tip regions for 









Using the Polygon selection function the outer edges of the tip were traced and using 
the Measure function the surface area of the selection was measured and the area 
measurement was recorded. This was repeated a total of 3 times per tip to provide a 
mean measure and ensure increased accuracy as the area was identified by hand. 
 
iii) Counting BrdU positive nuclei. 
 
The image showing the BrdU (TRITC channel only) was and converted to greyscale 
using the Greyscale function. The Background Intensity and its Standard Deviation 
was measured using the Measure function and the data was recorded. The image was 
thresholded using the Threshold  function to a level equal to ((Background Intensity 
x 3) + Standard deviation) as previously used by Michael and Davies (Michael and 
Davies 2004). 
Pixels with a value above this threshold were recorded as BrdU positive. To resolve 
whether closely positioned pixels belonged to the same nuclei the threshold value 
was lowered and subsequently raised again. All positive nuclei within the tip 
boundary were recorded. 
This protocol was repeated for the stack sections that were 3µm above and below the 
middle section of each tip. The alternative point 2 which indicates the tip/stalk 
boundary was directly determined by drawing a 100µm line from alternative point 1 
which was determined by eye based on the work done on the middle section. Nuclei 
appearing in more than one image were counted as separate nuclei to ensure than no 
two or more nuclei were wrongly considered as one.   
All tips within each stack were analysed and the total number of nuclei were deduced 





Fig.2.1 BrdU analysis in ureteric bud tips 
 
 
2.6 Proliferation assay using phosphorylated histone 3 as a mitosis marker 
 
2.6.1 Kidney culture conditions  
 
E11.5 CD1 embryos were dissected and cultured as described above. Experimental 
kidneys were cultured in CKCM with 75µM Rac1 inhibitor NSC23766, 150nM 
Methotrexate (MTX) (M8407/SIGMA) or 250nM MTX. At t=48hrs kidneys were 
fixed in -20ºC methanol. Staining protocols were followed for Phospho-Histone 3-
(Ser10). Kidneys were stained for rabbit-Phospho-Histone 3-(Ser10) (H3(p)) and 
mouse-E-cadherin. These were detected with anti-mouse-IgG-FITC and anti-rabbit-
IgG-TRITC and counterstained with TO-PRO-3 Iodide. Kidneys were sequentially 
Not to scale 
100µm 













scanned at 5µm section intervals from the top to the centre of the kidney using a 40x 
lens (Leica).  
 
 
2.6.2 Quantification of mitotic cells 
 
The top section of the kidney was identified as the first section displaying E-cadherin 
positive ureteric bud staining. The sections below this, at a depth of 5µm and 10µm 
were chosen for analysis. Using ImageJ 1.40g the TO-PRO-3 stain was separately 
and manually enhanced using the Enhance Contrast function to ensure all nuclei 
were clearly detectable. The image was further processed using the Smooth function 
and made into a binary image using the Make Binary function. In order to split nuclei 
that on the image appeared merged, the image was treated using the Watershed 
function. The number of nuclei was counted using the Analyze Particles function, set 
to detect particles of a size between 300 and 5000pixels (73µm2 – 1220µm2). These 
parameters included most whole nuclei whilst excluding background noise. The 
number of H3(p) positive nuclei was counted manually using the Cell Counter plug-
in as this appeared to be the most reliable method. The mitotic cells were quantified 
as a percentage of the total number of nuclei per analysed slide. 
 
 
2.7 Quantitative analysis of nephron abnormality 
 
E11.5 CD1 embryos were dissected and cultured as described above. Controls and 
experimental cultures were initially kept in CKCM for 48hrs and then transferred to 
either CKCM or medium with 1.25µM Glycyl-H1152 dihydrochloride and cultured 
for an additional 72hrs. The quantification of morphological and gene expression 
abnormality required the following protocol.  
All nephrons in samples were identified using rabbit anti-Laminin and mouse anti-E-
cadherin antibodies detected with anti-laminin-IgG-TRITC and anti-mouse-IgG-
FITC. Each identified nephron was individually labelled and characterised (Fig.2.2 
A,B). Each nephron was given a record of nephron stage, morphology and E-
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cadherin expression as described in (Fig.2.2B). Nephrons were staged using an 
adapted ontology from GUDMAP (www.GUDMAP.org)/ (Little et al 2007). 
Nephrons were staged as: Renal Vesicle (RV) – epithelial cyst with no evidence of 
glomerular cleft formation; Comma- and S-shaped body (CSB) – more mature 
cyst/tubule with glomerular cleft; S-shaped body + (SB+) – elongated tubular 
structure more advanced than S-shaped body stage. The CSB category was created to 
contain nephrogenic structures more mature than RV stage (clear glomerular cleft 
and/or some tubular elements) but not sufficiently tubular or elongated for SB+ 
stage. Nephron morphology was categorised as normal or abnormal compared to 
control nephrons. E-cadherin expression was categorised as normal or abnormal 
where E-cadherin expression showed normal segment specific expression or ectopic 
proximally expanded expression compared to control nephrons. In both cases, 
samples that could not be assigned with certainty to normal or abnormal categories 











•RV (renal vesicle stage) 
•CSB (comma & s-shaped body 
stage) 


















Fig.2.2 Quantitative analysis of nephron abnormality  
 
Fig.2.2 (A) shows a representative confocal section of a stack where nephrons have 
been identified and numbered – white circles and numbers – and each nephron has 
been classified according to its developmental stage, morphology and protein 
localisation; ontology shown in (B). 
E-cadherin   Laminin 
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2.8 Segment specific gene expression analysis 
 
This contains protocols and specific information explaining the analysis of the 
nephron proximal-distal axis gene expression. 
  
 
2.9 Standard laboratory techniques 
 
2.9.1 Primers design 
 
Primers were designed using Primer3 (v. 0.4.0) (http://frodo.wi.mit.edu/) and 
FASTA sequences obtained from NSBI- Entrez Gene. Gene names, Gene IDs and 
primers are shown below.  
Gene name GI number Amplicon  Forward primer Reverse primer 
Brn1/Pou3f3 GI:112421035 127 CAGCCTACAGCTGGAAAAGG GGTACCCACCTGCGAGTAGA 
Hunk/MAP-
V/MAK-V 
GI:118131024 372 TCCCATCCTTCAAATGCTTC CATCAGTAGCCACAGGCTGA 
THP/Uromodulin 
Uromucoid 
GI:145301571 156 TCAGCCTGAAGACCTCCCTA GAAAAGCCTCAGTGGACAGC 
Hes5 GI:145966833 380 AAGAGCCTGCACCAGGACTA AGCCTTCGGAAGAAGGTAGC 
Irx3 GI:55741684  GACGAGGAAGAGAGCAAACG TCGTCCGAGTCGCTAGTTTT 
Cdh-6/K-
cadherin 
GI:110665731  ACATACAGGCCACCAAGAGG CGTGACTTGGACCACAAATG 
Hey1 GI:117606331  AGCAGTGAGGTGAAGGGAGA AACGGTGAAATCCGTGAGAC 
SGLT2/Slc5a2 GI:117606331  ATTGTCTCGGGCTGGTATTG TTAGAGCAGCCCACCTCAGT 
β-actin GI:142378181  TGTTACCAACTGGGACGACA GGGGTGTTGAAGGTCTCAAA 
 
 
2.9.2 RNA isolation, cDNA synthesis and PCR reactions 
 
Cultures were set up in control conditions and experimental conditions as specified 
in Chapter 4.4. Cultures were set up in duplicates with a total of 7-10 kidneys per 
condition. At the point of RNA isolation, the kidneys were removed from the filters 
using glass pipettes and placed in ice-cold Minimum Essential Medium Eagle’s 
(M5650/SIGMA) in a 1.5mL Eppendorf tube (616201/Greiner Bio-One) and kept on 
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ice until all kidneys were collected. The kidneys were gently spun down using a 
micro-centrifuge (MICROCENTAUR/MSE) and the Minimum Essential Medium 
Eagle’s was removed. The RNA isolation was carried out using SV total RNA 
isolation (Z3100/Promega) according to product protocols. All solutions and 
components described below were part of that product. Briefly, the kidneys were 
dissociated in 175µL RNA Lysis Buffer by vigorous pipetting using a 200µL Gilson 
Pipette. 350µL DNA Dilution Buffer was added and the sample was placed at 70ºC 
for 3min using a heating block (QBT1/Grant). The sample was centrifuged at 
130000rpm for 10min. The lysate was transferred to a new 1.5mL Eppendorf tube 
and 200µL of 95% ethanol + 5% dH2O was added and mixed. The solution was 
transferred to the spin columns and spun at 130000rpm for 1min. The collected 
nucleic acids were washed in 600µL RNA Wash Solution and spun at 130000rpm for 
1min. The DNA was degraded using 5µL DNase I in 40µL Yellow Core Buffer and 
5µL 0.09M Manganese chloride (MnCl2) for 15min at room temperature. The 
degradation was terminated using 200µl DNase Stop Solution and the sample was 
spun at 130000rpm for 1min. The sample was washed with 600µL RNA Wash 
Solution and spun at 130000rpm for 1min. The sample was additionally washed with 
250µL RNA Wash Solution and spun at 130000rpm for 2min.  The RNA was eluted 
in 100µL dH2O and spun down into a fresh 1.5µL Elution tube at 130000rpm for 
1min. RNA quantification was carried out using a 1:25 dilution (40µL RNA + 960µL 
dH2O). For RNA quantification the absorbance was measured at 260nm and 
quantified as 1 unit absorbance equalling 40µg RNA per mL. 200ng RNA was 
carried into each cDNA synthesis reaction using M-MLV reverse transcriptase 
(M1701/Promega). Briefly, each cDNA synthesis reaction contained: 1µL Random 
Primers, 2µL dNTPs, 0.5µL RNase Inhibitor, 4µL MLV Buffer, 1µL MLV-RT, 
200ng RNA, adjusted amounts of dH2O. Total volume was 20µL. Random Primers, 
RNA and dH2O were initially mixed and placed at 70ºC for 5min before the 
remaining components were added. The cDNA synthesis was carried out at 37ºC for 
1hr followed by 10min at 75ºC using a PRC machine (TC-312/Techne). PCR 
reactions were performed using GoTaq DNA polymerase (M3175/Promega) with 35 
cycles of (94ºC:1min, 55ºC:1min, 72ºC:1min). β-actin was used as a loading and 
DNA-content control. PCR reactions were run on a 1% agarose gel (15517-
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014/Invitrogen):1xTris Borate EDTA (0.089M Tris borate, 2mM EDTA as specified 
by SIGMA) (T-3913/SIGMA).  
 
2.10 Statistical analysis 
 
Comparisons of two sets of data were analysed using a one-tailed Student’s unpaired 
t-test between control samples and experimental samples. Data is expressed as the 

















The development of the kidney requires intricate mechanisms to regulate the 
morphogenesis of several different structures. The molecular components and the 
mechanisms that regulate these processes remain largely unknown. This thesis 
contains two results chapters that describe experiments aimed at determining what 
these processes are. In this chapter, Chapter 3, I focus on the protein Rac1-GTPase 
(Rac1) and I attempt to elucidate whether Rac1 has a function during nephron 
formation, ureteric bud differentiation, branching morphogenesis and kidney growth. 
In Chapter 4 I present work that describes the role of the RhoA-GTPase effector 
Rho-kinase and in a similar manner to in Chapter 3, also try to show what the role is 
for Rho-kinase in kidney development. Initially, Rac1 and Rho-kinase received equal 
attention, but as the Rho-kinase branch was considered more interesting and 
ultimately more publishable, I decided to concentrate on that. As a result of this, 
some aspects of Chapter 3 were not pursued to the level of depth that is sometimes 
presented in Chapter 4.  
 
Rac1 has been shown to be a very versatile protein that is important for numerous 
cellular functions such as motility (Ridley et al 1992; Nobes and Hall 1995; 
Machesky and Hall 1997; Nobes and Hall 1999), tubulogenesis (Montesano, 
Schaller, and Orci 1991; Montesano et al 1991; Pollack, Runyan, and Mostov 1998; 
Rogers et al 2003) and proliferation (Minden et al 1995; Westwick et al 1997; Gu et 
al 2003). Rac1 has also been linked to the planar cell polarity pathway in vivo, 
regulating convergent extension in Xenopus (Habas, Dawid, and He 2003). Because 
Rac1 regulates such a wide array of processes, I will highlight important functions in 
the introduction to ensure that the results sections are as focussed as possible. Each 
introductory section below is labelled with the Rac1-function described therein. 
Some of the functions described in the introduction are not directly demonstrated in 
the results but they are important to consider.  
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3.1.2 Rac1 and mechanisms of motility 
 
Cellular motility is a possible mechanism that accounts for branching morphogenesis 
of the ureteric bud and may also be important for nephron formation during the 
condensation of pretubular aggregates. In the mammary glands, collective cell 
migration  is necessary for the formation of new ducts and branching, a process that 
is Rac1 dependent (Ewald et al 2008). Evidence suggesting a role for motility and a 
tight regulation of actin filaments during ureteric bud branching has also emerged 
(Michael and Davies 2004; Watanabe and Costantini 2004; Michael, Sweeney, and 
Davies 2005; Meyer et al 2006; Kim and Dressler 2007). Rac1 regulates cellular 
motility by acting as an organiser for the cytoskeleton (Ridley and Hall 1992; Ridley 
et al 1992; Nobes and Hall 1995; Machesky and Hall 1997; Nobes and Hall 1999). 
Cellular motility is produced by the nucleation of actin filaments which in turn is 
regulated by a multiprotein-complex Arp2/3 (Welch, Iwamatsu, and Mitchison 1997; 
Robinson et al 2001). The Arp2/3 complex is continuously bound to the WASP 
family Verproline homologous proteins (WAVE) complex that becomes active upon 
recruitment to the plasma membrane by Rac/Nck/Abi1 (Innocenti et al 2004), 
reviewed by Bompard and Caron (Bompard and Caron 2005). The actin nucleation at 
the leading edge of cells produces the force which the cells use to move, reviewed by 
Stossel (Stossel 1993). A mechanism of ‘elastic Brownian ratchet’ has been proposed 
by Mogilner and Oster, where it is suggested that the elasticity of actin filaments and 
the plasma membrane, in conjunction with the thermal motion by both these 
structures, allow the actin filaments to ‘sway’ away and towards the plasma 
membrane (Mogilner and Oster 1996; Mogilner and Oster 2003). This allows actin 
polymerisation to occur when the filament is in an ‘away’ position and consequently, 
upon swaying back into the ‘towards’ position, the actin filament will be longer and 
hence force the plasma membrane forwards. The net force generated by numerous 
actin filaments would be sufficient for cellular motion (Mogilner and Oster 1996; 





3.1.3 Rac1 in cystogenesis and tubule formation 
 
Rac1 is important for cell cystogenesis and the formation tubules from such cysts 
(Montesano, Schaller, and Orci 1991). In the immediate context, cystogenesis and 
tubule formation refer to the formation of epithelial cysts and tubules from an 
existing epithelium rather than the cystogenesis that is seen during the mesenchymal-
to-epithelial transitions which give rise to the nephrons. The formation of new 
tubules from an existing epithelium, is a recurring phenomenon during embryonic 
development that is exemplified in the kidneys and the lungs (Miettinen et al 1997; 
Michael and Davies 2004). Tubule formation can be studied using several different 
culture systems such as epithelial cell cultures in collagen gels, isolated ureteric buds 
in matrigel and whole in vitro embryonic kidney and lung cultures. Rac1 has been 
shown to be directly involved in the in vitro formation of tubular structures from 
MDCK cell cysts (Rogers et al 2003). When cultured in a three-dimensional collagen 
type-I assay system, MDCK cells form cysts that, when stimulated with hepatocyte 
growth factor (HGF), form branched tubules (Montesano, Schaller, and Orci 1991; 
Montesano et al 1991). This formation of tubules from MDCK cysts follows a 
specific pattern of four stages (extension, chain, cord and tubule) which are 
characterised by modifications of cell-cell adhesion and apical/basolateral polarity 
(Pollack, Runyan, and Mostov 1998). Rac1-GTPase has been demonstrated to be 
important for MDCK cystogenesis and tubulogenesis (O'Brien et al 2001). Cysts 
derived from MDCK cells with a dominant-negative Rac1 mutation, rac1N17, (see 
Table 3.1 for Rho-GTPases mutants), lacked the ability to polarise normally. The 
apical surface, facing the lumen, normally marked by glycoprotein 135 (gp135) and 
microvilli, was lost and gp135 was redistributed to the fringes of the cyst. The 
basolateral markers E-cadherin and p58 were found on all cell surfaces unlike wild 
type cysts where they are excluded from the apical surface (O'Brien et al 2001). 
Rac1N17 cysts lacked normal laminin assembly basally, a phenotype that could be 
rescued by the addition of laminin (O'Brien et al 2001). This abnormal laminin 
staining observed basally was speculated to be a result of the decreased amount of 
α3β1 integrin which was detected. The authors hypothesised that there may be a 
signalling pathway where Rac1 stimulates α3β1 integrin, resulting in laminin 
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assembly basally, which in turn provides a cue for the basal pole to be specified 
(O'Brien et al 2001). Importantly for this discussion, the MDCK cyst that formed 
with inversed polarity failed to form tubules (Rogers et al 2003). MDCK cell lines 
have been produced that carry inducible dominant negative and constitutively active 
rac1, rhoA and cdc42 genes (Table 3.1) as were used by Rogers and colleagues 
(Rogers et al 2003).  
 
 
Table 3.1 Rho-GTPase mutant forms 
 
Rogers and colleagues focussed on the roles of Rac1, RhoA and Cdc42 GTPases 
during cystogenesis and tubulogenesis (Rogers et al 2003). Only rhoAV14 
completely disrupted cystogenesis and tubulogenesis whereas the other mutants 
exhibited lesser effects (Rogers et al 2003). rhoAN19, rac1N17, cdc42V12 and 
cdc42N17 MDCK cell cysts all exhibited inversions of cyst polarity, with the effects 
in cdc42N17 and cdc42V12 MDCK cell cysts being the most prominent (Rogers et al 
2003). Of those mutant cell lines which formed cysts, only rac1N17 MDCK cell 
cysts inhibited tubulogenesis (Rogers et al 2003). MDCK cells carrying the rac1V12 
gene were however capable of tubulogenesis in the absence of HGF (Rogers et al 
2003). These studies indicate a critical role for Rac1, RhoA and Cdc42 expression for 
in vitro cystogenesis and tubulogenesis. It is arguable to what extent that data from 
such in vitro cell culture studies can be extrapolated to a whole organ. Although, as 
mentioned in the previous paragraph, Rac1 has been demonstrated to be necessary 
for the formation of new tubules during mammary gland duct formation via the 
process of migration (Ewald et al 2008).  These results underline the importance of 
carrying out additional studies to determine whether Rac1 might regulate similar 
processes in the kidney.  
 
 
Gene name Dominant negative mutant form Constitutively active mutant form 
rac1 rac1 T=>N17 rac1 G=>V12 
cdc42 cdc42 T=>N17 cdc42 G=>V12 
rhoA rhoA T=>N19 rhoA G=>V14 
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3.1.4 Rac1, a regulator of proliferation 
 
Rac1 has previously been shown to have a role during kidney development (Osafune 
et al 2006). It was reported that Rac1, possibly acting via a Jun N-terminal Kinase 
(JNK) planar cell polarity pathway, regulates the size of renal progenitor cell cultures 
(Osafune et al 2006). A possible mechanism for this control would be through the 
regulation of proliferation. Rac1 has been shown to be an important regulator of 
proliferation and cell cycling (Minden et al 1995). The life cycle of a cell is 
characterised by several phases consisting of: Growth-phase 1 (G1), DNA-synthesis 
(S), Growth-phase 2 (G2), Mitosis (M) and a quiescent phase (G0) which is not 
directly involved in cellular proliferation (Johnson and Walker 1999). Cell cycle 
progression and entry from the G0-phase is tightly regulated due to the potential 
hazards of uncontrolled cellular proliferation. Rac1 has been demonstrated to 
regulate cell cycling in a number of different cell types in vitro. Gu and colleagues 
studied the roles of Rac1 and Rac2 for haematopoietic stem/progenitor (HSC/P) cells 
using a conditional Rac1
flox/flox
 (Gu et al 2003). Their findings strongly suggest that 
Rac1 is necessary for HSC/P cells’ growth and progression of the cell cycle. Rac1
-/-
 
cells failed to enter S, G2 or M phase and this was likely due to an absence of cyclin 
D1 protein, as compared to normal HSC/P cells. Cyclin D1, D2 and D3 are important 
for G0 to S-phase progression, as is extensively reviewed by Johnson and Walker 
(Johnson and Walker 1999). Cyclin D1 is known to activate Cyclin-dependent 
kinases 4 and 6 (Cdk4 and Cdk6) and to phosphorylate retinoblastoma tumour 
suppressor protein (Rb) (Johnson and Walker 1999). This phosphorylation disrupts 
the binding of Rb to the transcription factor family E2F which are essential for 
progression from G0-phase to S-phase (Johnson and Walker 1999). Rac1 can bind 
PAK and induced the transcription of cyclin D1 (Westwick et al 1997). Rac1 can 
activate JNK and p38MAPK, which in turn induces the transcriptional activity of c-
Jun which is important for cell-cycle progression (Westwick et al 1997).  
 
Plenty of research supports the theory that Rac1-stimulated proliferation can be a 
result of adhesion-regulated proliferation (Mettouchi et al 2001). Human umbilical 
vein endothelial cells (HUVECs) display adhesion dependent proliferation rates 
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where HUVECs cultured on fibronectin proliferate and enter S-phase, whereas 
HUVECs cultured on laminin-1 enter growth arrest (Mettouchi et al 2001). Cell 
culture medium supplemented with the growth factors, basic fibroblast growth factor 
(bFGF) and insulin cause the cells to apoptose (Mettouchi et al 2001). This 
difference in cellular behaviour was shown to be a result of different integrins. 
HUVECs express α5β1 integrin and binding of α5β1 to fibronectin triggered the 
activation of Rac through a signalling pathway that included a number of proteins 
such as Shc, FAK, PI-3-K and SOS (Mettouchi et al 2001). This activation was 
shown to result in increased translation of cyclin D1 protein (Mettouchi et al 2001). 
Importantly, the amounts of cyclin D1 were found to be the same in HUVECs 
cultured on fibronectin and on laminin-1 (Mettouchi et al 2001). This was explained 
by the PAK/p42/p44MAPK pathway still being active and as a result regulating 
cyclin D1 (Mettouchi et al 2001). On the other hand, Moore and colleagues tested the 
effects of injecting a dominant negative Rac1 (Rac1N17) adenovirus into Rat2 
fibroblast cells (Moore et al 1997). They found that, in an adenovirus-Rac1N17 
concentration-dependent manner, cells accumulated in G2/M transition. The highest 
percentage of cells in G2M transition was found in those cultures which had received 
the highest concentration of the adenovirus (Moore et al 1997). Further tests by 
Moore and colleagues using injections of dominant negative RhoA and Cdc42 
adenoviruses did not have the same effects (Moore et al 1997).  
 
It is clear that Rac plays an important role in the cell cycle and proliferation at 
several different levels. An interesting prospect would be that Rac1 regulates kidney 
proliferation via the MAP-Kinase (MAPK) signalling cascades. MAP-Kinases 
p42MAPK and p44MAPK, also known as ERK2 and ERK1, are important for re-
entry from the G0 to the S-phase (Pages et al 1993). In the absence of activated 
p42/44MAPK the cells were arrested in the G0-phase (Pages et al 1993). Lavoie and 
colleagues later discovered that the regulation of cell cycle progression was regulated 
by p42/44MAPK and another MAPK; p38/HOGMAPK (Lavoie et al 1996). 
Activation of the p42/44MAPK pathway resulted in the expression of cyclin D1 and 
G0 to S-phase progression. Activation of p38/HOGMAPK, on the other hand, 
inhibited cyclin D1 transcription resulting in cell cycle arrest. Cyclin D1 expression 
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can also be negatively regulated by transforming growth factor β1 (TGF-β) 
signalling via the MAPK kinase kinase (MKK) transforming growth factor-β 
activating kinase-1 (TAK1) which activates the MKK3/6-P38MAPK pathway 
(Terada et al 1999). This leads to cell cycle arrest (Terada et al 1999). These authors 
also showed cyclin D1 to be positively regulated by the p42/44MAPK pathway 
(Terada et al 1999).   
 
In the kidney both p42MAPK and p44MAPK are expressed and activated in both the 
ureteric bud and in the metanephric mesenchyme of E11 kidneys (Fisher et al 2001). 
Inhibition of MAP kinase kinase 1 (MEK1) and to a lesser extent MAP kinase kinase 
5 (MEK5) resulted in several changes in kidney morphology and cell behaviour 
(Fisher et al 2001). E11.5 kidneys cultured in vitro in the presence of the MEK 
inhibitor exhibited long un-branched ureteric buds where tubule elongation was 
preserved but branching was clearly disturbed (Fisher et al 2001). The formation of 
new branches was abolished by MEK inhibitor concentration dependent manner 
(Fisher et al 2001). Normal apical localisation of actin at the apical surface of cells in 
the ureteric bud tips was found to be reduced or absent. Significantly, the 
proliferation rate was markedly reduced in the ureteric bud (Fisher et al 2001). 
Furthermore, Fisher and colleagues explored upstream regulators of p42MAPK and 
p44MAPK activation and found that in the kidney, GDNF is important for activation 
of these MAP kinases (Fisher et al 2001).  
 
Rac1 is a regulator of MAPKs. In vitro experiments have shown that dominant 
negative Rac1 could effectively inhibit JNK activation and constitutively active Rac1 
had a strong opposite effect (Coso et al 1995; Minden et al 1995). This connection 
between Rac1 and JNK could provide the direct pathway regulating renal progenitor 
cell cultures (Osafune et al 2006). The dominant negative and constitutively active 
Rac1 mutants did not have any effect on the activation of the p42/p44MAPK 
pathway (Coso et al 1995; Minden et al 1995). Rac1 also can activate p38MAPK 
(Minden et al 1995). Interestingly, contrary to previous reports, it has also been 
shown that Rac1 can activate the p42MAPK pathway (Eblen et al 2002). The 
activation of p42MAPK was promoted by cell adhesion to fibronectin, again 
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suggesting a role for Rac-PAK in adhesion regulated cell cycling (Eblen et al 2002). 
The possibility that Rac1 regulates proliferation rates in the kidney needs to be 
investigated in order to better understand possible mechanisms of size regulation. 
 
 
3.1.5 Rac1 and the kidney 
 
Rac1 is present in the majority of embryonic kidney compartments in the mouse 
metanephric kidney (www.GUDMAP.org). Rac1 has been suggested to have a role 
during kidney development where Rac1 affects a planar cell polarity pathway, 
possibly acting through Jun N-terminal Kinase (JNK) (Osafune et al 2006). Osafune 
and colleagues showed that it is possible to culture, in vitro, what they identified as 
embryonic nephron progenitor cells (Osafune et al 2006). In their results they 
described that, Rac1 is capable of regulating the size of such cultures (Osafune et al 
2006). In whole kidney cultures it was demonstrated that, JNK can act as a regulator 
for the size of these kidneys (Osafune et al 2006). The disruption of JNK signalling 
in the nephron progenitor cultures resulted in these cells failing to express markers 
for differentiation (Osafune et al 2006). This previous data demonstrated that Rac1 
might have a role in kidney development but it did not present a mechanism 
accounting for how Rac1 controls nephron progenitor culture sizes or whether Rac1 
might be an upstream regulator of the JNK regulation.  
 
In this chapter I will discuss several experiments carried out in order characterise the 
role of Rac1 during branching morphogenesis and nephrogenesis. In order to regulate 
Rac1 activity I used a commercially available Rac1 inhibitor (NSC23766), which 
blocks Rac1 activation (Gao et al 2004). Point mutation experiments in several 
regions of Rac1 have identified residues important for Rac1-activation by GEF and 
GEF recognition specificity (Gao et al 2004). Through the introduction of point 
mutations into specific regions, referred to as switch I, β2/β3 and switch II of Rac1, it 
was determined that residues 53-72 of Rac1 were important for Rac1/GEF 
recognition (Gao et al 2001). In particular, residue Trp56 in the region known as β3 
was crucial (Gao et al 2001; Gao et al 2004). Trp56 was necessary for Rac1 to 
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recognise GEFs such as Trio, T-cell lymphoma invasion and metastasis 1 (Tiam1) 
and GEF-H1 (Gao et al 2001; Gao et al 2004). When Cdc42F56W mutants were 
generated, these showed similar binding to GEFs as Rac1 (Gao et al 2001; Gao et al 
2004).  Through a structural based virtual screening, chemical compounds were 
identified that were capable of interacting with this region and compound NSC23766 
was isolated (Gao et al 2004). At 50µM, NSC23766 was found to inhibit Tiam 
binding to Rac1 by 50% and TrioN binding to Rac1 at a similar amount (Gao et al 
2004). Significantly, at this concentration the authors were unable to detect any 
effects of the drug on RhoA or Cdc42 binding to their GEFs (Gao et al 2004). The 
authors specified several reason why they argue in favour of NSC23766 acting in a 
Rac1 specific manner and not on other targets (Gao et al 2004). Firstly, NSC23766 
specifically inhibited Rac1 activation by Rac1-specific GEFs and Gao and colleagues 
did not detect any interference of the drug with GEFs that are not Rac1 specific or 
that interact with the other Rho-GTPases RhoA and Cdc42 (Gao et al 2004). 
Secondly, the authors did not detect any effects of NSC23766 on constitutively 
active Rac1 mutants, suggesting that the effects are specific on the activation of Rac1 






3.2.1 Inhibition of Rac1-GTPase reduces ureteric bud branching. 
 
In order to determine whether Rac1-GTPase (Rac1) plays a role during kidney 
development, Rac1 inhibitor NSC23766 was used.  
 
To establish whether Rac1 plays a role during kidney development, whole kidney 
cultures were set up and treated with several different concentrations of NSC2376. 
The highest concentration used was equivalent to that which has been published for 
experiments on mammary gland development (Ewald et al 2008). The lowest 
concentration used was that specified to inhibit 50% of Tiam-Rac1 binding in NIH 
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3T3 cells (Gao et al 2004). The amount/degree of branching was used as indicator 
whether Rac1 inhibition affected ureteric bud branching. The degree of branching 
was assessed by counting the number of ureteric bud tips i.e. the terminal regions of 
the ureteric bud tree that are most distal to the ureter. 
 
Whole kidney cultures were set up as specified in Chapter 2 and maintained for 
72hrs in control conditions or in 50µM, 75µM or 100µM NSC23766. For the 
remainder of the thesis I will interchangeably refer to experimental controls as 
simply “controls” or to samples in “control conditions”. Alternatively, the 
abbreviation for complete kidney culture medium (CKCM) is also used. Controls 
contained a volume of carrier equal to that used in the experimental conditions. To 
count the ureteric bud tips, the cultures were incubated with anti-Calbindin D-28K 
which was detected with a fluorescent secondary anti-mouse antibody that allowed 
for immunofluorescent visualisation of the entire ureteric bud. Calbindin D-28K 
protein is only found in the ureteric bud in the kidney at this stage (Davies 1994). 
Quantification of ureteric bud tips showed that compared to controls (Fig.3.1A,E) 
cultures in 50µM of NSC23766 displayed only 60% of ureteric bud tips (Fig.3.1B,E) 
n=10,10 kidneys, p=0.00034. At 75µM NSC23766 (Fig.3.1C,E) the decrease is 
marginally greater as they have only 58% of the number of tips in control conditions, 
n=9 kidneys, p=0.00057. At the higher concentration of 100 µM (Fig.3.1D,E), the 
cultures had ~48% of the number of ureteric bud tips seen in controls, n=9 kidneys, 
p=0.000006. These reductions in branching were statistically confirmed using 
separate unpaired one-tailed Student’s t-test comparing the number of ureteric bud 
tips in the kidneys in each experimental culture condition against the control kidneys. 
The decrease in branching was not accompanied by abnormal branching morphology 
or abnormal epithelial morphology compared to controls (Fig.3.1A-D). These results 
are in agreement with previously published data, which using a dominant negative 
Rac1, demonstrated that Rac1 positively regulates renal progenitor cell culture size 
(Osafune et al 2006). They showed that cultures with the dominant negative Rac1 
were only 46% of the size of control cultures. This data thus shows that inhibition of 
Rac1 not only affects the renal progenitor cell population but also negatively affects 
an important process of kidney development, namely ureteric bud branching. The 
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concentration chosen for further experiments was 75µM NSC23766 which is lower 
than the 100µM NSC23766 utilised in order to study mammary gland development 












































Fig.3.1 The effects of Rac1 inhibition on kidney branching 
 
Fig.3.1 shows kidneys that were cultured in CKCM or CKCM containing 50µM, 75µM or 100µM 
NSC23766 for 72hrs and then fixed in methanol and stained for Calbindin D-28K-mouse which was 








Kidney cultured in 50µM NSC23766 in CKCM (n=11). (C) Kidney cultured in 75µM NSC23766 in 
CKCM (n=10). (D) Kidney cultured in 100µM NSC23766 in CKCM (n=10). (E) Bar chart showing 
the mean values ± SEM of the number of ureteric bud tips for kidneys cultured in each culture 
condition. Data was analysed separately using unpaired one-tailed Student’s t-tests. T-test p-values 
for: CKCM vs. 50µM NSC23766 p= 0.00034, 50µM NSC23766 vs. 100µM NSC23766 p = 0.014. 
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3.2.2 Inhibition of Rac1-GTPase decreases overall kidney growth and branching in a 
reversible manner. 
 
The effects that the Rac1 inhibitor NSC23766 had on ureteric bud branching required 
additional experiments to characterise these results. Firstly, it was necessary to 
determine whether the effects of the inhibitor were permanent or if the withdrawal of 
the inhibitor would allow for the kidney to revert to normal branching. Secondly, I 
investigated whether the reduced branching could be a result of an overall decrease 
in kidney growth since the branching appeared morphologically normal. The degree 
of kidney growth can be estimated by measuring the diameter of the kidneys in 
culture. Kidneys are not circular, so the diameter will vary depending on where the 
measurements are taken. To take this into account the diameter was derived as an 
approximation by measuring the largest and smallest diameter from the centre of the 
first ureteric bud bifurcation to the kidney periphery. The diameter used was the 
mean of these two values. The degree of branching was again quantified using the 
average number of ureteric bud tips per kidney. These two measurements were both 
used to determine whether the effects of the Rac1 inhibitor were reversible.  
 
Four sets of whole kidney cultures were set up and cultured as follows: 
 
Set Conditions Time (hours) 
A Control conditions 72hrs 
B 75µM NSC23766 72hrs 
C 75µM NSC23766 72hrs 
---> + control conditions 72hrs 
D 75µM NSC23766 72hrs 
---> 75µM NSC23766 72hrs 
Table 3.1 Culture conditions to test reversibility of effects by NSC23766. 
 
In order to test for reversibility, cultures were initially maintained in their respective 
conditions for 72hrs. At that time point set A (Fig.3.2A) and set B (Fig.3.2B), were 
fixed. The other two set of cultures (set C and set D), were maintained for an 
additional 72hrs in control conditions, set C (Fig.3.2C), or in fresh 75µM NSC23766 
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medium, set D (Fig.3.2D). To determine whether the effects were reversible, set A 
was compared with set C. The data was analysed using separate unpaired one-tailed 
Student’s t-tests. There was no significant difference in the average number of 
ureteric bud tips between these cultures, n=7,6 kidneys, p=0.32 (Fig.3.2E). In 
addition, there was no difference in the average diameter of the kidneys in these sets, 
p=0.12 (Fig.3.2F). The control set B, that demonstrates the effectiveness of the Rac1 
inhibitor during the initial 72hrs displayed a reduction in branching compared to set 
A as in previous experiments, (Fig.3.2E), n=7,7 kidneys, p=0.016, thus 
demonstrating the Rac1 inhibitor was effective for the first 72hrs in these 
experiments. The average diameter of SetB was 70% of that in SetA p=0.00019 
(Fig.3.2F). 
Those kidneys in ‘reversed’ conditions, set C, had significantly more tips (Fig.3.2E,) 
than those that were cultured in inhibitor for a total of 144hrs, set D (Fig.3.2D) n=6,6 
kidneys, p=0.00067. They also displayed increased average diameter (Fig.3.2F), 
p=0.013. The same was seen when comparing the ‘reversed’ conditions, set C, with 
those kidneys cultured for 72hrs in inhibitor, set B: average ureteric bud tips 
(Fig.3.2E) n=6,7 kidneys, p=0.006; average diameter (Fig.3.2F) (p=0.00026). These 
results demonstrate that the ‘recovery’ of set C displays real differences to kidneys 
that were not permitted to recover, set D, and have subsequent to the transfer to 
control conditions now branched to a degree much higher than at 72hrs.    
It was also confirmed that kidneys cultured in control conditions exhibit significant 
growth and branching past the initial 72hrs and until 144hrs, n=4,4 kidneys, 
p=0.0016 (Fig.3.2G). This was confirmed to ensure that the significant differences 
described above were indeed direct effects of the drug NSC23766 and not results due 
to limitations of the culture system beyond 72hrs of culture.  
 
This data shows that the addition of NSC23766 to kidney cultures results in 
replicable, quantifiable effects where Rac1 inhibition leads to reduced branching and 
reduced overall growth. The inhibiting effects are reversible through the removal of 
the drug. The complexity of kidney development and the crosstalk of inductive and 
inhibitory signals (Saxen 1987) allows for several hypotheses to be investigated. The 
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multitude of Rac1 functions also adds additional possibilities for how Rac1 inhibition 











































Fig.3.2 The effects of Rac1 inhibition on kidney branching, growth and the 
reversibility of these effects 
 
Fig.3.2 (A-F) shows the effects of and the reversibility of the effects by NSC23766 on growth and 
branching morphogenesis. (A) Kidney cultured for 72hrs in CKCM (n=7). (B) Kidney cultured for 
72hrs in CKCM with 75µM NSC23766 (n=7). (C) Kidney cultured for 72hrs in CKCM with 75µM 
NSC23766 and then transferred to CKCM for an additional 72hrs (n=6). (D) Kidney cultured for 
72hrs in CKCM with 75µM NSC23766 medium and then transferred to CKCM also with 75µM 
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NSC23766 for an additional 72hrs (n=6). Kidneys were stained for Calbindin D-28K which was 
detected with anti-mouse-FITC. Kidneys were also stained with Propidium Iodide (TRITC). (E) The 
graph shows the mean values ± SEM of the number of ureteric bud tips for each treatment category. 
P-values were derived separately using an unpaired one-tailed Student’s t-test. T-test p-values for: Set 
A vs. Set C p=0.32, Set A vs. Set B p=0.016, Set C vs. Set D 0.00067, Set B vs. Set C p=0.006. (F) 
The graph shows the mean values ± SEM of the diameter of kidneys for each treatment category. T-
test p-values for: Set A vs. Set C p=0.12, Set A vs. Set B p=0.00019, Set C vs. Set D 0.013, Set B vs. 
Set C p=0.00026. (G) The bar chart shows the mean values ± SEM of the diameter of kidneys cultured 
in CKCM for 72hrs n=4 and 144hrs n=4, p=0.00016.  
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3.2.3 Inhibition of Rac1-GTPase does not, markedly affect the actin cytoskeleton 
neither in the ureteric bud nor in surrounding mesenchyme. 
 
The distribution of actin filaments within the ureteric bud has been shown to be 
regulated by several proteins and pathways. Inhibition of the RhoA pathway by (use 
of) Rho-Kinase inhibitor Y-27632 results in the loss of apical localisation of actin in 
the ureteric bud tips (Michael, Sweeney, and Davies 2005). The same effect was seen 
when MEK1 and the p42/44MAPK pathway was inhibited (Fisher et al 2001). Rac1 
is closely connected to both the RhoA-pathway (Habas, Dawid, and He 2003; 
Rosenfeldt et al 2006) and it is also possibly connected to the p42/44MAPK pathway 
(Eblen et al 2002). It is therefore necessary to investigate whether Rac1 might also 
regulate this apical actin localisation. 
Kidney cultures were set up in control conditions or in 75µM Rac1 inhibitor 
NSC23766 in order to determine what effect inhibition of Rac1 had on the actin 
cytoskeleton both in the ureteric bud and in the surrounding metanephric 
mesenchyme. Cultures were fixed after 72hrs and stained using FITC-conjugated 
phalloidin, as previously used by Michael, Sweeney and Davies (Michael, Sweeney, 
and Davies 2005). This allowed for high-resolution confocal scanning of the samples 
visualising the actin cytoskeleton. Unlike RhoA, inhibition of Rac1 in kidney 
cultures with 75µM NSC23766 had no discernable effects on the apical actin 
cytoskeleton in the ureteric bud tips. Control kidneys (Fig.3.3A) and those kidneys 
cultured in 75µM NSC23766 (Fig.3.3B) displayed cells with highly structured actin 
cytoskeletons. The ureteric bud tips show slightly elevated localisation of actin to the 
apical and basal surfaces compared to stalk regions. The metanephric mesenchyme 
surrounding the tips, the cap mesenchyme, displays highly organised actin filaments. 
These were also unaffected by the inhibition of Rac1.  
The roles of Rac1 and RhoA are evidently different in terms of their regulation of the 
actin cytoskeleton in the kidney. However, as Rac1 affects the formation of cellular 
lamellipodium (Ridley et al 1992) which is more of a micro-structure, it is not 
expected to affect the localisation of large bundles of actin filaments in the same way 
as the RhoA pathway. Nevertheless, as Rac1 has been shown to both inhibit and 
activate RhoA in different cell types (Nobes and Hall 1995; Rosenfeldt et al 2006) it 
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was a possibility that Rac1 inhibition would have an effect on structures proven to be 






































Fig.3.3 The effects of Rac1 inhibition filamentous actin distribution in the kidney 
 
Fig.3.3 shows the effects of NSC23766 on the distribution of filamentous actin in the ureteric bud tips. 
(A) Kidney cultured for 72hrs in CKCM. (B) Kidney cultured for 72hrs in CKCM supplemented with 
75µM NSC23766. Kidneys were stained for filamentous actin using FITC-conjugated Phalloidin. UB- 













3.2.4 Inhibition of Rac1-GTPase does not affect tip-to-stalk ureteric bud 
differentiation. 
 
The ureteric bud can, during early kidney development, be divided into at least two 
discrete regions; stalks and tips. The stalk regions make up the majority of the 
arboreal collecting duct system, and the ureteric bud tip regions only defines the 
extreme terminal parts of the collecting duct system most distal to the Wolffian Duct 
(Michael, Sweeney, and Davies 2007). During early stages of ureteric bud growth, 
the cells in the ureteric bud tips are capable of differentiating in a tip-stalk direction 
(Shakya, Watanabe, and Costantini 2005; Marose et al 2008). Interestingly, stalk 
regions can also be made to revert to a tip-like state and regain the capability to 
induce nephron formation and to branch (Sweeney, Lindström, and Davies 2008). 
One potential explanation for the reduced branching and growth exhibited by kidneys 
cultured in the presence of Rac1 inhibitor NSC23766 could be a failure of the 
maintenance of the ureteric bud tip identity in appropriate areas.  
I decided to investigate whether the stalk-domain was properly defined and excluded 
from the tip regions when Rac1 activity is inhibited. The lectin Dolichos biflorus 
agglutinin (DBA) binds to the ureteric bud stalk and is excluded from the ureteric 
bud tips (Michael, Sweeney, and Davies 2007). This exclusion is complementary to 
the gene Wnt11 which is normally expressed only in the ureteric bud tips (Kispert et 
al 1996; Michael, Sweeney, and Davies 2007). If ureteric bud branching is artificially 
inhibited by reducing GDNF signalling, the DBA binding expands to the tip regions 
(Michael, Sweeney, and Davies 2007). This suggests that DBA can be used as an 
indicator of whether the tip identity is maintained and functional. Kidney cultures 
were set up and cultured for 48hrs in control conditions or in medium with 75µM 
NSC23766. After fixation, the cultures were stained using anti-β-laminin which was 
detected with anti-rabbit-TRITC. FITC-conjugated DBA was also used. β-laminin is 
present in the whole of the ureteric bud. Controls showed a normal distribution of 
DBA (Fig.3.4A). DBA is clearly excluded from the tips. Demonstrating the areas of 
co-localisation of laminin and DBA-binding (Fig.3.4A’) clearly shows that co-
localisation does not occur in the ureteric bud tips. Cultures in Rac1 inhibitor 
displayed the same exclusion of DBA from the ureteric bud tips (Fig.3.4B) which is 
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again highlighted by illustrating the co-localisation of DBA-binding and laminin 
(Fig.3.4B’). These results indicate that normal ureteric bud stalk-tip identities are 
maintained. In order to ensure that the ureteric bud tip regions are normal, in addition 
to determining whether the ureter forms normally, it would be necessary to look at 
markers specific for those regions. Wnt11 would be a good marker to study the 
ureteric bud tip regions and Uroplakin, a marker of ureter differentiation, would be 
suitable to determine whether the ureter differentiates normally (Kispert et al 1996; 
































Fig.3.4 The effects of Rac1 inhibition on kidney stalk-tip boundaries  
 
Fig.3.4 shows kidneys that were grown for 48hrs in CKCM with or without Rac1 inhibitor NSC23766 
before being stained for laminin-rabbit and FITC-conjugated DBA-lectin. The β-laminin antibody was 
detected with anti-rabbit-TRITC. (A) Kidney cultured in CKCM. (B) Kidney cultured in CKCM with 
75µM NSC23766. (A’,B’) shows the points of co-localisation of laminin and DBA-lectin 
demonstrating the absence of DBA binding from ureteric bud tips in both conditions. 
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50µm 








3.2.5 Inhibition of Rac1-GTPase does not negatively affect nephrogenesis or 
nephron maturation and differentiation. 
 
Kidney development is regulated by elaborate cross-talk between the ureteric bud 
and the metanephric mesenchyme components (Sainio et al 1997; Carroll et al 2005). 
Mesenchymal factors such as WT1 and GDNF have been shown to be necessary for 
ureteric bud induction and branching (Kreidberg et al 1993; Sainio et al 1997). 
Inhibition of Rac1 in cultured kidneys results in reduced ureteric bud branching and 
reduced kidney growth. A possible explanation for these reductions might be a 
disturbed development of the mesenchymal portion of the kidneys as this could lead 
to abnormal mesenchymal-to-ureteric bud signalling. Several reasons make it 
interesting to consider whether Rac1 could regulate nephron formation. Firstly, the 
branching defects observed upon Rac1 inhibition may not have been a result of direct 
effects of the inhibitor on the ureteric bud as demonstrated in Wnt4 mutant mice 
(Wnt4 is only expressed in the nephrogenic structures in the metanephric 
mesenchyme) where the absence of nephrons also results in greatly reduced 
branching (Stark et al 1994). Secondly, Rac1 is a component of the planar cell 
polarity pathway and it has previously been shown that Rac1 regulates renal 
progenitor cell cultures by controlling the culture size (Osafune et al 2006). In 
addition, the downstream effector of Rac1, JNK, regulates the differentiation and 
expression of markers for nephron maturation in progenitor cell cultures (Osafune et 
al 2006). Thirdly, Rac1 might regulate nephron development in a previously 
unknown mechanism. As discussed in Chapter 1, the mechanisms behind the 
formation of the pretubular aggregates, renal vesicles and glomerular cleft are 
unknown. One possibility is that Rac1 might control part of these processes, either by 
affecting cellular motility which could be important for pretubular aggregate 
formation or perhaps by the regulation of cell adhesion or the progression through 
the mesenchymal-to-epithelial transition. Regulation of Rac1 activity has been linked 
to the mesenchymal-to-epithelial transition during somitogenesis (Takahashi et al 
2005). 
Here, I have divided nephrogenesis into three parts where I investigate the important 
of Rac1. For a complete picture of nephron formation, please read the detailed 
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descriptions in Chapter 1. The first stage is the developmental phase of the nephron 
that spans the period between the initial induction of cap metanephric mesenchyme 
until the stage where the epithelial renal vesicle is formed. The second stage is the 
phase that encompasses the comma- and s-shaped body stages. These are particularly 
important as a large array of processes is initiated at this point. Most notably of these 
processes are the formation of the glomerular cleft, specification of the parietal and 
visceral epithelia, podocyte differentiation, and the proper structural and genetic 
differentiation of the proximal-distal axis (Saxen 1987). The third stage contains the 
development and maturation that occurs post s-shaped body stage. This is mainly 
characterised by the differentiation of the elements that contribute to the 
segmentation along the proximal-distal axis. Several cadherins display selective 
expression patterns along the proximal-distal axis suggesting differential adhesion 
might play a role during nephron maturation (Cho et al 1998; Dahl et al 2002). 
 
  
3.2.5.1 Inhibition of Rac1-GTPase does not affect the cap mesenchyme or the 
formation of renal vesicles. 
 
The first nephron stages to be considered here are the cap mesenchymes, the 
pretubular aggregates and the renal vesicles that are the earliest nephrogenic 
structures (Little et al 2007). The cap mesenchyme surrounding the ureteric bud tips 
expresses neural cell adhesion molecule (NCAM) and this expression endures during 
the formation of the nephrogenic pre-tubular aggregates and into the renal vesicle 
stage (Klein et al 1988a; Bard et al 2001). This makes it an excellent marker to 
visualise early nephron formation from the stage of cap mesenchyme until renal 
vesicle.  
Kidney cultures were set up in control conditions (Fig.3.5A) or in 75µM NSC23766 
(Fig.3.5B) for 72hrs and stained for NCAM and counterstained with TO-PRO-3 to 
visualise the nuclei. Confocal microscopy revealed NCAM distribution in controls 
and in experimental set-ups with indistinguishable localisation patterns. The cap 
mesenchyme in controls and in experimental conditions displayed similar levels of 
NCAM in the cap mesenchyme. The cap mesenchyme is highly ordered as is also 
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shown by immunofluourescent imaging of its actin cytoskeleton (Fig.3.3). Cultures 
with Rac1 inhibitor also displayed morphologically normal renal vesicles compared 
to controls. This data strongly suggests that inhibition of Rac1 does not perturb 
normal renal vesicle formation. The renal vesicles in control conditions and in 
experimental conditions appeared similar in size. The size of the nephrons was not 
quantified. The reason for this is that it would be very difficult to generate 
meaningful data regarding the nephron sizes. This is because nephrons form in a 
sequential and continuous manner and an average size for a nephron would thus have 
to depend on its exact stage. Whilst it is possible to stage a nephron with some 
certainty, even nephrons within a stage will vary in size depending on whether they 
are in the beginning of that stage or just about to progress into the next 
developmental phase. The size of the nephrons could be an important issue since it 
has been shown that the size of nephron progenitor cell cultures is regulated by JNKs 




























Fig.3.5 The effects of Rac1 inhibition on early nephrogenesis. 
 
Fig.3.5 shows E11.5 kidneys that were cultured in CKCM with or without 75µM Rac1- inhibitor 
NSC23766 for 72hrs and fixed in -20ºC methanol before being stained with anti-NCAM. The NCAM 
antibody was detected using anti-mouse-FITC. TOPRO-3 (Cy5) was used to stain the cell nuclei. (A) 
Kidney cultured in CKCM. (B) Kidney cultured in CKCM with 75µM NSC23766. NCAM expression 



























conditions. White arrows – pretubular aggregates and renal vesicles. (A’ and B’) show schematic 
representations of numbered nephrons in (A and B). Diagrams were produced by careful inspection of 
nephrons at maximum resolution. UB- ureteric bud, MM-metanephric mesenchyme, CM-cap 
mesenchyme. 
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3.2.5.2  Inhibition of Rac1-GTPase does not affect the formation of comma- 
and s-shaped bodies or podocyte differentiation. 
 
Subsequent to the renal vesicle stage is the comma-shaped body stage and then the s-
shaped body stage (Saxen 1987; Little et al 2007). In the mouse, Wilms Tumour 1 
(WT1) is expressed at low levels in the metanephric mesenchyme and, as the 
nephron matures and develops, the expression of WT1 become significantly elevated 
in the comma-shaped body and in the S-shape body (Armstrong et al 1993; Huber et 
al 2000). Comma- and s-shaped body stage nephrons are characterised by the 
differentiation of the parietal and visceral epithelia. Here I use WT1 as a tool to 
indicate both podocyte differentiation and the development of the visceral and 
parietal epithelia. WT1 is a suitable marker for this because it can be use to both 
show that podocyte differentiation initiates and it can also be used as a structural 
marker because its localisation pattern highlights the characteristic physical 
appearance of the flattened parietal epithelium which is separated from the columnar 
visceral epithelium by the Bowman’s space (see Fig.1.2 for a structurally labelled 
nephron). 
Kidney cultures and spinal cord-induced mesenchyme cultures were set up to 
investigate whether Rac1 plays a role during the formation and differentiation that 
takes place to form the comma- and s-shaped bodies. The purpose of using both sets 
of cultures was to:  
 
A) In whole kidney cultures demonstrate whether podocyte differentiation and 
comma-, s-shaped body stage nephron formation is affected by Rac1 
inhibition. 
B) Assess whether any potential effects of Rac1 inhibition were a result of Rac1 
affecting the ureteric bud. 
 
As described in Chapter 2, metanephric mesenchyme can be separated from the 
ureteric bud at E11.5 and cultured in the presence of spinal cord in order to induce 
nephron formation (Saxen 1987). In such cultures, typical comma- and s-shaped 
bodies form (Saxen 1987). Whole kidney cultures were set up in control conditions 
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(Fig.3.6A) or in 75µM NSC23766 (Fig.3.6B). Cultures were maintained for 72hrs 
and subsequently fixed and stained for Calbindin D-28K and WT1. Calbindin D-28K 
is found exclusively within ureteric bud during early kidney development. Nephrons 
that formed in the presence of Rac1 inhibitor NSC23766 showed similar 
development to those nephrons that formed in control cultures. Nephrons in both 
cultures had progressed to a similar degree of maturation. Podocyte differentiation 
occurred in both conditions. Spinal cord induction cultures in control conditions 
(Fig.3.6C) and in experimental conditions (Fig.3.6D) showed normal nephron 
development and podocyte differentiation. Control and experimental cultures 
displayed structurally correct visceral and parietal epithelia separated by a lumen. 
The spinal cord induction cultures were also stained for Calbindin D-28K to ensure 
that no ureteric bud fragments remained in the cultures. The TRITC stain in the 
images is shown to display the fluorescence background levels. These results 
indicate that inhibition of Rac1 does not disturb nephron development from renal 
vesicle stage to comma- and s-shaped body stages in terms of visceral and parietal 




































































Fig.3.6 The effects of Rac1 inhibition on the formation of comma-shaped and s-
shaped nephrons and podocyte differentiation 
 
Fig.3.6 shows whole kidney cultures (A,B) and metanephric mesenchyme that was induced using 






stained with Calbindin D-28K-Rabbit and WT1-Mouse antibody stains. Primary antibodies were 
detected using anti-rabbit-TRITC and anti-mouse-FITC. (A) Whole kidney in CKCM. (B) Whole 
kidney in CKCM supplemented with 75µM NSC23766. (C) Metanephric mesenchyme in CKCM. (D) 
Metanephric mesenchyme in CKCM supplemented with 75 µM NSC23766 medium. 
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3.2.5.3  Inhibition of Rac1-GTPase does not affect nephron maturation. 
 
Rac1 inhibition appears not to be important during early stages of nephron formation, 
or during the formation of podocytes and the glomerular cleft, as shown in previous 
sections. The final stage that I decided to investigate follows the s-shape body stage. 
This stage of nephron development is mainly characterised by the nephron 
elongating and acquiring the segmentation that is associated with the mature nephron 
as well as becoming vascularised (Saxen 1987). During the formation of the 
proximal-distal axis, a planar axis, the nephron organises itself into several 
molecularly distinct segments. The mature nephron has recently been characterised 
in terms of the expression pattern of the large number of solute-carriers that are 
found in the nephron. The mature murine nephron displays, 8 solute-carrier defined 
segments (Raciti et al 2008). These segment markers, in addition to others, can be 
used as indicators for nephron development as many are only expressed when the 
nephron matures. I set up experiments in order to evaluate whether the inhibition of 
Rac1 affects proximal-distal axis differentiation. 
 
 CD15 is a protein marker exclusively present in the proximal portions of the 
developing tubule (Bard and Ross 1991; Davies 1994). Expression of CD15 can only 
be weakly detected at the s-shaped body stage but becomes higher during maturation. 
Kidney cultures were set up in control conditions (Fig.3.7A,C) or in medium with 
75µM NSC23766 (Fig.3.7B,D). The cultures were maintained for 144hrs to allow for 
progression beyond the s-shaped body stage. The cultures were fixed and stained for 
CD15 and β-laminin to show the proximal tubule and the basal membrane. Nephrons 
forming in control conditions and those forming in experimental conditions showed 
normal morphology and displayed typical localisation of CD15 to the apical domain 
of proximal tubules. The nephrons also showed fusion to the collecting duct system. 
The segments of the nephrons adjacent to the ureteric bud (distal tubule) were 
negative for CD15 staining. It has previously been shown that JNK, a downstream 
effector of Rac1 in the planar cell polarity pathway, is necessary for the expression of 
markers indicative of nephron maturation in nephron progenitor cell cultures 
(Osafune et al 2006). As previously mentioned, the nephron progenitor cells cultures 
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were derived from single-cell colonies of Sall1 positive cells that were expanded and 
cultured on Wnt4 expressing 3T3 cells (Osafune et al 2006). This makes those 
cultures very different to the whole kidney cultures I have used here since the 
nephron progenitor cultures are two dimensional and at the very best only contain 
parts of the environment that nephrons in a kidney are normally exposed to. I found 
no evidence to support the hypothesis that Rac1 is necessary for nephron maturation 
as the maturing nephrons that formed during Rac1 inhibition were morphologically 
normal and displayed characteristic proximal-distal differentiation.  
 
As a summary to the data presented here, which relates to nephron formation and 
development, this data suggests that nephron development, as has been studied at 
several different stages of maturity, appear to proceed normally in the presence of 
75µM of the Rac1 inhibitor drug NSC23766. This apparently normal nephron 
development makes it unlikely that the effects exhibited by the inhibitor on 
branching and growth rates were secondary effects resulting from abnormal 
nephrogenesis. The same concentration of inhibitor produced the branching and 
growth defects. This is one of the areas that unfortunately do not display the depth of 
investigation that I would have wished for but this was suffered in order to focus on 
the Rho-kinase research. This data does not contradict the work by Osafune and 
colleagues (Osafune et al 2006), however, it does not directly agree either. Their 
research showed that inhibiting JNK1 and JNK2 can alter the ‘differentiation’ of the 
nephron progenitor cell cultures by blocking the expression of several genes that 
indicate nephron maturation. The reason for considering that the inhibition of Rac1 
might result in similar results is based on the knowledge that Rac1 regulates JNK in 
the planar cell polarity pathway (Habas, Dawid, and He 2003), a pathway thought to 
be active in the nephrons (Park, Valerius, and McMahon 2007). A real possibility is 
that, although the concentration of Rac1 inhibitor used here produces branching 
defects and correlates well with what others have used (Ewald et al 2008), I have 
inhibited Rac1 insufficiently to alter nephrogenesis. The explanation might lie in that 
although I might have inhibited Rac1 activity by 80%, nephron formation might only 
require 5% of normal Rac1 activity. This was the next step that would have been 
pursued if the Rac1 research had been prioritised. It is possible to assess the level of 
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Rac1 activity utilising an assay system where active Rac1 bound to GTP is pulled 
down using a pull-down assay binding active Rac1 to a PAK1 fusion protein tagged 
to glutathione. Thus it might have been possible to affect nephron formation with 
more optimised levels of Rac1 inhibition. 
It is important to bear in mind that Rac1 might not act via the planar cell polarity 
pathway in the nephrons and therefore the effects of JNK1 or JNK2 inhibition are 
completely unrelated. Equally possible is that JNK1 and JNK2 are not regulated via 
the planar cell polarity pathway but are activated through different signals. It is also 
important to note that the effects of JNK1 and JNK2 inhibition were studied in a 
more artificial environment than the whole kidney cultures used here which are 
likely to be significantly better at mimicking in vivo development. Another prospect 
is that Rac1 does not actually play a role during nephron development, yet still 
negatively affect the transduction of signals from the nephron to surrounding tissues 
and in that way regulate ureteric bud branching and growth. Rac1 might play a role 
in other components of the metanephric mesenchyme, such as uninduced 






































































Fig.3.7 The effects of Rac1 inhibition on nephron proximal-distal segments 
 
Fig.3.7 shows whole kidney cultures set up in CKCM with or without 75µM Rac1- inhibitor 
NSC23766 and cultured for 144hrs. Cultures were fixed in -20ºC methanol before being stained for 
















tubules. The primary antibodies were detected using anti-rabbit-TRITC and anti-mouse-FITC. (A,C) 
Kidneys cultured in CKCM. (B,D) Kidneys cultured in CKCM with 75µM NSC23766. White arrows 
– nephrons expressing CD15 normally. (A’-D’) show schematic representations of numbered 
nephrons in (A-D). Nephrons are in turquoise and the UB in black. Green portions of the nephron 
signifies regions positive for CD15. Diagrams were produced by careful inspection of nephrons at 
maximum resolution.  
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3.2.6 Proliferation as a mechanism for growth and branching in the kidney. 
 
Previous experiments discussed in Chapter 3 have shown that inhibition of Rac1 
negatively affects the rate of branching and growth in kidneys in culture and that 
these effects are likely not to be a result of abnormal nephron development. As is 
described in Chapter 1, cellular proliferation is a potential mechanism of 
morphogenesis that may be required not only for ureteric bud induction but also 
during subsequent branching and growth (Michael and Davies 2004). This was 
demonstrated by both the relatively higher rates of cellular proliferation seen in the 
ureteric bud tips, but also by the evidence showing that inhibition of proliferation 
results in reduced ureteric bud induction (Michael and Davies 2004). One example of 
a proliferation stimulating factor is glial cell line derived growth factor (GDNF), 
which is considered a central kidney growth factor (Michael and Davies 2004; 
Shakya, Watanabe, and Costantini 2005). Rac1 has been demonstrated to play an 
important role during cell cycling and proliferation as is covered in the introduction 
to Chapter 3. In light of previous experiments in Chapter 3, and from the knowledge 
that Rac1 can regulate proliferation rates (Minden et al 1995), I investigated the 
possibility that the effects that inhibiting Rac1 had on branching and growth were a 
result of reduced proliferation. This is a prospect that would fit well with the 
unchanged morphology of the kidney and the ureteric bud as well as the overall 
“general reduction” in kidney growth that is displayed in cultures with Rac1 
inhibitor. The possibility that Rac1 might regulate proliferation was always 
considered and experimental analysis of this was initiated directly when it was 
demonstrated that the inhibition Rac1 reduces branching and overall growth. These 
experiments represent an important portion of the findings presented in this chapter. 
The original thought was to discuss the effects of Rac1 on proliferation directly after 
I discussed how Rac1 reduces branching and growth. However, because several 
experiments were carried out, each adding support to the previous ones, it became 
clearer to discuss all experiments together. Thus I have decided to aggregate these 
findings and discuss them in a more unified and coherent manner with the advantage 
of looking back at the previously described result and perhaps offer some more 
insightful conclusions. The experiments are presented in sections 3.2.6-3.2.8. In 
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these sections I will discuss: (1) experiments studying proliferation in the ureteric 
bud tips using Bromodeoxyuridine; (2) problems with the approach using 
Bromodeoxyuridine and the solutions to these problems using phosphorylated 
histone 3 as a mitosis marker; (3) possibilities of mimicking branching defects by 
inhibiting proliferation; (4) the prospect of proliferation directly regulating branching 
as well as Rac1 only regulating proliferation in the kidney. 
 
 
3.2.7 Inhibition of Rac1-GTPase negatively affects proliferation in the kidney as 
shown using BrdU. 
 
Cell proliferation was analysed using Bromodeoxyuridine (BrdU) in a manner 
previously optimised by Michael and Davies and used for publication (Michael and 
Davies 2004). A detailed protocol for BrdU experiments and the image analysis 
carried out can be found in Chapter 2. Kidneys were cultured for 46hrs of which the 
last 16hrs were in 100µM BrdU. Cultures were maintained in either control 
conditions or in 75µM NSC23766.  After fixation, the cultures were staining for 
BrdU and Calbindin D-28K. Kidneys were scanned on a Leica TCS-NT confocal 
microscope at 3µm intervals on the z-axis. BrdU incoproration was expressed as the 
average number of BrdU positive nuclei per 1000µm
2
 of kidney tissue as discussed 
by Michael and Davies (Michael and Davies 2004). BrdU positive nuclei were 
identified by applying a consistent threshold to reduce background and identify true 
positives. The choice to describe proliferation of cells based on the area, rather than 
as a percentage of the number of nuclei, stemmed from the paper by Michael and 
Davies (Michael and Davies 2004). They discuss that the thickness of the kidneys in 
culture makes it difficult to reliably label nuclei. Michael and Davies also mention 
that using histological sections is not ideal either since it can be difficult to 
differentiate ureteric bud tips from other tubules in these sections (Michael and 
Davies 2004).  
  
BrdU positive nucleu were counted in the ureteric bud tips, as described by Michael 




 was found in ureteric bud tips of kidneys cultured in control conditions 
(Fig.3.8A) and those in experimental cultures (Fig.3.8B). Two experiments were 
carried out. In the first experiment, 16 and 9 ureteric bud tips from kidneys in control 
and experimental conditions were analysed. In the second experiment, 11 and 9 
ureteric bud tips were analysed, respectively. The difference in the number of tips 
analysed stems from that the kidneys in Rac1 inhibitor conditions branched less. 
Data from experiment 1 suggest an average decrease of 24% of BrdU positive nuclei 
in ureteric bud tips in Rac1 inhibitor conditions, p=0.066 as was analysed using an 
unpaired one-tailed Student’s t-tests (Fig.3.8C). The variability is expressed using the 
standard error of the mean (SEM). Data from experiment 2 displayed an average 
decrease of 24%, p=0.0027 (Fig.3.8C). Combining the data from experiment 1 and 
experiment 2 for analysis (27 control ureteric bud tips and 18 experimental tips) 
resulted in the data showing an average of 20% reduction in the number of BrdU 
positive nuclei in experimental ureteric bud tips, p=0.054 (Fig.3.8C). A reduction of 
BrdU incorporation, and thus also possibly proliferation rates, could be hypothesised 
to lead to a reduction in the ureteric bud size. In order to determine whether this was 
the case, the data from section 3.2.1 was reanalysed. The branch lengths were 
measured in every kidney from the first bifurcation of the ureteric bud and of along 
each branch to every ureteric bud tip. This gave a good estimate to what degree if 
any, that the ureteric bud had decreased in size. For the kidneys in control conditions, 
5 kidneys were analysed and 154 branch distances were measured. For the kidneys in 
75µM NSC23766, 6 kidneys were analysed and 120 branch distances were 
measured. Again, the lower number of branch distances was a result of the 
experimental kidneys displaying reduced branching. The average branch length for 
control kidneys was 465.7µm ± 7.6µm (SEM) and for experimental kidneys it was 
343.9µm ± 7.0µm (SEM). The average branch lengths in kidneys cultured in 75µM 
Rac1 inhibitor was 73% of that in control kidneys (p=1.72x10
-25
) as analysed using 
an unpaired one-tailed Student’s t-test. This reduction in ureteric bud length closely 




The BrdU analysis provided some problems that were necessary to tackle. The 
problems and the solutions that were chosen are discussed in the following 
paragraph. I have chosen to discuss these issues here because it is important to 
understand the problems with BrdU and the reasons for changing the strategy of 
indicating cellular proliferation before continuing with the next results sections.   
 
The data from the BrdU analysis were statistically significant; however, the samples 
displayed a large degree of variation in terms of the average number of BrdU 
positive nuclei per 1000µm
2
. For the controls, the average number of BrdU positive 
nuclei per 1000µm
2
 was 4.14 in experiment 1 and 7.7 positive in experiment 2. This 
is almost a 2 fold difference. This variation might be accountable for by the problems 
with BrdU antibody staining, which on kidney explants proved to be difficult and 
often yielded very variable background noise from non-specific antibody binding. A 
second problem was the presentation of BrdU positive nucleu as a fraction based on 
a unit area. Combining the measurement of a specific number of nuclei with an area 
presented problems mainly because of the possibility of variable cell densities. 
Although this was not a major problem when analysing proliferation in the ureteric 
bud, which is relatively uniform, it did pose problems when considering extending 
the analysis to the rest of the kidney. The metanephric mesenchyme might have 
displayed large variations in cell density in particular as a result of nephron 
formation thus making it difficult to interpret any results in a meaningful way. A 
third problem might be a result of analysing only ureteric bud tips and not whole 
sections. The analysis of a smaller number of cells will automatically increase the 
potential for variation. Fourthly, one important aspect of using BrdU is the use of a 
suitable BrdU incubation period. This period had previously been described by 
Michael and Davies and it had been shown that the period could be reduced from 
16hrs to 4hrs without reducing the proportional differences seen in BrdU 
incorporation displayed between ureteric bud tips and stalk regions (Michael and 
Davies 2004). This suggests that, as long as the incubation period was consistent 
between control and experimental conditions, any variation should be detectable. 




The problems with BrdU originated mainly from that the BrdU antibodies did not 
work well. I chose to approach this problem by testing the use alternative markers of 
proliferation. Mitosis-specific marker, phosphorylated histone 3-Ser10 (H3(p)), 
which can be detected using a specific antibody, presented such an alternative. Using 
H3(p) as a marker for proliferation added the benefit of marking only those cells that 
were currently in mitosis, as opposed to BrdU which marked all cells that went 
through synthesis within the BrdU incubation period. As a result, using H3(p) 
eliminated both the use of BrdU and the necessity to determine an optimal BrdU 
incubation period. During the optimisation of the H3(p) strategy some issue arose. 
Firstly, problems were seen with the depth that the H3(p) would enter the kidney 
tissue and remain easily detectable with the secondary fluoropore-conjugated 
antibody. This could present problems during the quantification of H3(p) positive 
nuclei because poor antibody penetration could mimic low detection levels and 
falsely indicate a low proportion of cells in mitosis. In order to ensure that this would 
not affect the quantification, the sections analysed were consistently chosen so that 
the same µm depth from the surface of the kidney was analysed for each kidney and 
in each culture condition. Secondly, the H3(p) antibody displayed some diffuse non-
specific binding which decreased the reliability of categorising nuclei as positive or 
negative for H3(p) binding. Antibody optimisation using blocking solutions with 
serum markedly reduced this. These modifications to the protocol appeared to 
provide good solutions since the antibody staining was thereafter consistent, clear 
and readily quantifiable in the sections analysed. The protocol is described in detail 
in Chapter 2. 
 
Another problem with the BrdU technique was the issue that came from presenting 
the BrdU incorporation as a function of unit area, in particular as I wished to analyse 
proliferation throughout the kidney tissues. Michael and Davies opted for the ‘area’ 
approach because they described difficulties with reliably labelling nuclei in whole 
kidneys (Michael and Davies 2004). I encountered the same problems in attempting 
to label whole kidneys with nuclei marker TO-PRO-3. However, the penetration of 
the TO-PRO-3 nucleic dye was actually better than expected, and did not present 
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major problems when analysing sections that were all at the same µm depth, as 
described in the previous paragraph. Using the nucleic marker TO-PRO-3 allowed 
for rapid semi-automated quantification of the total number of nuclei. This meant 
that the number of mitotic cells could be expressed as the number of H3(p) positive 
nuclei over the total number of nuclei within a section. As a result it provided a 
robust protocol for measuring the mitotic index that could be used to analyse whole 
sections of kidneys as opposed to small regions. A detailed protocol is described in 
























































Fig.3.8 The effects of Rac1 inhibition on ureteric bud tip BrdU incorporation. 
 
Fig.3.8 shows kidneys that were dissected and cultured in CKCM or CKCM supplemented with 75µM 
NSC23766. The kidneys were cultured for 30hrs and then exposed to 100µM BrdU for an additional 
16hr period after which the kidneys were fixed and stained with rabbit anti-Calbindin antibody and 
mouse anti-BrdU antibody which were detected using anti-rabbit-FITC and anti-mouse-TRITC 
secondary antibodies. (A) Kidneys cultured in CKCM. (B) Kidneys cultured in CKCM supplemented 
with 75µM NSC23766. (C) Bar-Chart indicating the mean values ± SEM of BrdU positive nuclei 
detected per 1000µm
2
 of ureteric bud tip for each treatment. P-values were derived separately using 
unpaired one-tailed Student’s t-tests.  
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3.2.8 Mimicking effects of Rac1 inhibition by direct inhibition of proliferation. 
 
The inhibition of Rac1 produced replicable effects on BrdU incorporation. It is 
important to verify these results using the more reliable H3(p) method. It is also 
necessary to determine whether the effects of inhibiting Rac1 on branching are 
entirely the result of the effects seen on BrdU incorporation and thus DNA synthesis. 
To resolve this, proliferation was directly inhibited using Methotrexate (MTX), 
which stops proliferation by blocking DNA synthesis and cell cycling (Chabner and 
Young 1973). The aim of directly blocking cell cycling, was to determine three 
things: (A) to show whether the direct inhibition of proliferation reduces the rate of 
branching; (B) to optimise MTX concentrations to inhibit branching to a degree 
equivalent to that achieved by Rac1 inhibition; (C) to determine whether the equally 
reduced branching as produced by MTX and Rac1 inhibitor results in an equivalent 
decrease in proliferation; as estimated by BrdU incorporation. The third point is the 
most significant as it will establish whether inhibition of Rac1 might affect other 
kidney functions in addition to cellular proliferation.  
 
 
3.2.8.1  Direct inhibition of proliferation reduces branching. 
 
In order to show whether direct inhibition of proliferation results in reduced 
branching, kidneys were cultured in control conditions or in a range of different 
MTX concentrations using the 500nM concentration previously used by (Davies et al 
1995) as a starting point. Kidneys were cultured for 96hrs in control conditions, 
50nM, 250nM or 500nM MTX (Fig.3.9A-D), respectively. Cultures were stained for 
Calbindin D-28K in order to allow for the quantification of branching by counting 
ureteric bud tips. Compared to kidneys cultured in control conditions (Fig.3.9A,E) 
(n=5kidneys), those cultured in 50nM MTX (Fig.3.9B,E) showed no decrease in the 
average number of branches or abnormal branching morphology (p=0.44, n=4 
kidneys). P-values were derived using unpaired one-tailed Student’s t-tests. Kidneys 
cultured in 250nM MTX (Fig.3.9C,E) exhibited a 32% reduction in branching 
(p=0.08, n=5 kidneys). Kidneys cultured in 500nM MTX (Fig.3.9D,E) displayed a 
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52% reduction in branching (p=0.002, n=5 kidneys). The branching morphology of 
the kidneys cultured in 250nM and 500nM MTX was different from that observed in 
control kidneys. It is also different from kidneys cultured in 75µM or 100µM 
NSC23766 (Fig.3.1C,D), where the degree of reduction in branching is similar. 
Although it was difficult to articulate the difference in branching morphology, the 
term “umbrella-like” was ascribed to those ureteric buds seen in high concentrations 
of MTX.  
Firstly, these results demonstrate that the direct inhibition of proliferation results in 
decreased branching. Secondly, this data shows that 250nM MTX results in a 
decrease in branching (32%) that falls within the range also seen in cultures with 















Fig.3.9 The effects of proliferation-inhibition on kidney branching. 
 
Fig.3.9 shows E11.5 kidneys that were dissected and cultured in various concentrations of 
methotrexate (MTX) (SIGMA, M8407). After 96hrs of culture, the kidneys were fixed in methanol 
and stained for Calbindin-D28K. (A) Control kidneys cultured in CKCM, n=5 kidneys. (B) Kidneys 







MTX, n=5 kidneys. (D) Kidneys cultured in CKCM with 500nM MTX, n-5 kidneys. (E) Bar chart 
showing the mean values ± SEM of the number of ureteric bud tips for kidneys cultured in each 
culture condition. Data was analysed separately using unpaired one-tailed Student’s t-test. T-test p-
values for: CKCM vs. 50nM MTX p= 0.44, CKCM vs. 250nM MTX p= 0.04, CKCM vs. 500nm 
MTX p= 0.002. The colour in images (A-D) has been inverted for contrast and display purposes. 
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3.2.8.2 Inhibition of proliferation might account for Rac1 inhibitor effects on 
branching and growth. 
 
I have shown that directly blocking proliferation with MTX reduces ureteric bud 
branching. This answers question (A) in the previous section. I also showed that a 
250nM of MTX reduces branching similarly to 75µM NSC23766. This completes 
question (B). Question (C) asked whether it is possible to phenocopy the effects of 
Rac1 by just inhibiting proliferation. To answer this questions it is necessary to 
quantify the decrease in proliferation produced by 250nM MTX and 75µM 
NSC23766. If 75µM of the Rac1 inhibitor reduces both branching and proliferation 
equally to 250nM MTX, this would suggest that the reduced branching is solely an 
effect of decreased proliferation.  
 
Experiments were set up where kidney cultures were maintained for 46hrs in control 
conditions, 75µM NSC23766, 150nM MTX or 250nM MTX. Kidneys were fixed 
and stained for H3(p), E-cadherin and nuclei marker TO-PRO-3. Proliferation were 
quantified using the H3(p) protocol where the number of mitotic cells was expressed 
as a percentage of the total number of nuclei present on each section analysed.  
 
In control conditions (Fig.3.10A,E), 3.27% of detectable nuclei were positive for 
H3(p), and thus in mitosis. This value corresponds quite well with previously 
published mitotic indeces for the kidney (Foley and Bard 2002) where the authors 
used nuclear morphology, as visualised by Propidium Iodide stains, as an indicator of 
cells in mitosis. The mitotic index described therein was 2.1% (Foley and Bard 
2002). Significantly, their work was carried out on kidneys not cultured in vitro but 
directly dissected for fixation and staining. Differences in the protocol and the mouse 
strains as well as the serum used in my experiments could account for the slightly 
higher proliferation rate recorded in my samples. The proliferation rate for kidneys in 
control conditions was determined by analysis of 18 sections from 9 kidneys. 
Quantification of proliferation rates in kidneys cultured in 75µM NSC24766 was 
previously done using BrdU. Here it was repeated using the H3(p) method. Kidneys 
cultured in 75µM NSC24766 contained an average of 2.16% of cells that were in 
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mitosis (Fig.3.10B,E). This represents a 34% reduction in the number of cells in 
mitosis compared to those kidneys in control conditions, p=0.0088. The same 
number of slides and kidneys were analysed for the samples cultured in 75µM 
NSC23766 as in controls. The P-values were calculated using unpaired one-tailed 
Student’s t-tests with the standard error of mean (SEM) as the indicator of sample 
variability. This decrease in proliferation is similar to that described when using 
BrdU to detect proliferating cells. There, the decrease of BrdU incorporation was 
estimated to be 20-24%.  
The analysis of kidneys cultured in 150nM (Fig.3.10C) or 250nM (Fig.3.10D) MTX 
showed that 2.73% and 1.34% of cells were in mitosis (Fig.10E). These percentages 
represents reductions of 18% (p=0.069) and 58% (p=0.00029) compared to controls, 
respectively. For the 150nM and the 250nM concentrations, 12 slides and 6, from 6 
and 3 kidneys were analysed, respectively. The percentage of mitotic cells in control 
conditions, 75µM NSC23766, 150nM MTC and 250nM MTX were thus: 3.27%, 
2.16%, 2.73% and 1.34%. Neither of mitotic indeces for the MTX cultures was equal 
to that of the 75µM NSC23766 cultures.  
 
The number of ureteric bud tips was counted for each condition by use of the E-
cadherin stain which stained the ureteric bud. Kidneys cultured in control conditions, 
75µM NSC23766, 150nM MTX and 250nM MTX had an average of 21.9, 15.2, 
12.43 and 6.4 ureteric bud tips (Fig.3.10F). Compared to control conditions, this 
represents reductions by 31%, 43% and 70% for the kidneys cultured in Rac1 
inhibitor cultures and the two MTX cultures, respectively. 
 
These results show that inhibiting Rac1 reduces branching less than what would be 
expected if Rac1 only controlled proliferation in the ureteric bud. It also shows that 
inhibition of proliferation does not produce a linear decrease in branching. It is 
difficult to explain why the Rac1 inhibitor inhibits proliferation more than 150nM 
MTX but decreases branching to a lesser extent. Firstly, Rac1 might be necessary as 
a negative regulator of branching through an unknown mechanism as well as being 
needed for proliferation. The inhibition of Rac1 suggests that proliferation is 
decreased and at the same the branching is somehow rescued. Secondly, Rac1 and 
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MTX might affect proliferation differently in the metanephric mesenchyme and in 
the ureteric bud. Diffusion problems might be the simples answer to this. MTX and 
Rac1 inhibitor NSC23766 have similar molecular weights of 454g and 531g, 
respectively, but their diffusion dynamics might be very different. Here I 
demonstrated that the Rac1 inhibitor reduces the proportion of cells progressing 
through DNA synthesis and mitosis in the ureteric bud tips and in whole sections of 
the kidney thus suggesting a decrease in actual proliferation rates. This suggests that 
the Rac1 inhibitor reaches the ureteric bud. However these results could be an 
indirect of a process affected in the mesenchyme. For example, a reduction in 
metanephric mesenchyme proliferation could lead to a reduction in available space 
for the ureteric bud to branch. The MTX might on the other hand affect both the 
metanephric mesenchyme and ureteric bud proliferation directly. It is not know how 
proliferation is regulated in the ureteric bud tips although inhibition of the 
Erk/MAPK pathway and GDNF reduces the ureteric bud tip proliferation (Fisher et 

























































































**  p < 0.01 






















Fig.3.10 The effects of Rac1 inhibition on kidney proliferation analysed using H3(p) 
and Methotrexate. 
 
Fig.3.10 shows kidneys that were cultured in (A) CKCM, (B) with 75µM NSC23766, (C) with 150nM 
Methotrexate or (D) with 150nM Methotrexate for 48hrs, fixed in methanol and stained for mouse-E-
cadherin and rabbit-phosphorylated histone 3. These were detected with anti-mouse-FITC and anti-
rabbit-TRITC. Kidneys were stained with TO-PRO-3. (E) Bar chart showing the mean percentage of 
nuclei positive for phosphorylated histone 3 out of the total number of nuclei ± SEM. Data was 
analysed separately using unpaired one-tailed Student’s t-tests. T-test p-values for: CKCM vs. 75µM 
NSC23766 p= 0.0088 (18 slides per group, 9 kidneys per group), CKCM vs. 150nM Methotrexate p = 
0.069 (18 and 12 slides, 9 and 6 kidneys per group, respectively) CKCM vs. 250nM Methorexate p 
=0.00029 (18 and 6 slides, 9 and 3 kidneys per group, respectively). (F) Bar chart showing the mean 
number of ureteric bud tips ± SEM. Data was analysed separately using unpaired one-tailed Student’s 
t-tests. T-test p-values for: CKCM vs. 75µM NSC23766 p= 0.031 (n= 11 and 10 kidneys, 
respectively), 75µM NSC23766 vs. 150nM Methotrexate p = 0.18 (n=10 and 7 kidneys, respectively). 
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3.2.8.3 Inhibition of Rac1 or proliferation does not affect ureteric bud cell 
size. 
 
The reduced branching and reduced kidney size in cultures where Rac1 is inhibited 
have been shown to be regulated by affects on proliferation. There is another 
possibility that could result in a decrease in the overall size of the kidneys. A 
decrease in the general cell size could result in smaller kidneys. As mentioned 
before, it has previously been shown that a planar cell polarity regulates the size of 
nephron progenitor cells in two dimensional in vitro cultures (Osafune et al 2006). It 
is thus necessary to determine whether a decrease in cell size is accountable for the 
decrease in branching or kidney size in cultures treated with Rac1 inhibitor.  
 
Using the data that has previously been described in (Fig.3.10), it was possible to 
measure the cell width of cells in the ureteric bud. For a more detailed description of 
measurements of the cell width, see Chapter 4 where the cell width in the ureteric 
bud is discussed in relation to Rho-kinase. The cell width was measure in the ureteric 
bud from kidneys cultured in control conditions, 75µM NSC23766 or 150nM MTX. 
Table 3.3 shows the average width of the ureteric bud cells in each condition. 
 
Condition Cell count Average width (µm ±StDev) 
Controls 89 6.55 ± 1.7 
75µM NSC23766 90 6.5 ± 1.6 
150nM MTX 110 6.4 ± 1.7 
Table 3.3 Ureteric bud cell width 
 
Ureteric bud cell width is not affected by 75µM NSC23766 compared to controls 
(p=0.44), nor is it affected by a decrease in proliferation by 150nM MTX (p=0.26). 
In fact, the cell width is remarkably consistent both within every sample as well as 
between kidneys in different conditions. Cell width can however be affected by 
specific proteins as will be discussed in Chapter 4. These data supports the 
suggestion that decreased proliferation is at least one of the major causes for the 




3.3 Chapter discussion 
 
3.3.1 Evidence of Rac1 affecting nephrogenesis 
 
The only data that support a role for Rac1 during nephrogenesis come from the 
demonstration that JNK1, JNK2 and Rac1 regulates the size of cultures of nephron 
progenitor cells (Osafune et al 2006). This data from Osafune and colleagues is 
based a novel method where a population of Sall1-positive cells from the 
metanephric mesenchyme are cultured on a layer of layer of 3T3 cells expressing 
Wnt4 (Osafune et al 2006). The cultures were derived from single cells from the 
metanephric mesenchyme that in culture demonstrated the potential to express a 
large array of genes expressed in the nephron suggesting that they are multipotent 
and can differentiate down a wide array of nephron lineages. Inhibition of either 
JNK1 or JNK2 disrupted the ‘maturation’/differentiation of these cultures and the 
inhibition of JNK1, JNK2 or Rac1 results in decreased culture sizes (Osafune et al 
2006). Inhibition of JNK1 or JNK2 also resulted in smaller kidneys in culture. The 
authors suggested that Rac1, JNK1 and JNK2 all participate in a planar cell polarity 
pathway which acts to regulate nephron differentiation and kidney and nephron size.  
I investigated whether the inhibition of Rac1 affects nephron development in vitro 
using whole kidney cultures and cultures of spinal cord induced metanephric 
mesenchyme. No evidence that was gathered suggests that Rac1 affects the 
differentiation of nephrons in culture. Equally, the size of nephrons in culture 
appears to be unaffected by the inhibition of Rac1. 
It is unclear whether these results are in contradiction. Osafune and colleagues never 
showed whether Rac1 affects the differentiation of nephron progenitor cells, and it is 
very difficult to determine whether the size of nephrons are affected in whole kidney 
cultures as previously explained. It would be of interest to determine whether the 
results obtained by Osafune and colleagues are replicable in whole kidney cultures or 
in transgenic models for in vivo studies. Equally, it would be interesting to determine 
whether a planar cell polarity pathway is specifically used in nephron progenitor cell 
populations in the kidney. Since it is possible to alter genes conditionally in a 
particular subset of cells, one attractive line of investigation would be to delete JNK1 
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or Rac1 conditionally from the nephron progenitor cell population, as done for β-
catenin by Park, Valerius and McMahon (Park, Valerius, and McMahon 2007). 
 
 
3.3.2 Rac1 regulating proliferation and ureteric bud branching in the kidney 
 
Proliferation in the kidney has previously been shown to be regulated, at least in part, 
by GDNF/c-Ret signalling (Michael and Davies 2004). The Rac1 and RhoA 
pathways have both been implicated in regulating the size of kidneys in culture 
(Meyer et al 2006; Osafune et al 2006). RhoA and Rac1 can both be activated by the 
Wnt-Frizzled planar cell polarity pathway (Habas, Dawid, and He 2003). 
Interestingly, in the kidney Rac1 and RhoA appear to promote opposite regulations 
of kidney growth. Whereas inhibition of RhoA or Rho-kinase results in increased 
culture sizes (Meyer et al 2006; Osafune et al 2006), the inhibition of Rac1 has the 
opposite effect (Osafune et al 2006). Inhibition of Rho-kinase has been demonstrated 
to result in increased proliferation in whole kidney cultures (Meyer et al 2006). The 
inhibition of Rac1 has not previously been carried out in whole kidney cultures, nor 
has the effects of Rac1 been characterized. 
I show that Rac1 is necessary to maintain normal proliferation in the kidney. 
Inhibition of Rac1 also results in reduced branching of the ureteric bud although it is 
uncertain whether this is a direct effect from the reduced proliferation. It is however 
possible to reduce branching by directly limiting proliferation. Proliferation has 
previously been linked to ureteric bud induction and also as a possibly mechanism 
for branching (Michael and Davies 2004). This data supports the hypothesis that 
proliferation is a plausible mechanism for ureteric bud branching although it does in 
no way prove it. An interesting follow-up to these experiments would be to 
determine whether the direct inhibition of proliferation, exclusively in the ureteric 
bud tips would result in reduced terminal bifurcations. Specific inhibition of 
proliferation in the ureteric bud tips, using for example a Wnt11-Cre and conditional 
Rac1 would provide great insights not only to whether Rac1 regulates proliferation in 
the ureteric bud tips, but also whether branching would now occur at all.  
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3.3.3 Rac1 and cellular migration in the kidney 
 
The prospect of Rac1 regulating a mechanism of cellular motility stemmed from 
research indicating such a process in the ureteric bud (Watanabe and Costantini 
2004; Michael, Sweeney, and Davies 2005; Meyer et al 2006; Kim and Dressler 
2007). Unlike the pten mutant described by Kim and Dressler (Kim and Dressler 
2007), I found no evidence that the inhibition of Rac1 disturbed the basement 
membrane at the ureteric bud tips. From experience, the basement membrane at the 
tips does however display quite a variable appearance as would be expected from 
such as dynamic structure. The evidence of cell scattering from the ureteric bud tips 
of kidneys treated with cytochalasin D (Michael, Sweeney, and Davies 2005) is 
likely to be an artefact of cell death. In a preliminary study, I attempted to replicate 
these results and found that the cell scattering effect is difficult to replicate in a 
reliable manner. Those ‘cells’ that did scattered were briefly analysed using 
propidium bromide as done by Foley and Bard (Foley and Bard 2002) and the cells 
displayed nuclei that were clearly apoptotic (data not included). It is however 
possible that apoptosis was a consequence rather than the effect that resulted in cell 
scattering. Migration is still an intriguing possibility in particular because many of 
the molecular cues needed for cellular motility are present in the kidney. Rac1 has 
been demonstrated to be important for tubulogenesis from MDCK cell cysts (Rogers 
et al 2003). However, since this process is dependent on polarity rearrangements and 
on the actions of single cells it is not clear whether this can be extended to suggest 
that Rac1 might be important for branching in the ureteric bud as neither of the 
processes described, is evident. Further studies would be required to determine 












Rho-kinase, a regulator of nephrogenesis, nephron 







RhoA-GTPase is a sister protein to Rac1-GTPase which is discussed in Chapter 3. 
Rac1-GTPase (Rac1) and RhoA-GTPase (RhoA) are important for several common 
processes such as regulation of migration, adhesion and polarity. This chapter 
focuses on the RhoA-pathway and in particular on the RhoA effector Rho-kinase.  
The importance of Rho-kinase (ROCK) for the development of the metanephric 
nephron has not previously been reported, although ROCK has been investigated in 
the metanephric kidney (Michael, Sweeney, and Davies 2005; Meyer et al 2006) and 
in renal progenitor cell cultures (Osafune et al 2006). These investigations have used 
soluble cell permeable ROCK inhibitors that have been administered directly via the 
medium to kidneys or kidney tissues in culture. Data have suggested that inhibition 
of ROCK in renal progenitor cell cultures has no effect on cell differentiation but 
possibly acts via a planar cell polarity pathway to regulate culture size (Osafune et al 
2006). These effects on culture size have also been shown in whole kidney cultures 
where the inhibition of ROCK results in higher rates of proliferation (Meyer et al 
2006). The aim of this chapter is to discuss the possibility that ROCK regulates 
several other aspects of kidney development. In the introduction I will focus on the 
role of ROCK in stress-fibre formation and the regulation of cell adhesion and cell 
polarity as these are likely to be important factors regulating ureteric bud 
morphogenesis and in particular nephrogenesis and nephron maturation.  
 
 
4.1.2 The Rho-ROCK pathway: stress-fibres 
 
The RhoA-GTPase pathway branches out to exert control over a large number of 
processes including regulation of proliferation, adhesion, and stress-fibre formation. 
Downstream effectors such as Citron, protein kinase (PKN), Rho-kinase (ROCK) 
and Diaphanous homologues (mDia) are involved in the regulation of these 
processes, reviewed by Schwartz (Schwartz 2004). In this chapter the focus is on the 
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signalling pathway leading from RhoA to its kinase ROCK, and the closely 
connected Dia1 pathway which together regulate stress fibre formation (Watanabe et 
al 1999); the pathway is outlined in (Diagram4.1). The ROCK pathway diverges to 
regulate the activity of proteins such as Lin11, Isl1 and Mec3 Kinase (LIMK), 
myosin light chain (MLC) and myosin light chain phosphatase (MLCP) (Amano et al 
1996; Kimura et al 1996; Kawano et al 1999; Maekawa et al 1999) as well as ezrin, 
radixin and moesin (ERM) proteins, sodium-hydrogen exchanger 1 (NHE1) and 
Adducin, as reviewed by Riento and Ridley (Riento and Ridley 2003). The proteins 
regulated by RhoA and ROCK for the formation and contraction of actin-myosin are 
LIMK, MLC, MLCP and mDia1. RhoA activates ROCK (Matsui et al 1996) and 
ROCK activates MLC by phosphorylation primarily on Ser19 (Amano et al 1996). 
The activation of MLC results in its interaction with actin and the activation of 
myosin ATPase, resulting in the contraction of non-muscle actin-myosin (Amano et 
al 1996). Rho-kinase also phosphorylates MLCP, an inhibitor of MLC, and thus 
inhibits its activity and increases the levels of phosphorylated MLC (Kimura et al 
1996; Kawano et al 1999). MLC is also activated by myosin light chain kinase 
(MLCK), through the phosphorylation of MLC on Thr18 and Ser19, discussed by 
Amano and colleagues (Amano et al 1996). MLC is negatively regulated by Protein 
kinase C (PKC) which phosphorylates MLC on Ser1 Ser2 and Thr9, also discussed 
by Amano and colleagues (Amano et al 1996). 
 
The connection between ROCK and the stability of the actin cytoskeleton has been 
demonstrated to occur via LIMK and cofilin (Maekawa et al 1999). ROCK 
phosphorylates LIMK which in turn phosphorylates cofilin and stops its actin 
depolymerising activity (Maekawa et al 1999). This presumably results in the 
inhibition of actin disassembly and the stabilisation of the actin-myosin stress-fibres. 
mDia1 is also activated by RhoA, and it acts in parallel with the ROCK pathway 
(Watanabe et al 1999). In fact, it seems as if ROCK and mDia1 act together, where 
ROCK regulates myosin phosphorylation, and thus the capacity to contract, whereas 
Dia1 regulates, through profilin, the actin polymerisation (Watanabe et al 1999). It 
has been demonstrated that Dia1 produces thin actin fibres and depending on the 
ratio of Dia1 and ROCK, the thickness and morphology of the stress-fibres can be 
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regulated which might have an impact on the function of the stress-fibres (Watanabe 
et al 1999). As mentioned, ROCK also regulates other proteins such as the ERM 
proteins, NHE1 and Adducin, which has recently been reviewed by Riento and 




































Diagram4.1 The Rho-kinase pathway (protein interactions are as described and cited 


































4.1.2.1 ROCK: adhesion and polarity 
 
RhoA induces the formation of focal adhesion complexes and regulates adherens 
junctions (Ridley and Hall 1992; Sahai and Marshall 2002). The stress fibres formed 
by ROCK are in fact linked to the extracellular matrix via integrins in focal adhesion 
complexes (Ridley and Hall 1992; Nobes and Hall 1995). Activation of RhoA results 
in the formation of focal adhesions (Nobes and Hall 1995) a process acting via 
ROCK (Amano et al 1997). A particularly interesting property of the Rho-
ROCK/Dia1 pathway is its ability to regulate adherens junctions. It has been 
demonstrated that the physical force exerted by actin-myosin contractions can result 
in the disruption of adherens junctions and that the activity of Dia1 can stabilise them 
(Sahai and Marshall 2002); see Diagram4.2. Adherens junctions consist of several 
components including β-catenin which is bound to cadherins, as reviewed by Fukata 
and colleagues (Fukata et al 1999). This has an additional level of interest since the 
canonical β-catenin signalling pathway has been demonstrated during nephron 
development and ureteric bud tip identity maintenance (Park, Valerius, and 
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The Rho-ROCK pathway has been studied mainly in vitro using cell culture systems. 
A system relevant to the kidney is the culture technique where Madin-Darby Canine 
Kidney (MDCK) cells are seeded into an extracellular matrix gel and undergo both 
cystogenesis and tubulogenesis (Montesano, Schaller, and Orci 1991). Several 
studies have determined that RhoA can regulate apicobasal polarity (Rogers et al 
2003; Yu et al 2008). MDCK cells expressing a dominant-negative RhoA have been 
shown to display inverted apicobasal polarity (Rogers et al 2003), although in other 
studies, neither the expression of ROCK-I, ROCK-II or RhoA shRNA nor inhibition 
of ROCK with moderate levels of ROCK inhibitor disturbed normal polarity (Yu et 
al 2008). Epithelial cells that are developing an apicobasal polarity require polarity 
cues from the extracellular matrix. MDCK cells in gel cultures have been shown to 
use β1-integrin, which in turn can activate Rac1, discussed by Yu and colleagues (Yu 
et al 2008). Blocking β1-integrin resulted in reduced Rac1 activity, increased RhoA 
activity and inverted apicobasal polarity, the latter which could be rescued by the 
expression of ROCK-I or RhoA shRNA as well as by inhibition of ROCK or myosin 
II (Yu et al 2008). Similarly, the expression of dominant negative Rac1 in MDCK 
cells resulted in inverted apicobasal polarity (Rogers et al 2003; Yu et al 2008), 
which could also be rescued by the inhibition of the RhoA-pathway (Yu et al 2008). 
 
An important point is that the effects on polarity that were produced through the 
inhibition of the RhoA-pathway or β1-integrin were only potent during the first 3 
days of culture. Thereafter, inhibition of β1-integrin could not invert polarity, and 
equally the ‘rescue’ of normal polarity in β1-integrin blocked cysts, by inhibiting the 
RhoA-pathway, could not occur (Yu et al 2008). This suggested that, rather than 
continuously regulating the polarity, these proteins are important for the 
establishment of polarity (Yu et al 2008); a point that will be important at a later 
point in this chapter. However, the inverted polarity produced by the expression of 
dominant negative Rac1 in MDCK cell cysts was reversible even after 4 days of 
inverted polarity if the dominant negative Rac1 expression was stopped (O'Brien et 
al 2001). The inversion produced through dominant negative Rac1 lead to abnormal 
laminin deposition on the basal surface of MDCK cell cysts (O'Brien et al 2001). 
Although the apicobasal inversion in MDCK cell cysts expressing dominant negative 
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Rac1 resulted in apical makers being detected on the basal surface, basal laminin was 
not deposited inside the cysts (O'Brien et al 2001). 
 
The RhoA-pathway has been shown to be important in whole organs as well as in 
cell cultures. In mammary glands, in culture large-scale epithelial reorganisations are 
required (Ewald et al 2008). Mammary glands in gel cultures initiate duct formation 
in a Rac1 and proliferation dependant manner where the growing ducts display a 
non-polarised, multi-layered epithelial structure (Ewald et al 2008). During 
maturation and establishment of proper ducts the epithelium becomes polarised and 
expresses markers for apical and basal surfaces (Ewald et al 2008). The organisation 
of this polarity has been demonstrated to be dependent on ROCK, as the inhibition of 
ROCK results in persistently multi-layered, and overly branched ducts with abnormal 
apicobasal polarity (Ewald et al 2008). No mechanism has been proposed to explain 
these effects apart from abnormal cell morphology (Ewald et al 2008). 
 
The RhoA-pathway has also been shown to be important for polarity in terms of 
regulating the stability of the basement membrane (Nakaya et al 2008). During 
gastrulation, presumptive mesodermal cells in the epiblast down-regulate RhoA 
activity in order to break down the adjacent basal membrane so that they can detach 
and ingress (Nakaya et al 2008). The basement membrane was shown to be 
controlled by RhoA positively regulating microtubule stability (Nakaya et al 2008).  
 
These examples demonstrate that RhoA is in fact involved in a wide array of process 
that regulate polarity and in some cases this has been shown to be controlled via 
ROCK, which can maintain or establishment a proper apicobasal polarity.  
 
 
4.1.2.2 ROCK I, ROCK II: knockouts and drugs 
 
Two very closely related ROCK proteins exist: ROCK-I (formerly known as ROCKβ 
and p160ROCK) and ROCK-II (formerly known as ROKα and Rho-kinase), 
reviewed by Riento and Ridley (Riento and Ridley 2003). The ROCK inhibitors used 
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in this thesis inhibit both of the ROCK proteins. The ROCKs consist of a kinase 
domain (with 92% similarity), a Rho-binding domain (highly similar) and pleckstrin-
homology domains (65-70% similarity), reviewed by Riento and Ridley, and 
Yoneda, Multhaupt and Couchman (Riento and Ridley 2003; Yoneda, Multhaupt, 
and Couchman 2005). ROCK-I and ROCK-II regulate different myosin dependent 
processes. ROCK-I is necessary for MLC and MLCP phosphorylation leading to 
stress-fibre and focal adhesion formation, processes in which ROCK-II is not 
normally involved (Yoneda, Multhaupt, and Couchman 2005). ROCK-II on the other 
hand regulates phagocytosis and also has an effect on both stress fibres and focal 
adhesions although these effects are not fully characterised (Yoneda, Multhaupt, and 
Couchman 2005). ROCK-I and ROCK-II also play different roles during fibronectin 
matrix assembly, but this might be linked to the differences in their roles in 
regulating stress-fibres (Yoneda et al 2007). 
 
Knockouts of been made of both ROCK-I (Shimizu et al 2005) and ROCK-II 
(Thumkeo et al 2003). The ROCK-I knockout died after birth and displayed open 
eyelids at birth together with omphalocele (Shimizu et al 2005). The defects seen in 
eyelid closure were speculated to be a result of abnormal actin-myosin cable 
formation in the eyelids during development (Shimizu et al 2005). No obvious 
abnormalities were detected in the majority of embryonic organs, including the 
kidney (Shimizu et al 2005). The ROCK-II knockout had placental defects and died 
after E13.5. As well as placental defects, the other obvious abnormality was 
haemorrhaging in the capillaries of the hind limbs (Thumkeo et al 2003). 
Interestingly, no phenotypes were detected in the majority of organs, including the 
kidney. In cell cultures from the ROCK-II
-/-
 mice, the authors demonstrated that the 
ROCK-II
-/-
 mutation was not sufficient to cause alterations of the actin cytoskeleton; 
however, upon the addition of ROCK-inhibitor, the cytoskeleton became highly 
abnormal (Thumkeo et al 2003). It was suggested that this was a result of ROCK-I 
being inhibited by the ROCK-inhibitor as well as ROCK-II being absent (Thumkeo 
et al 2003). 
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Although there is some evidence that ROCK-I and ROCK-II play non-redundant 
roles, it is clear that the interplay between ROCK-I and ROCK-II is not well 
understood as the inhibition of ROCK-II affects the ROCK-I regulated actin-myosin 
cables and focal adhesions by an unidentified mechanism (Yoneda, Multhaupt, and 
Couchman 2005). To my knowledge no compound knockouts of ROCK-I and 
ROCK-II have yet been made, but in cells doubly targeted with ROCK-I and ROCK-
II siRNA, these resemble ROCK inhibitor treated cells (Yoneda, Multhaupt, and 
Couchman 2005). It is likely that double mutants, ROCK inhibitors and specific 
targeting using conditional mutants, will yield much more informative data.  
 
As mentioned, soluble cell-permeable inhibitors of ROCK-I and ROCK-II have been 
used in this thesis; these inhibitors are Y-27632 and glycyl-H1152 dihydrochloride 
(H1152). These have previously been used for organ culture studies (Michael, 
Sweeney, and Davies 2005; Meyer et al 2006; Ewald et al 2008). Uehata and 
colleagues identified the molecular compound Y-27632 as an effective inhibitor of 
smooth muscle contraction, focal adhesion formation and stress fibre formation in 
HeLa cells and in tissues such as smooth muscle in the vasculature and in the 
respiratory system (Uehata et al 1997). Y-27632 was shown to bind ROCK-I and 
ROCK-II with an affinity in excess of 200-2000 times that for binding to other 
kinases (Uehata et al 1997). In addition, Y-27632 did not inhibit PAK, which is 
important for Rac1 and Cdc42 signalling, as previously discussed by Westwick, and 
by Rosenfeldt (Westwick et al 1997; Rosenfeldt et al 2006). Y-27632 inhibits 
ROCK-I and ROCK-II by competing with ATP for binding (Ishizaki et al 2000). 
ROCK-I and ROCK-II can thus not be activated upon binding to Y-27632 (Ishizaki 
et al 2000). It is also speculated that the binding of Y-27632 to ROCK-I and ROCK-
II results in conformational changes of the proteins, although this has not been 
formally demonstrated (Ishizaki et al 2000). The second ROCK-I and ROCK-II 
inhibitor glycyl-H1152 dihydrochloride: (S)-(+)-4-Glycyl-2-methyl-1-[(4-methyl-5-
isoquinolinyl)sulfonyl]-hexahydro-1H-1,4-diazepine dihydrochloride (H1152) also 
functions by competing for ATP and thus ROCK-I and ROCK-II activation (Sasaki, 
Suzuki, and Hidaka 2002).  It is identified as compound 18 described by Tamura and 
colleagues (Tamura et al 2005). H1152 is approximately 15 times more potent in 
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inhibiting ROCK-I and ROCK-II compared to Y-27632, reviewed by Tamura and 
colleagues (Tamura et al 2005). Table 4.1 displays Inhibitor Concentration 50% 
(IC50) values (in µM) for 4 common ROCK inhibitors derived from in vitro assays. 
The table and the data were adapted from Tamura et al 2005. IC50 values for H1152 
were assumed to be those of compound 18 described in (Tamura et al 2005), based 
on the identical but only partial values listed for H1152 by the distributor (Catalogue 
number 2485/TOCRIS).  
 
It is important to point out that the concentrations stated in Table 4.1 reflects the IC50 
values from purified protein. These values can therefore not be directly used directly 
to estimate the concentrations required for in vitro, cell or organ cultures, which will 
need significantly higher values. The IC50 values in Table 4.1 should be used 
comparatively rather than be used as absolutes or indications. I have used Y-27632 
concentrations ranging from 5µM-20µM as used by Michael, Sweeney and Davies 
(Michael, Sweeney, and Davies 2005). H1152 concentrations were used for the same 
effects at concentrations ranging from 0.625-2.5µM, i.e. ~15x less as is specified in 
Tamura et al 2005.  
 
ROCK-I and ROCK-II are both found in the kidney in the ureteric bud and in the 
metanephric mesenchyme (Meyer et al 2006). The distribution of ROCK-II was also 
confirmed in my results (Appendix 2-Fig.A2.1). RhoA-GTPase, ROCK-I and ROCK-
II have also been annotated as being present in the majority of structures in the 
metanephric kidney (www.GUDMAP.org).  
 
The work described in Chapter 4 aims to show that ROCK is a necessary component 
of the pathway that drives epitheliogenesis and which gives rise to the nephrons, as 
well as for the mechanism that regulates the morphological maturation of the 




Table 4.1: IC50 µM of common ROCK inhibitors. 
The table and data were adapted from Tamura et al 2005. Glycyl-H1152 dihydrochloride has an IC50 µM concentration ~15 times lower compared to ROCK 
inhibitor Y-27632. The IC50 µM concentration of Glycyl-H1152 dihydrochloride towards ROCKII is ~200-280 times lower than that for other kinases Aurora A, 





4.2.1 Rho-kinase regulation in normal kidney development. 
 
To explore the possibility that Rho-kinase (ROCK) regulates aspects of de novo 
epithelial nephron formation, I employed in vitro kidney organ culture systems that are 
ideal for efficient targeting of specific proteins during tissue and organ development. 
These organ culture systems are the same as previously used for investigating the role of 
ROCK in the ureteric bud (Michael, Sweeney, and Davies 2005). ROCK inhibitor 
Y27632 has previously been used successfully for specific inhibition of ROCK function 
in organ culture (Michael, Sweeney, and Davies 2005; Meyer et al 2006; Ewald et al 
2008) and a previous form of H1152, (H1152 dihydrochloride) which is not glycylated, 
has also been used (Michael, Sweeney, and Davies 2005). Reports have shown that 
ROCK is an essential regulator of kidney development, proliferation and in particular 
ureteric bud branching morphogenesis (Michael, Sweeney, and Davies 2005; Meyer et al 
2006). The studies did detect nephron defects possibly as a result of the differences in 
techniques used; this will be elaborated on in section 4.2.3.   
 
 
4.2.2 Rho-kinase inhibition on ureteric bud morphogenesis. 
 
Using already optimised ROCK inhibitor concentrations for Y-27632 on whole kidney 
cultures, the initial experiments were aimed at replicating the previously observed 
ureteric bud morphology defects (Michael, Sweeney, and Davies 2005; Meyer et al 
2006). Kidneys were cultured for 72hrs prior to fixation and staining with mouse anti-
Calbindin D-28K. Kidneys were cultured either in control conditions/complete kidney 
culture medium (CKCM) or in CKCM with different concentrations of ROCK inhibitor: 
0µM, 5µM, 10µM or 20µM Y-27632, (Fig.4.1A-D) respectively. The effects of Y-
27632 on the ureteric bud morphology closely resemble those described in earlier 
reports (Michael, Sweeney, and Davies 2005; Meyer et al 2006). Specifically, the 
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ureteric bud increased in both width and overall area at the exposure to ROCK inhibitor 
Y-27632, an effect attributed to increased rates of proliferation (Meyer et al 2006). The 
form of H1152 used here, has been suggested to provide increased specificity and higher 
potency compared to Y-27632 (Tamura et al 2005), see Table 4.1 for additional details. 
From the IC50 data presented in Table 4.1, it was predicted that the concentrations of 
H1152 required to mimic those effects by Y-27632 would be around 15 times lower. To 
test whether H1152 would produce similarly disturbed ureteric buds at the predicted 
conditions, I set up identical experiments using H1152. H1152 was used at 
concentrations: 0µM, 0.625µM, 1.25µM or 2.5µM H1152, (Fig.4.2A-D) respectively. 
As can be seen from the morphology of the ureteric bud, a concentration of 20µM Y-
27632 (Fig.4.1D) is similar to a concentration of 1.25µM H1152 (Fig.4.2C); this is 16 
times lower. This suggests that the IC50 values presented in Table 4.1 were useful as a 
tool to indicate the concentrations of H1152 that would produce comparative results to 
the previously optimised Y-27632 concentrations. 
  
These data show that both Y-27632 and H1152 produce the same morphological defects 
in the ureteric bud. Michael, Sweeney and Davies mentioned that Y-27632 and H1152-
dihydrochloride produced different effects on proliferation where only H1152-
dihydrochloride increased proliferation (Michael, Sweeney, and Davies 2005). Meyer 
and colleagues, on the other hand, published that Y-27632 also produced an increase in 
the proliferation rates in the kidney (Meyer et al 2006). My results suggest that Y-27632 
and H1152 increases ureteric bud size equally at moderate concentrations, compare 
(Fig.4.1C) and (Fig. 4.2C). In this thesis both Y-27632 and H1152 have been used for 
the majority of experiments, and no differences were ever detected between the drugs 




Fig.4.1 Inhibition of ROCK results in altered branching morphology. 
 
Fig.4.1 shows E11.5 kidneys that were dissected and cultured for 48hrs. Varying concentrations of 
Y27632 Rho-Kinase Inhibitor were used. (A) Kidney cultured in CKCM. (B) Kidney cultured in CKCM 
supplemented with 5µM Y27632. (C) Kidney culture in CKCM supplemented with 10µM Y27632. (D) 
Kidney cultured in CKCM supplemented with 20µM Y27632. Kidneys were fixed after 48hrs using ice 









Fig.4.2 An additional ROCK inhibitor produces mimicking branching morphogenesis 
defects. 
 
Fig.4.2 shows E11.5 kidneys that were dissected and cultured for 72hrs. Varying concentrations of H1152 
Rho-Kinase inhibitor were used. (A) Kidney cultured in CKCM. (B) Kidney cultured in CKCM 
supplemented with 0.625µM H1152. (C) Kidney culture in CKCM supplemented with 1.25µM H1152. 
(D) Kidney cultured in CKCM supplemented with 2.5µM H1152. Kidneys were fixed after 72hrs using 
ice cold methanol. Kidneys were stained with mouse anti-pan-cytokeratin and detected using anti-mouse-










4.2.3 Rho-kinase inhibition reduced nephron formation. 
 
The role of ROCK during nephrogenesis has not been investigated. Michael, Sweeney 
and Davies, and Meyer and colleagues suggested that nephrons do form normally in the 
presence of ROCK inhibitor, although their development was not studied in detail 
(Michael, Sweeney, and Davies 2005; Meyer et al 2006). My main aim was to determine 
whether ROCK plays a role during nephrogenesis. In Chapter 1, nephron development is 
described in some detail and some of the key genes are highlighted. From the 
introduction it is clear that although some of the inducers of nephron formation are 
emerging, the mechanisms of nephrogenesis remain unknown. In this chapter I outline 
the importance of ROCK for several different epithelial processes such as the regulation 
of polarity and adhesion. The remainder of this chapter focuses on the importance of 
ROCK during nephron formation and the subsequent stages of maturation which the 
nephron progresses through in order to become physiologically functional. 
 
In order to visualise nephron development I used immunofluorescent staining for 
Calbindin D-28K and β-laminin to show both the ureteric bud and the basement 
membrane of the ureteric bud and the forming nephrons. Kidneys were cultured for 
72hrs in control conditions, CKCM, (Fig.4.3A) (n=9 kidneys) or in CKCM 
supplemented with ROCK inhibitor (Fig.4.3B) (n=8 kidneys) prior to fixation and 
immunostaining. The number of nephrons in control conditions and in cultures with 
ROCK inhibitor was counted. The inhibition of ROCK reduced the number of nephrons 
that formed to only 54% of control numbers (Fig.4.3C). The reduction was shown to be 
statistically significant, p=0.03, using a one-tailed Student’s t-test. This reduction in 
nephrons suggested that ROCK is important for the earliest stages of nephron formation. 
Possible reasons for this could be that ROCK is necessary for nephron induction or that 
ROCK is necessary for the mesenchymal-to-epithelial transition. β-laminin will only be 
present on nephrons that have become epithelial so stages earlier than the renal vesicle 
stage would not have been detected using this antibody. 
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Not only did the inhibition of ROCK result in significantly fewer nephrons but those 
nephrons that formed appeared morphologically abnormal, (Fig.4.3 and subsequent 
figures).  
The differences between my results and those of Michael, Sweeney and Davies, and 
Meyer and colleagues (Michael, Sweeney, and Davies 2005; Meyer et al 2006) can be 
explained because of the differences of techniques that were used in order to study 
kidney development. The focus of previous reports has been on the role of ROCK for 
the branching morphogenesis of the ureteric bud (Michael, Sweeney, and Davies 2005; 
Meyer et al 2006). Because of this, the authors rarely utilised techniques that displayed 
both the nephrogenic components as well as the ureteric bud. In the majority cases, 
antibodies for Calbindin D-28K and lectin Dolichos biflorus were used, in combination 
with dark-field and phase-contrast microscopy (Michael, Sweeney, and Davies 2005; 
Meyer et al 2006). Calbindin D-28K and lectin Dolichos biflorus exclusively bind to the 
ureteric bud during early development and as such do not allow for the study of nephron 
development (Davies 1994; Michael, Sweeney, and Davies 2007). I on the other hand, 
specifically wished to determine whether ROCK is necessary for nephrogenesis and as 
such used appropriate markers for the purpose of visualising nephrons in addition to 
observing the nephrons closely.   
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Fig.4.3 Inhibition of ROCK reduces nephron formation. 
 
Fig.4.3 shows E.11.5 kidneys cultured for 72hrs in (A) CKCM or (B) 1.25µM H1152. Kidneys were fixed 
in ice cold methanol, stained for rabbit β-laminin and mouse calbindin D-28K and detected with anti-
rabbit-TRITC and anti-mouse-FITC. White dashed-lined arrows indicate nephrons. (C) Bar chart showing 
the mean values ± SEM of the number of nephrons per kidney for each culture condition. Data was 
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4.2.4 Rho-kinase inhibition disturbs normal nephron formation. 
 
As previously described in Chapter 1, nephron development proceeds through several 
“descriptively termed” stages (Fig.1.1). It is possible to identify nephrons and stage them 
based on their morphology and it is also possible to recognise those nephrons that 
display developmental abnormalities. The nephrons forming in ROCK inhibitor 
conditions did not appear morphologically normal. I decided to investigate this further. 
Firstly, in order to determine the nature of the nephron abnormality, a higher detailed 
analysis was required. Secondly, it was necessary to determine whether any 
abnormalities detected were secondary effects of the abnormal ureteric bud. To provide 
a better background for any renal abnormalities, it is worthwhile to refer to (Fig.1.1) and 
(Fig.1.2) which show the normal development of a nephron in the human and a detailed 
diagram of an s-shaped mouse nephron, respectively. 
  
Whole kidney cultures were set up in control conditions which generated nephrons in 
both the comma-shaped body (CB) and s-shaped body (SB) stages after 72 hrs 
(Fig.4.4A). Whole kidney cultures treated with inhibitors of ROCK showed nephrons 
which were considerably different (Fig.4.4C). These nephrons were either completely 
morphologically abnormal or abnormal towards their proximal parts, see (Fig.1.2) for a 
normal human nephron with labelled structures. In order to determine whether the 
morphological abnormalities were just an indirect result of the known effects that the 
ROCK inhibition has on the ureteric bud (Michael, Sweeney, and Davies 2005), I set up 
cultures of isolated metanephric mesenchyme that were induced to form 
morphologically organotypical nephrons by signalling, transfilter, from spinal cord 
(Saxen 1987). After 72 hrs of culture, control spinal cord induction cultures contained 
nephrons that were at either comma-shape body (CB) stage or at s-shape body (SB) 
stage (Fig.4.4B). Many nephrons grown under ROCK inhibiting conditions exhibited 
morphological abnormalities characterised by aberrant epithelial structures and cyst 
formation although some resembled normal nephrons (Fig.4.4D). These results indicate 
that ROCK is necessary for normal nephron formation and that abnormal nephrogenesis 
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is not an effect secondary to inhibiting ROCK in the ureteric bud. I also demonstrated 
the effects of ROCK inhibition on nephron formation using the metanephric 
mesenchyme from a WT1
+/GFP
 mouse, (kindly supplied by Peter Hohenstein-
HGU/MRC, Edinburgh) as is shown in (Appendix 2-Fig.A2.2). This mouse expresses 
GFP under the WT1 promoter (Hohenstein, P. Personal Communication). These results 
demonstrate that the effects of ROCK inhibition on nephrogenesis are not strain-specific 
as the WT1
+/GFP































































Fig.4.4 shows immunostaining of nephrons formed in control conditions or in the presence of ROCK 
inhibitor. The morphology of nephrons formed in CKCM (A,B) was compared with that of nephrons 
formed in CKCM with 20µM Y-27632 (C,D). (A) and (C) show nephrons formed in kidney cultures 
whereas (B,D) show nephrons formed in spinal cord induced metanephric mesenchyme. All cultures were 
kept for 72hrs after which they were fixed and stained with rabbit anti-β-laminin-rabbit and anti-rabbit-
TRITC. Yellow arrowheads - comma-shaped nephrons, green arrowheads - s-shaped nephrons, white 
arrows - abnormal nephrons and abnormal epithelialisation. (A’-C’) show schematic representations of 
numbered nephrons in (A-C). Nephrons are in turquoise and the ureteric bud in black. Diagrams were 
produced by careful inspection of nephrons viewing them at the maximum image resolution. 
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4.2.5 ROCK is necessary for glomerular cleft formation but nephron-ureteric bud 
fusion is preserved. 
 
I used confocal microscopy to analyse the structural malformations of the nephrons 
formed under ROCK inhibiting conditions in detail. The nephrons in previous 
experiments showed some indications that the proximal portions of the nephrons might 
be more affected than the distal portions. To further investigate this, I set up whole 
kidney cultures where I allowed the nephron development to progress further than in 
previous experiments. In order to provide increased resolution of the abnormalities, I 
used three markers: Pan-cytokeratin, which binds cytokeratins present in the ureteric bud 
only; β-laminin which marks the basement membrane of both the ureteric bud and the 
forming nephrons, and TO-PRO-3, a nuclear marker. 
 
In whole kidney cultures, nephrons formed after 96hrs of culture clearly displayed 
structural components of the proximal parts of the nephron, see (Fig.1.2) for a labelled 
nephron. The nephrons showed glomerular clefts, apical-basal flattening of the parietal 
epithelium, the Bowman’s lumen and the visceral epithelium which gives rise to the 
podocytes (Fig.4.5A,B). Nephrons forming in ROCK-inhibitor conditions formed as one 
or two cysts in very close proximity of each other (Fig.4.5C). The cyst-like nephrons had 
no defining proximal or distal segments. A second type of nephrons formed in ROCK-
inhibiting conditions where the nephrons consisted of a single tubule attached to the 
ureteric bud (Fig.4.5C,D). These tubules lacked proximal structures such as a glomerular 
cleft. These nephrons maintained the ability to fuse successfully to, and form a 
continuous lumen with, the ureteric bud (Fig.4.5C,D), suggesting that distal segments 
may retain normal function. These results also demonstrated that, regardless of the 
morphological deformities of the ureteric bud, adequate bud-nephron interactions were 
maintained in order to allow fusion. This ureteric bud fusion is an interesting process 
which can be disrupted in for example Six2 mutant mice (Self et al 2006). The main 
morphological defect that could be characterised was the lack of a glomerular cleft. As 
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discussed in Chapter1, the mechanisms that drive the formation of the glomerular cleft 
























Fig.4.5 The effects of ROCK inhibition on glomerular cleft formation and nephron 
morphology 
 
Fig.4.5 shows immunostains of kidneys cultured for 96hrs. Images show nephrons formed in CKCM 
without (A and B) and with 1.25µM H1152 (C and D). Samples were fixed in methanol and stained with 
mouse anti-pan-cytokeratin, rabbit anti-laminin, anti-mouse-FITC, anti-rabbit-TRITC and TOPRO-3. 
Yellow arrowheads – nephrons with normal glomerular clefts, white arrowheads – abnormal nephrogenic 
cysts, white arrows – abnormal nephrons fused to the ureteric bud. (A’-D’) show schematic 
representations of numbered nephrons in (A-D). Nephrons are in turquoise and the ureteric bud in black. 
Diagrams were produced by careful inspection of nephrons at maximum resolution. 
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4.2.6 ROCK is necessary for the nephron proximal-distal axis patterning. 
 
The defects of the nephrons forming in the ROCK inhibitor conditions suggest that the 
proximal portions of the nephrons are negatively affected by the ROCK inhibition. To 
further characterise the nephron defects caused by inhibition of ROCK, and to test the 
possibility that the development of proximal and distal segments is affected 
differentially, I examined the expression of markers for proximal and distal portions of 
the nephron.   
 
 
4.2.6.1 Rho-kinase inhibition disturbs distal nephron patterning. 
 
E-cadherin has previously been shown to be present from the renal vesicle (RV) stage, 
the stage before the comma-shaped body (CB) stage, in the presumptive distal nephron 
and to be absent from the presumptive proximal nephron (Cho et al 1998). E-cadherin 
can therefore be used as an early marker for distalness and nephron proximal-distal 
polarity.  
 
Whole kidney cultures were set up in either control or ROCK inhibiting conditions and 
cultured for 72hrs. Nephrons forming in whole kidney cultures grown in plain CKCM  
displayed a clear boundary between areas that were positive for E-cadherin and those 
that were negative (Fig.4.6A,C). The areas that were negative for E-cadherin included 
the proximal tubule and the parietal and visceral epithelia. Nephrons developing in 
ROCK-inhibiting conditions showed a more variable profile of E-cadherin localisation. 
A portion of nephrons that were clearly morphologically abnormal, as previously 
described, showed E-cadherin localisation throughout (Fig.4.6B,D). Some did, however, 
have normal E-cadherin localisation despite having abnormal proximal segments 
(Fig.4.6B).  
These results show that a portion of the nephrons in ROCK inhibiting conditions display 
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Fig.4.6 The effects of ROCK inhibition on nephron proximal-distal segmentation (I) 
 
Fig.4.6 shows immunostainings of kidneys cultured for 72hrs. Images show nephrons formed in CKCM 
(A) and (C) and nephrons in 1.25µM H1152 (B) and (D). Samples were fixed in methanol and stained 
with mouse anti-E-cadherin and rabbit anti-β-laminin that were detected with anti-mouse-FITC and anti-
rabbit-TRITC. (C) and (D) show highlighted regions in (A) and (B), respectively. Blue arrowheads – 
normal E-cadherin localisation in nephrons, yellow arrowheads – abnormal E-cadherin localisation in 
abnormal nephrons, - yellow arrow – normal E-cadherin localisation in abnormal nephron. (A’-D’) show 
schematic representations of numbered nephrons in (A-D). Nephrons are in turquoise and the ureteric bud 
in black. Green segments of the nephron indicate parts positive for E-cadherin. Diagrams were produced 
by careful inspection of nephrons at maximum resolution.  
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4.2.6.2 Rho-kinase inhibition disturbs proximal nephron patterning. 
 
I speculated that either of two mechanisms might account for the expression of E-
cadherin throughout the nephron structure. Firstly, the proximal parts might have failed 
to form and only distal parts of the nephron formed. Secondly, proximal parts formed 
but failed to differentiate into the proximal phenotype and E-cadherin expression 
expanded into segments normally destined to be proximal. To test these hypotheses, I 
used markers for the proximal portions of the nephron. CD15 is normally detected in the 
proximal brush-border as the nephron matures (Bard and Ross 1991) and has previously 
been used as a marker for nephron maturation and proximal development (Davies 1994). 
 
In control nephrons in whole kidney cultures cultured for 120hrs, CD15 was strongly 
detected in proximal tubules beyond the SB stage (Fig.4.7A). Inhibition of ROCK 
resulted in abnormal detection of CD15. CD15 was detected in nephrogenic cyst-like 
structures and in nephrons where CD15 was detected throughout (Fig.4.7B). In nephrons 
formed by spinal cord induction, control nephrons showed well organised CD15 
localisation that was confined to one portion of the nephron (Fig.4.7C). ROCK 
inhibition resulted in the formation of non-tubular and short segments of tubular 



















Fig.4.7 The effects of ROCK inhibition on nephron proximal-distal segmentation (#II) 
 
Fig.4.7 shows immunostains of normal kidney cultures (A and B) and spinal cord induced MM (C and D). 
Controls were treated with CKCM (A and C) or with CKCM containing 20 µM Y-27632 (B and D). 
Cultures were maintained for 120hrs prior to fixation and subsequent staining with rabbit anti-β-laminin 
and mouse (IgM) anti-CD15 which were detected using anti-rabbit-TRITC and anti-mouse (IgM)-FITC. 
Magenta arrowheads – punctuated/abnormal CD15 localisation in nephrons, magenta arrows – nephrons 
with CD15 localised throughout, white dashed line – nephrons with normal CD15 localisation. (A’-D’) 
show schematic representations of numbered nephrons in (A-D). Nephrons are in turquoise and the 
ureteric bud in black. Green segments of the nephron indicate parts positive for CD15. Diagrams were 
produced by careful inspection of nephrons at maximum resolution.  
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4.2.6.3 Rho-kinase inhibition disturbs proximal-distal patterning in the same nephron. 
 
In the previous sections, two developmental defects have been described in the 
nephrons. A portion of nephrons has been shown where E-cadherin or CD15 is detected 
ectopically. In order to determine whether nephrons that expressed E-cadherin 
ectopically also mis-express proximal tubule marker CD15, and vice versa, cultures 
were set up for co-staining of the two markers.  
 
To allow for nephron maturation and elongation of the proximal-distal axis, the kidney 
cultures were maintained for 144hrs. Samples were stained for mouse (IgG) anti-E-
cadherin and mouse (IgM) anti-CD15, which were detected with anti-mouse (IgG) 
AlexaFluor 647nm and anti-mouse (IgM)-FITC. Nephrons that formed in control 
conditions expressed E-cadherin and CD15 in clearly defined distal and proximal 
regions, respectively (Fig.4.8A,C). CD15 and E-cadherin were found extensively in the 
same segments in ROCK inhibitor nephrons (Fig.4.8B,D). Control nephrons, 
demonstrated a high degree of apical-membrane polarised E-cadherin expression in 
distal segments (Fig.4.8C). At this stage of nephron development, capillary loop (CL) 
stage, E-cadherin was also weakly detected at the apical-membrane in proximal regions, 
although the expression was very diffuse. These differences in E-cadherin will be more 
clearly shown in (Fig.4.9).  
These data clearly show that nephrons in ROCK inhibiting conditions ectopically 
express E-cadherin and CD15 in the same segments. This demonstrates that ROCK is 
necessary for normal nephron maturation along the proximal-distal axis. 
An interesting effect of the ROCK inhibition is the ability of some nephrons to undergo 
multiple fusions to the ureteric bud (Fig.4.8B). This might indicate that the abnormal 
proximal-distal patterning disturbs the nephron’s sense of orientation and regulation of 









































Fig.4.8 The effects of ROCK inhibition on nephron proximal-distal segmentation (#III) 
 
Fig.4.8 shows whole kidney cultures maintained for 144hrs in control conditions (A, C) or in 1.25µM 
H1152 (B,D). Cultures were fixed in methanol and stained for mouse (IgG) anti-E-cadherin and mouse 



















anti-mouse (IgM)-FTIC (displayed in magenta). The images are pseudocoloured as the AlexaFluor 647nm 
displays poorly on paper. In control nephrons, segments expressing high levels of E-cadherin are separate 
from those that express high levels of CD15 (A,C). Kidneys cultured in CKCM with ROCK inhibitor 
display nephrons that stably express both E-cadherin and CD15 in the same segments (B,D) and are 
capable of double-fusions to the ureteric bud. Green arrows – normal nephrons, orange arrows – abnormal 
nephrons. (A’,B’,C’,D’) show schematic representations of highlighted nephrons in (A,B,C,D). Nephrons 
are in turquoise and the ureteric bud in black. Magenta segments of the nephron indicate parts positive for 
CD15. Diagrams were produced by careful inspection of nephrons at maximum resolution. 
 
 169 
4.2.6.4 Rho-kinase inhibition disturbs proximal-distal patterning in the same nephron 
after renal vesicle formation. 
 
ROCK is necessary for the patterning of the proximal-distal axis as shown using CD15 
(proximal marker) and E-cadherin (distal marker). The experiments used to describe 
these effects yielded a relatively low number of nephrons since the inhibition of ROCK 
resulted in a large decrease in nephron formation; as shown in (Fig.4.3). Nephrogenesis 
is continuous and sequential, and new nephrons being constantly induced by the ureteric 
bud tips during development. In whole kidney cultures, where E11.5 kidneys are isolated 
and cultured, after 48hrs these samples contain nephrons that have progressed to renal 
vesicle (RV) and sometimes comma-shaped body (CB) stage. Since ROCK is necessary 
for nephron formation, one possible adjustment to the protocol that could produce a 
higher number of nephrons would be deferring the addition of ROCK inhibitor to after 
48hrs of culture. This alteration would also show whether the nephrons are sufficiently 
polarised at the RV stage for them not to be affected by the inhibition of ROCK.  
 
Whole kidney cultures were set up in control conditions and cultured for 48hrs. After 
48hrs, half of the cultures were transferred to medium containing ROCK inhibitor and 
the other half simply remained in control conditions for an additional 72hrs. 
Concentrating on the proximal-distal border, control nephrons expressed E-cadherin and 
CD15 in clearly defined distal and proximal regions, respectively (Fig.4.9A,B). As 
described previously, nephrons at this advanced stage of maturity also expressed E-
cadherin in the proximal segments although differently from in distal segments. Control 
nephrons demonstrated a high degree of apical-membrane polarised E-cadherin 
expression in distal segments, here magnified for clarity (Fig.4.9C). The E-cadherin that 
is weakly detected at the apical-membrane in proximal regions shows a very diffuse 
pattern (Fig.4.9D).  
In ROCK inhibitor conditions, nephrons extensively show CD15 and E-cadherin in the 
same segments (Fig.4.9E,F). Large portions showed atypical CD15 and E-cadherin co-
localisation (Fig.4.9G,H). Cells that displayed strong distal-like expression patterns of 
 170 
E-cadherin also strongly expressed CD15 in a proximal-like manner (Fig.4.9G,H). These 
data clearly shows that the effects of ROCK are not just a consequence of the early 
developmental problem caused by ROCK inhibition. In fact, this demonstrates that the 
nephrons require ROCK for proximal-distal patterning subsequent to the RV stage. In 
the previous section, I showed that inhibition of ROCK resulted in some nephrons fusing 
to the ureteric bud at more than one place. This was likely to be a defect of proximal-
distal segmentation because the ROCK inhibitor could be added after 48hrs (Fig.4.9I,J) 
or 72hrs (Fig.4.9K) with the same result as if the inhibitor was added at the start. The 
nephrons presented in this section display identical abnormalities to those presented in 
the previous section although nephrogenesis was much more prevalent. This made me 
opt for using this altered protocol for the subsequent experiments on proximal-distal 



































































I J K 
25µm 25µm 25µm 
Pan cytokeratin  Laminin Laminin E-cadherin 
+48hrs +48hrs +72hrs 
 172 
Fig.4.9 The effects of ROCK inhibition on nephron proximal-distal segmentation (#IV) 
 
Fig.4.9 (A,B) Control nephrons cultured for 120hrs in CKCM show that segments with correctly patterned 
E-cadherin are mutually exclusive with those that express high levels of CD15, white dashed lines. (C,D) 
High magnification images of E-cadherin expression from (B), white arrowheads – no. 1-2, show 
distinctly different E-cadherin expression in distal segments where CD15 is absent (C) and in proximal 
segments where it its present (D). (E,F) Kidneys cultured for 48hrs in CKCM and then treated with ROCK 
inhibitor for 72hrs display nephrons that stably express both E-cadherin and CD15 in the same segments, 
magenta dashed lines. (G,H) High magnification images of E-cadherin expression from (F), magenta 
arrowheads – no. 3-4, reveal co-localisation of distal-like expression of E-cadherin and CD15. 
(A’,B’,E’,F’) show schematic representations of highlighted nephrons in (A,B,E,F) . Nephrons are in 
turquoise and the ureteric bud in black. Green segments of the nephron indicate parts positive for CD15. 
Diagrams were produced by careful inspection of nephrons at maximum resolution. 
(I,J) and (K) Kidneys cultured for 48hrs or 72hrs in CKCM, respectively, prior to continued culturing in 
ROCK inhibitor for a total culture time of 144hrs. Turquoise arrowheads – nephron ureteric bud fusions. 
 
 173 
4.2.6.5 Inhibition of ROCK disturbs proximal-distal patterning as shown using CD15 
and WT1 
 
The proximal-distal patterning defects shown in the previous sections could result from 
the disruption of two different mechanisms. Either the cells differentiate improperly and 
express markers for both proximal and distal segments or the cells differentiate 
appropriately but fail to segregate into the proper segments. The second mechanism 
could also result in abnormal differentiation. A disruption of cell segregation could 
result in cells being located in a signalling environment that induces ectopic gene 
expression and abnormal differentiation. In order to investigate the reason for the 
abnormal patterning, it is first necessary to show whether, on a single cell level, cells 
express markers for both proximal and distal segments or whether two cell types might 
be intimately mixed. It is also essential to demonstrate whether this mixing of segment 
fates can be show using different markers. To investigate these points I chose to use 
CD15 and WT1 as the markers. The expression pattern of CD15 has previously been 
described. In nephrons at this stage of maturity, WT1 is expressed in the podocytes, and 
weakly in the parietal cells. WT1 is clearly detected within the nucleus and in the 
cytoplasm (Hammes et al 2001). 
 
Whole kidney cultures were set up as in the previous section where they were cultured 
for 48hrs and the transferred either to ROCK inhibitor conditions or maintained in 
control conditions. After 144hrs of culturing the samples were fixed and stained for 
mouse (IgG) anti-WT1, mouse (IgM) anti-CD15 and rabbit anti-β-laminin. These were 
detected with anti-mouse (IgG) AlexaFluor 647nm, anti-mouse (IgM)-FITC and anti-
rabbit-TRITC. In control conditions, the nephrons showed well developed glomeruli, 
proximal tubules and distal tubules (Fig.4.10A). Nephrons that matured in ROCK 
inhibiting conditions showed abnormal glomeruli, where the glomeruli appears to be 
“burst” and not properly enclosed. Significantly, WT1 was detected in the CD15 
positive tubule portions (Fig.4.10B). Co-localisation detection using ImageJ 1.40g, on 
single z-sections revealed that the WT1 stain co-localised with the CD15 in the tubular 
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portions of the nephron (Fig.4.10D). This did not occur in the control nephrons 
(Fig.4.10C).  
These results show that there were cells in the tubular portion of the nephron which 
ectopically expressed WT1 in addition to expressing the endogenous marker proximal 
tubule marker CD15. This indicates that cells are displaying a defect in differentiation 
and that ROCK is necessary for normal nephron differentiation. This data suggest that 
close mixing of normally differentiated cell types was not the reason why different 
segment markers were detected in the same regions. The hypothesis which suggested 
that cells first failed to segregate and subsequently displayed erroneous differentiation is 
still plausible. Together with the data which showed E-cadherin and CD15 in the same 
cells, this strongly argues for the point that ROCK is required for the normal 
specification of cellular fates along the proximal-distal nephron axis. 
 
I also attempted to use L1-cell adhesion molecule, a distal tubule specific protein 
(Debiec, Christensen, and Ronco 1998), as a marker. L1-cell adhesion molecule turned 
out to be unsuitable for this analysis because nephrons formed in control conditions 
displayed large regions of overlapping expression between L1-cell adhesion molecule 
and CD15. This suggests that L1-cell adhesion molecule is perhaps not as restricted to 
distal regions during early development as previously suggested (Debiec, Christensen, 
and Ronco 1998), although my results could be a result of the culture systems used in 































Fig.4.10 The effects of ROCK inhibition on nephron proximal-distal segmentation (#V) 
 
Fig.4.10 (A) Nephron developed in control conditions for 144hrs show normal expression of CD15 in the 
proximal tubule, WT1 in the podocytes and β-laminin in the basement membrane. (B) Shows abnormal 
nephron developed in 1.25µM H1152 medium where the tubule portion is shortened and CD15 is present 
throughout. The glomerulus is abnormal as shown by the aberrant WT1 and β-laminin expression. (C,D) 
single z-sections of each nephron showing co-localisation of WT1 and CD15 as shown in white. (C) no 
co-localisation at all. (D) WT1 is detected in the CD15 expressing segment where co-localisation is 
Laminin   CD15   WT1 








evident. The detected WT1 in (A,B) and WT1, CD15 and β-laminin in (C,D) are pseudocoloured for 
contrast or display purposes. Magenta arrows – points of co-localisation. (A’,B’) show schematic 
representations of nephrons in (A,B). Nephrons are in turquoise, green and grey segments of the nephron 
indicate parts positive for CD15 and WT1, respectively. Diagrams were produced by careful inspection of 
nephrons at maximum resolution. 
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4.2.7 Inhibition of ROCK does not prevent expression of nephron segment-specific 
genes. 
 
In the previous sections, it was shown that ROCK is necessary for normal proximal-
distal nephron patterning. This data suggested that the inhibition of ROCK affects 
normal differentiation and can directly, or by a secondary mechanism, affect gene 
expression. A noteworthy observation was that in spite of ROCK inhibition disturbing 
proximal-distal differentiation, this did not lead to an actual loss in the number of 
segment markers present; at least not in terms of L1-cell adhesion molecule, WT1, E-
cadherin and CD15. This might suggest that ROCK does not regulate gene expression, 
but as suggested, ROCK could be part of the structural mechanism that produces the 
proximal-distal axis. 
 
To investigate this point I decided to monitor the effects of ROCK inhibition on the 
expression of genes that have been shown to have an expression pattern restricted to 
either the presumptive Proximal Tubule, Loop of Henle, or the Distal Tubule. A large 
number of genes have been shown to display expression patterns that are specific to 
particular nephron segments (Raciti et al 2008). The purpose of this investigation was to 
determine whether the inhibition of ROCK might genetically affects the induction of 
nephron segmentation or if the inhibition of ROCK primarily affects a particular portion 
of the nephron more so than the other segments. The genes that were selected were 
chosen because they have highly restricted expression patterns. The proximal segment 
markers were: sodium glucose transporter 2/solute carrier family 5 member 2 
(sglt2/slc5a2), hairy/enhancer-of-split related with YRPW motif 1 (hey1) and cadherin-6 
(cdh6) since they have been demonstrated to be expressed in the proximal portions of 
the nephron with no expression in distal parts or in other kidney structures (Cho et al 
1998; Rubera et al 2004; Chen and Al Awqati 2005). Similarly, iroquois related 
homeobox 3 (irx3) and hairy and enhancer of split 5 (hes5) were picked as Loop of 
Henle markers, as they are not expressed in the more proximal or distal potions of the 
nephron or elsewhere in the kidney (Piscione, Wu, and Quaggin 2004; Reggiani et al 
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2007). Brn1/Pou3f3, Tamm-Horsfall protein (THP) and hormonally upregulated neu-
associated kinase/mak-v (hunk/mak-v) were used as markers for the distal segments of 
the nephron for the same reasons as have been stated for the proximal and Loop of 
Henle markers (Nakai et al 2003; Sakai et al 2007). 
 
Cultures were set up to monitor the expression of genes at several time-points of 
nephron maturation (24 hrs, 48 hrs, 72 hrs, 96 hrs and 144 hrs) (Fig.4.11). As in the 
previous sections, the ROCK inhibitor was added after 48hrs to allow for the formation 
of renal vesicles (RV). This meant that for time-points ‘24hrs’ and ‘48hrs’, these 
samples had only been cultured in control conditions. For time-points ‘72hrs’, ‘96hrs’ 
and ‘144hrs’, these contained separate sets of kidneys that had been cultured from the 
48hrs point in either control or ROCK inhibitor conditions. Multiple cultures were set up 
for each condition and cultured separately. RNA was isolated from the cultured kidneys 
at the specified time-points and represents RNA from 7-10 kidneys per condition and 
time. Protocols for RNA isolation, cDNA synthesis, primer design and PCRs are as 
described in Chapter 2. β-actin was used as a cDNA loading protocol. All original gel-
images used to produce (Fig.4.11) are shown and labelled in Appendix 2-Fig.A2.3. 
 
Expression of proximal tubule markers sglt2 (Rubera et al 2004), hey1 (Chen and Al 
Awqati 2005) and cdh6 (Cho et al 1998), was similar in kidneys cultured in control and 
in ROCK inhibiting conditions. However, the expression of the segment markers was 
slightly lower in ROCK inhibitor cultures compared to control cultures. The same trend 
was seen when Loop of Henle markers irx3 (Reggiani et al 2007) and hes5 (Piscione, 
Wu, and Quaggin 2004) were analysed. Hes5 was never detected in ROCK inhibitor 
cultures; however it was only weakly detected at 144hrs in control condition cultures 
and may have appeared if the cultures could have been maintained for a longer time. 
Whole kidney cultures maintained for more than 144hrs appeared non-viable. Distal 
tubule markers brn1 (Nakai et al 2003), THP and hunk (Sakai et al 2007) showed the 
same tendency as previously discussed genes. Each gene specified is accompanied by 
the relevant reference specifying its restrictive expression pattern. These results indicate 
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that the inhibition of ROCK did not severely prevent gene expression during nephron 
maturation. Since the ROCK-inhibiting cultures displayed reduced nephron formation 




Fig.4.11 Inhibition of ROCK does not disturb nephron segment-specific gene expression 
 
Fig.4.11 shows the expression profile of kidneys that were cultured in CKCM for the first 48hrs and then 
further cultured in either CKCM (C) or 1.25µM H1152 ROCK inhibitor (H) until 144hrs. RNA was 
isolated at time-points: 24hrs, 48hrs, 72hrs, 96hrs and 144hrs. Gene expression was detected using end-
point PCRs. The presence or the absence of particular gene transcripts at each time point and under each 
condition is scored as; ‘+’ where the transcript was abundant, ‘-’ where it was not detected or ‘(+)’ where 
detection was very low. Genes known to display restricted and specific expression to Proximal Tubule 
(maroon), Loop of Henle (navy blue) and the Distal Tubule (purple) were chosen to in order to monitor 
nephron-segment differentiation and maturation. The expression of each gene in each condition is read 
across the table. Differential expression where transcripts were not detected or were only very weakly 
detected have been circled in red. The original gel-images are included in Appendix 2-Fig.A2.3 where the 
corresponding bands have been similarly marked. 
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4.2.8 Inhibition of ROCK disturbs normal nephron maturation and in particular renal 
vesicle formation. 
 
Inhibition of ROCK resulted in abnormal proximal-distal axis patterning but at the same 
time, nephron cells displayed E-cadherin, CD15, L1-cell adhesion molecule and WT1 
protein and kidneys cultured in ROCK inhibitor conditions were shown to be expressing 
7 proximal-distal segment specific genes. Although the abnormal proximal-distal 
patterning might account for the failed glomerular cleft formation seen in ROCK-
inhibitor nephrons, I decided to further elucidate the importance of ROCK for both 
nephron formation and maturation by quantifying the degree and type of abnormality on 
a background of specific nephron stages. The aim was to determine critically the major 
stage of nephron formation affected by ROCK inhibition. The nephrons in control and 
ROCK-inhibiting conditions were scored using their morphology, E-cadherin 
localisation and stage. This enabled accurate assignation of nephrons into three stage 
groups: (1) Renal Vesicles (RV), consisting of simple cyst-like nephrons, (2) Comma- 
and S-shaped Body (CSB), nephrons that displayed a condensed tubular structure with a 
clearly visible glomerular cleft, and (3) S-shaped Body + (SB+), nephrons that showed 
an expansive tubular morphology.  
  
Whole kidney cultures were set up as described in sections 4.2.6.4 - 4.2.7 where the after 
48hrs of culture the ROCK inhibitor was added to the experimental samples and the 
kidneys maintained for a total of 120hrs. The cultures were fixed and stained for β-
laminin and E-cadherin. 136 nephrons were examined of which 58 were nephrons from 
control kidneys and 78 were nephrons formed in ROCK inhibitor kidneys. In control 
cultures, nephrons displayed clearly restricted E-cadherin expression (Fig.4.12A,B) 
compared to ROCK inhibition cultures where E-cadherin expression was expanded into 
the whole of the nephrons (Fig.4.12C,D). In control cultures, nephrons of categories RV, 
CSB and SB+ stages contained 0%, 3% and 0% of nephrons which were classified as 
abnormal. A small proportion of control nephrons displayed ambiguous localisation of 
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E-cadherin and/or morphology and could not be classified with certainty as neither 
normal nor abnormal (Fig.4.12E).  
Contrary to the control nephrons, 71% of ROCK inhibitor nephrons displayed abnormal 
morphology and 50% had abnormal localisation of E-cadherin (Fig.4.12E). The majority 
of nephrons formed in ROCK inhibiting conditions were in CSB or SB+ stages, 43% 
and 39%, respectively (Fig.4.12F). However, the proportionally larger number of 
nephrons at SB+ stage may have been a result of the morphological defects that these 
nephrons showed. A large number of SB+ nephrons were simply long tubules with no 
signs of proximal segments but with a more tubular morphology than what would be 
classified as a CB or SB nephron. The abnormal morphology and aberrant localisation of 
E-cadherin was seen in all stages of ROCK inhibitor nephrons but, proportionally, the 
greatest number of abnormal nephrons was seen at RV stage where 83% of nephrons 
were abnormal compared to CSB, 66%, and SB+, 72% (Fig.4.12G). These results show 
that nephrons forming in ROCK-inhibiting conditions develop anomalously and display 
segmental and morphological defects at several developmental stages. The relatively 
high proportion of abnormal renal vesicles presents the possibility that ROCK activity is 
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Fig.4.12 Quantitative analysis of ROCK effects on nephron maturation. 
 
Fig.4.12, (A,B) Confocal images of E-cadherin and laminin immunostaining illustrate morphology and 
protein localisation in control nephrons, white arrowheads – nephrons 1-4, after 120 hrs of culture. (C,D) 
Nephrons where ROCK inhibitor was added after 48hrs of culture show nephrons that display 
abnormalities in morphology and/or E-cadherin expression, white arrows – nephrons 5-6. UB – ureteric 
bud. (B’,D’) show schematic representations of numbered nephrons in (B,D). Nephrons are in turquoise 
and the UB in black. Green segments of the nephron indicate parts positive for E-cadherin. Diagrams were 
produced by careful inspection of nephrons at maximum resolution. (E) Quantitative analysis of nephrons 
show that 71% of all nephrons in the ROCK inhibitor cultures exhibited abnormal morphology and 50% 
had abnormal E-cadherin expression. (F) Nephrons were also scored for their developmental stage; Renal 
Vesicle (RV) stage, Comma and S-shaped body stage (CSB) or S-shaped body +  (SB+). Inhibition of 
ROCK results in a slight increase of nephrons that were SB+ stage compared to controls. (G) Inhibition of 
ROCK resulted in proportionally similar numbers of abnormal nephrons in CSB and SB+ stage whereas 
most nephrons in RV were classified as abnormal. 58-CKCM nephrons and 78-ROCK inhibitor nephrons 
were analysed. 
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4.2.9 ROCK is necessary for apicobasal polarity formation during early nephrogenesis. 
 
To establish whether the reduced nephron formation and the high proportion of 
abnormal renal vesicles in ROCK inhibiting cultures could be a result of early 
nephrogenic defects, I decided to investigate the first structurally defined stages of the 
epithelial nephron. As a nephron forms from the mesenchymal-to-epithelial transition of 
the cells that surround and receive inductive signals from the ureteric bud tip, it is 
necessary for these epithelialising cells to develop apical, basal and lateral polarities in 
the process of becoming epithelial. Normal nephron cells possess an apical, luminal, side 
and a basal, admesenchymal, surface. Previous studies, displayed here as (Fig.4.13D,E) 
with kind permission from Dr Lipschutz, have shown Rho and ROCK to play an 
important role for apicobasal polarity formation in Madin-Darby Canine Kidney 
(MDCK) cell cysts that are cultured in collagen gels (Rogers et al 2003; Yu et al 2008). 
MDCK cells expressing a dominant-negative form of RhoA show inverted polarity with 
the apical surface facing the outside (Rogers et al 2003). One possibility is that the 
morphologically abnormal nephrons in my experiments may have formed as a result of 
the epithelialising cell’s experiencing problems with properly defining their apicobasal 
axis during initial steps of the mesenchymal-to-epithelial transition.  
To investigate whether apicobasal polarity formation occurred normally, spinal cord 
induction cultures were set up. In plain CKCM, nephron cells formed with normal 
polarity, the basal marker laminin being to the admesenchymal side of the epithelium 
and within the glomerular cleft (Fig.4.13A). In ROCK inhibitor cultures, the nephron 
cysts that formed in the spinal cord induction cultures displayed laminin on the luminal 
side of the epithelial cysts and not on the admesenchymal side (Fig.4.13B,C). These 
nephrons resembled the inverted MDCK cell cysts published by Rogers and colleagues 
where actin was used as a polarity marker (Rogers et al 2003). In whole kidney cultures, 
the concentration of ROCK inhibitor used prevented nephron formation but laminin 




























































Fig.4.13 Inhibition of ROCK disturbs early apical-basal polarity formation in the renal 
vesicle 
 
Fig.4.13 Shows immunostaining visualising the effects of ROCK inhibition on early stages of 
nephrogenesis. Transfilter spinal cord induced MM cultures were kept for 72hrs with (A) or without (B 
and C) 2.5µM H1152-glycyl. Cultures were stained for laminin using anti-laminin-rabbit and anti-rabbit-
TRITC. S-shaped bodies are indicated with yellow arrows. Abnormal laminin distribution is specified 
with red arrow heads. (D) and (E) have been taken and modified, with kind permission of Dr Lipschutz, 
from Rogers et al 2003. Original figure annotations for (D) and (E) were Fig. 2 B and F, respectively. (D) 
and (E) display Madin-Darby canine kidney cell cysts stained for actin using phalloidin. Normal apical 
actin staining is indicated by the white arrow and actin staining indicating abnormal polarity is pointed out 
with white arrowheads. (F,G) Whole kidney cultures kept for 72hrs in either plain CKCM or in 2.5µM 
H1152, respectively. These kidneys were stained for rabbit β-laminin and mouse Pan-cytokeratin that 
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arrows and abnormal laminin deposition is indicated with turquoise arrows. (A’) show a schematic 
representation of numbered nephrons in (A). The diagram was produced by careful inspection of nephrons 
at maximum resolution.  
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4.2.10 ROCK is necessary for normal positioning of the visceral and parietal epithelia. 
 
The inversion of apicobasal polarity shown in the previous section is further illustrated 
by immunostaining for Wilms’ tumour 1 homologue (WT1), a marker of developing 
podocytes. WT1-expressing, presumptive podocytes are normally located within the 
visceral epithelium and WT1 is also expressed at a lower level in the parietal epithelium. 
The process that structurally defines the parietal and visceral epithelia is the formation of 
the glomerular cleft. Glomerular cleft formation can be seen in (Fig.1.2), although these 
images show human samples. The glomerular cleft is lined with a basement membrane. 
In previous sections I have shown that glomerular cleft formation is interrupted as a 
result of blocking ROCK activity and the apicobasal polarity is disturbed in isolated 
nephrons. In this section I further investigate the formation of the glomerular cleft to 
determine whether the regulation of apicobasal polarity might play a role in this process. 
 
Isolated metanephric mesenchyme induced by spinal cord form typical comma- and s-
shaped bodies after 72hrs of culturing in control conditions (Fig.4.14A). The nephrons 
show high levels of WT1 expression in the visceral and parietal epithelia and the 
glomerular cleft also display clear deposition of laminin towards the cleft surface 
(Fig.4.14A). When ROCK is inhibited, nephrons form abnormally. WT1-expressing 
podocyte progenitors localised to the outside of the epithelial structures (Fig.4.14B,C) 
and there is no evidence of a flattened parietal epithelium or organised columnar 
epithelial cells resembling the presumptive podocytes in the visceral epithelium. 
Abnormal localisation of laminin to the interior of ROCK inhibitor nephrons is again 
evident. These data strongly support my hypothesis that the glomerular cleft is disturbed 
as a result of ROCK inhibition. In addition, as the apicobasal polarity of nephron cells 
was shown to be inverted in ROCK-inhibitor conditions, this suggests that the 
localisation of the WT1 expressing cells to the out side of the nephrogenic cysts could be 
a result of abnormal apicobasal polarity.  
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In whole kidney cultures, laminin localised in a more organotypical apicobasal manner 
in distal segments (Fig.4.5C,D). The morphologically abnormality shown by proximal 
segments, as has previously been described, makes the analysis of apicobasal polarity in 



































































Fig.4.14 Inhibition of ROCK results in abnormal localisation of WT1 positive nuclei 
indicating abnormal apical-basal polarity 
 
Fig.4.14 shows immunostaining showing the effects of ROCK inhibition on WT1 protein localisation. The 
morphology of nephrons formed in CKCM (A) was compared with that of nephrons formed in CKCM 
with 20µM Y-27632 (B and C). Nephrons were formed in spinal cord induced MM. All cultures were kept 
for 72hrs after which they were fixed and stained with rabbit anti-β-laminin, mouse anti-WT1, anti-rabbit-
TRITC and anti-mouse-FITC. Blue arrowhead – normal nephron, magenta arrowhead – abnormal 
nephron, white arrowheads – abnormal WT1 positive nuclei distribution. (A’ and B’) show schematic 
representations of numbered nephrons in (A and B). Diagrams were produced by careful inspection of 




4.2.11 ROCK is necessary for apicobasal polarity formation during development: a non-
reversible process. 
 
The effects of ROCK inhibition on apicobasal cell polarity raised the question whether 
ROCK is a necessary regulator of apicobasal cell polarity solely during nephron 
development or if inhibition of ROCK in more mature nephrons results in a transition 
from normal to inverted cell polarity. In MDCK cell experiments it has been shown that 
once MDCK cysts have polarised sufficiently after 4 days, it is no longer possible to 
inverse the polarity by blocking β1-integrin or expressing dominant negative Rac1 (Yu 
et al 2008). Here I investigate whether nephrons display a similar requirement for 
ROCK, where its function is only necessary during polarity development but not for 
subsequent polarity maintenance.    
 
To investigate this possibility, spinal cord induced mesenchyme was cultured in control 
conditions for 72hrs to allow nephrons to mature to SB stage. At this point the ROCK 
inhibitor was administered for an additional 72hrs. Control cultures, which were cultured 
continuously in control medium, displayed normal apicobasal polarity as shown by basal 
expression of laminin and apical expression of CD15 (Fig.4.15A). Nephrons transferred 
to ROCK inhibiting conditions did not display inversion of polarity, although some form 
of epithelial degeneration was clearly visible throughout the samples (Fig.4.15B,C).  
These results show that nephrons require ROCK for early apicobasal polarity 
development but the importance of ROCK for apicobasal polarity diminishes as the 











































Fig.4.15 Inhibition of Rho-kinase does not reverse existing apicobasal polarity 
 














Fig.4.15, (A) Normal nephrons are correctly polarised after 144hrs of culture as shown by tubular 
structures with correct basal and apical expression of laminin and CD15, blue arrowheads – nephrons 1-2. 
(B,C) Nephrons cultured for 72hrs in control conditions followed by 96hrs in ROCK inhibitor do not 
reverse polarity but do show severe loss of structure. Nephrons are illustrated using antibodies for laminin-
TRITC and CD15-FITC. (A’,B’,C’) show schematic representations of nephrons in (A,B,C). Diagrams 




4.2.12 ROCK acts via actin-myosin contraction to regulate functions during nephron 
formation and maturation. 
 
In the introduction to this chapter I briefly describe how ROCK regulates actin-myosin 
stress fibre formation via a pathway involving myosin light chain, myosin light chain 
phosphatase and myosin ATPase. In this section I tested whether the abnormalities seen 
in ROCK inhibitor nephrons can be mimicked by direct inhibition of actin-myosin 
contraction.  
 
Using the same type of cultures (whole kidney cultures and spinal cord induced 
mesenchyme) I set up experiments testing whether the inhibition of myosin ATPase 
results in similar nephrogenic defects as the inhibition of ROCK. Myosin ATPase was 
inhibited using 2,3 butanedione monoxime (BDM) as previously optimised (Michael, 
Sweeney, and Davies 2005). Control cultures (Fig.4.16A) showed normal nephron 
formation whereas inhibition of myosin ATPase with BDM, resulted in severely 
inhibited nephron formation where no or very few nephrons formed (Fig.4.16B). In 
spinal cord induced mesenchyme nephrons formed normally in control conditions 
(Fig.4.16C) but in BDM conditions abnormal nephrons formed (Fig.4.16D). The effects 
of BDM appeared to be more severe than those of the ROCK inhibitor, although 
similarities could be seen between the effects if the two inhibitors. Inhibition of myosin 
ATPase did not produce the same morphological defects in the ureteric bud. The degree 
of abnormality displayed by the nephrogenic epithelia formed under BDM conditions 
made apicobasal polarity analyses difficult. The epithelia that formed showed no basic 
structures identifiable as nephrogenic and were as such not possible to classify into 
defined nephrons with either correct or abnormal apicobasally patterning.  
Experiments were also carried out where BDM was added to whole kidney cultures, 
after 48hrs when renal vesicles (RV) had already formed. 56 nephrons from BDM 
conditions were examined and compared to previously described controls (Fig.4.12). 
The experimentally treated nephrons resembled the nephrons formed in ROCK 
inhibiting conditions in equivalent cultures (Fig.4.16E,F). 49% of BDM nephrons 
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showed structural abnormalities and 74% displayed aberrant E-cadherin expression 
(Fig.4.16G). The majority of BDM nephrons, 60%, were halted in the RV stage 
(Fig.4.16H). Half of BDM nephrons in RV stage displayed abnormalities, 47% 
(Fig.4.16I). The effects of BDM in kidney cultures appear to be more severe than the 
effects if ROCK inhibitors and it is more similar to what is seen when ROCK is 
inhibited in spinal cord-induced mesenchyme cultures. However, the apparent need for 
myosin ATPase before and after RV progression suggests similarities to the need for 
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Fig.4.16, (A) Kidney cultured in control conditions shows normal nephron formation, red arrow – nephron 
1. (B) Kidney cultured in myosin ATPase inhibitor, BDM, has interrupted nephron formation. (C) Spinal 
cord induced mesenchyme in control conditions with normal nephrons, red arrows – nephrons 3-4. (D) In 
spinal cord induced mesenchyme with BDM, nephrons form abnormally with severe defects, white 
arrows. Cultures were maintained for 72hrs. (E,F) Confocal images of E-cadherin and laminin 
immunostaining, full size (E) and magnified (F) illustrate morphology and protein localisation in nephrons 
where BDM was added after 48hrs of culture. (E) inset image shows controls as shown in (Fig.6A). 
Controls for (E-I) are the same as for Fig.6. White arrows specify nephrons that display abnormalities in 
morphology and/or E-cadherin expression, nephrons 4-7. UB – ureteric bud. (G) 49% of nephrons formed 
in BDM had morphological abnormalities and 74% displayed abnormal E-cadherin expression. (H) 
Nephrons were also scored for their developmental stage as described in (Fig.6). Inhibition of BDM 
resulted in the majority of nephrons remaining at RV stage. (I) The majority of nephrons with 
abnormalities were found at an RV stage. (A’-D’,F’) show schematic representations of numbered 
nephrons in (A-D,F). Nephrons are in turquoise and the ureteric bud in black. Green segments of the 
nephron indicate parts positive for E-cadherin. Diagrams were produced by careful inspection of nephrons 
at maximum resolution. 58-CKCM nephrons and 56-BDM nephrons were analysed. 
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4.3 Chapter discussion 
 
4.3.1 Inhibition of ROCK disturbs nephron and glomerular cleft formation: a polarity 
problem? 
 
Nephrogenesis is a complex process that involves numerous different stages and 
mechanisms where it is likely that a wide array of regulatory pathways play important 
functions. In Chapter 4 I show that ROCK is needed during several of the stages of 
nephron development and I argue that ROCK is necessary for apicobasal polarity 
formation, glomerular cleft development and for the patterning of the nephrons’ 
proximal-distal axis. I will discuss the roles of ROCK in the order that they seem to 
affect nephron development. 
 
The formation of nephrons requires ROCK. At a moderate concentration of ROCK 
inhibitor, only 54% of the normal number of nephrons form; this is a significant 
reduction. When the ROCK inhibitor is added after the renal vesicles have already 
developed, 71% of the nephrons display some form of abnormality. If this reflects the 
degree of abnormality seen when ROCK inhibits nephrogenesis, this would mean that 
only 16% of the normal number of nephrons form properly. A decrease of this 
magnitude would severely reduce the functional capacity of the kidney. 
One possibility is that a disruption of the mesenchymal-to-epithelial transition which 
gives rise to the nephrons could be the cause of the reduced nephrogenesis. An essential 
aspect of epitheliogenesis is the development of an apicobasal polarity (Davies and 
Garrod 1997). Kidney cells (MDCK cells) in 3D cultures have been shown to demand 
the Rho-GTPase family for normal apicobasal polarity formation (Rogers et al 2003; Yu 
et al 2008). It is clear that Rac1 is important for this polarity formation, possibly through 
activation via β1-integrin, but it is less clear what the role is of RhoA and its effector 
ROCK (Rogers et al 2003; Yu et al 2008). Rogers and colleagues clearly demonstrate 
that the expression of dominant negative RhoA, results in cellular cysts with inverted 
polarity (Rogers et al 2003). Yu and colleagues failed to replicate this finding using 
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RNAi to target RhoA or ROCK-I but they showed that a decrease in RhoA or ROCK 
could rescue the inverted polarity produced by the expression of dominant negative 
Rac1 (Yu et al 2008). To understand the importance of RhoA and ROCK for polarity, 
this discrepancy must be resolved. 
 
There is convincing evidence which argues that ROCK is needed for the apicobasal 
polarity formation in the mammary glands (Ewald et al 2008). The data shows that if 
ROCK is inhibited during mammary gland growth, the epithelial ducts fail to transit 
from a multilayered and growing state into stable monolayered and apicobasally 
polarized tubules (Ewald et al 2008). My data suggest that ROCK is important for 
apicobasal polarity formation during nephrogenesis. The inhibition of ROCK in spinal 
cord-induced mesenchyme leads to the development of nephrons with ectopic β-laminin 
deposition on the luminal side of the cysts. This lead to the hypothesis that the nephron, 
like the MDCK cells and the mammary glands also requires Rho or ROCK during the 
establishment of an apicobasal polarity. The development of an apicobasal polarity is a 
prerequisite to the formation of the renal vesicle. Therefore, without the apicobasal 
polarity it is unlikely that a glomerular cleft will form normally or that podocyte 
progenitor cells are localised normally. I show that this is the case. In whole kidney 
cultures, the main abnormality of the nephrons can be seen in the proximal regions 
where glomerular cleft formation is blocked. Nephrons with abnormal apicobasal 
polarity, in spinal cord induced mesenchyme, display cells with high levels of WT1 on 
the outside of the nephrogenic structures rather than the cells being located inside the 
structurally distinct visceral and parietal epithelia. 
 
These data are difficult to explain mainly because the results that I have represents 
snapshots of nephrogenesis, rather than the continuous development of a nephron. Time-
lapse microscopy could resolve this problem and the WT1
+/GFP
 mouse would be a useful 
tool for this. I carried out initial experiments to show that the inhibition of ROCK also 
disturbed nephron development in this mouse strain. The purpose of this was to evaluate 
whether a real-time analysis could be carried out to demonstrate exactly what happens 
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during nephron formation and glomerular cleft formation. It was concluded that, 
although real-time microscopy would be possible on the WT1
+/GFP
 mouse, there would 
definitely be a need for a marker of the basement membrane since light microscopy was 
insufficient to highlight the nephron structures. The combination of a basement 
membrane-fluorescent mouse with the WT1
+/GFP
 would provide the optimal components 
to investigate the effects of ROCK on apicobasal polarity formation.  
 
It is also important to discuss the differences between the results in spinal cord induced 
mesenchyme and whole kidney cultures. The induction of nephron formation by spinal 
cord is very efficient and in fact it appears to a more powerful inducer of nephron 
formation than the ureteric bud. This difference in efficiency might be explained by that 
the spinal cord continuously and widely induces the available mesenchyme whereas the 
ureteric bud induces nephron formation in a controlled manner where the optimum is not 
necessarily that all available mesenchyme is induced. The concentration of ROCK 
inhibitor that disturbed apicobasal polarity formation in spinal cord-induced 
mesenchyme almost completely blocked nephrogenesis in whole kidney cultures. I think 
that this difference is because the spinal cord seems to provide a stronger inductive 
signal and as such stimulates nephron formation to occur in spite of one of the 
mechanisms required (ROCK), not being present. The deposition of laminin in the 
mesenchyme of whole kidney cultures, where nephrogenesis would normally occur, 
supports the idea that nephron formation was attempted in these cultures but it failed as a 
result of ROCK inhibition. Further experiments highlighting the expression of nephron 
induction markers might add to this hypothesis. 
 
Several molecular components have been identified that, if removed, results in blocked 
nephron development, e.g. Wnt4, α6β1 integrin and α-laminin (Klein et al 1988b; 
Sorokin et al 1990; Stark et al 1994). I propose that ROCK is also required. The 
mechanism of activation of ROCK is not known, nor is it known whether the 
requirement of ROCK is a property displayed by all epithelialising cells or whether 
ROCK is specifically activated in the nephrons. ROCK activation can be regulated via 
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Wnt-dependent planar cell polarity pathways (Habas, Dawid, and He 2003). As the 
Wnt/β-catenin pathway has been demonstrated to induce nephron formation, it would be 
interesting to further investigate whether a planar cell polarity pathway is also important. 
Osafune and colleagues has published some data indicating that a planar cell polarity 
pathway is important for the size of nephron progenitor cell cultures in vitro, however, 
more work is required to cement this hypothesis (Osafune et al 2006). Park and 
colleagues showed that the Wnt/β-catenin pathway is sufficient to induce nephron 
formation but the epithelial-to-mesenchymal transition does not take place (Park, 
Valerius, and McMahon 2007). Perhaps this indicates that a non-canonical pathway is 
also necessary where for example, ROCK might play a role during proper apicobasal 
polarity formation.  
 
One possible way to determine whether ROCK is activated by the Wnt/non-canonical 
planar cell polarity pathway would be by blocking a crucial component of the pathway 
and measuring the level of ROCK activation. Dishevelled would provide a good 
candidate gene to block but as it is involved in the Wnt/β-catenin dependent pathway, 
this would have to be rescued in order to induce nephron formation. GSK3β inhibitors 
have been optimised and shown to work in kidney cultures; the use of such inhibitors 
could rescue the β-catenin pathway (Davies and Garrod 1995; Kuure et al 2007). This 
experiment could show whether blocking the planar cell polarity affects the activation of 
ROCK in nephrons or the kidney.  
 
 
4.3.2 ROCK is necessary for proximal-distal axis formation. 
 
The development of the proximal-distal axis in the nephron requires ROCK. Inhibition 
of ROCK before or after the renal vesicle stage produces nephrons with abnormally 
patterned proximal-distal axes. Proteins that are normally found in a segment-specific 
pattern were detected in the whole of the tubular segment of the nephron instead of 
being restricted to their appropriate domain. This abnormal patterning of markers even 
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included WT1 which is normally only expressed in the parietal and visceral epithelia. In 
the results section I provided two alternative explanations for this. Firstly, there is the 
possibility that the cells actually differentiate abnormally and therefore they express 
markers for both distal and proximal segments. The second hypothesis suggested that it 
could be a failure of segregation of proximal and distal cells, and not differentiation, 
which resulted in the mixing of segment markers. I also presented the possibility that a 
failure to segregate properly might lead to the first hypothesis where the non-segregated 
cells start to acquire an abnormal identity due to their environment and therefore express 
ectopic genes. My interpretation is that the co-localisation of WT1 and CD15 in tubular 
segments of the nephron, as well as the presence of CD15 in E-cadherin positive cells, 
suggests that abnormal differentiation is taking place. The mechanism that is disturbed 
to produce these results is still to be determined. To speculate on this point, it is a strong 
possibility that the abnormal differentiation is a result of abnormal segregation of cells. I 
find it plausible that the abnormal positioning of a cell might result in the cell being in 
an environment that is inductive towards the differentiation down a segment-specific 
pathway. Alternatively, it is also worthwhile considering that it is not the environment 
that stimulates differentiation, but instead it might be that all cells in the renal vesicle 
attempt to differentiate down all pathways and the segregation of cells forces them into 
environments that are inhibitory towards all fates other than that of the segment which 
they are in.  
 
It is possible that ROCK is important for cell segregation. Sahai and Marshall showed 
that ROCK can disrupt adherens junctions (Sahai and Marshall 2002). A number of 
cadherins show segment specific expression along the proximal-distal axis of the 
nephron although disruption of cadherin function has had quite limited phenotypes (Cho 
et al 1998; Mah et al 2000; Dahl et al 2002). Differential cadherin expression has, in 
other systems, been shown to result in cell sorting as explained by the differential 
adhesion hypothesis where cells expressing different cadherins or different levels of the 
same cadherin can successfully segregate (Foty and Steinberg 2005; Steinberg 2007). 
Interestingly, cadherin mediated segregation of cell populations might not necessarily be 
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a result solely based on differential cadherin expression but differences in the number of 
cadherin molecules may play a significant role, as discussed by (Foty and Steinberg 
2005). The possibility of non-sorting of cells is attractive as it could be accountable for 
the lack of nephron segmentation and cells expressing markers for more than one 
nephron segment.  
 
These data are not the first pieces of evidence showing the plasticity of nephron cells. 
Reggiani and colleagues showed that Irx3 is necessary for the differentiation of a 
particular segment in the Xenopus pronephros (Reggiani et al 2007). Deletion of Irx3 
lead to the loss of a specific segment differentiating as shown by the loss of expression a 
segment-specific marker (Reggiani et al 2007). In addition, supplying Irx3 mRNA 
resulted in the ectopic differentiation of the Irx3 regulated segment (Reggiani et al 
2007). It is uncertain when (or if) cells acquire a non-plastic segment-specific identity, 
although it is known that the Six2 positive nephron progenitor cells can contribute to all 
segments of the nephron (Kobayashi 2008). 
 
Regardless of which mechanism it is that disturbs the nephron proximal-distal axis 
patterning it is interesting to note that many segment-specific genes are still activated. I 
showed that L1-cell adhesion molecule, WT1, CD15, E-cadherin (immunofluorescence 
protein studies), Sglt2, Hey1, Cadherin-6, Irx3, Brn1, THP, and Hunk (RT-PCR/PCR 
studies) were all present/expressed in kidneys where ROCK had been inhibited. In the 
early nephron these proteins/genes represent every segment that is present at this stage. I 
speculate that, together with the data showing abnormal segment patterning with ectopic 
gene expression, these data indicate that ROCK is not likely to directly regulate cellular 
differentiation in the nephron. This would fit with the hypothesis that all the cells in the 
nephron have the capability to produce any portion of the nephron (Kobayashi 2008). I 
propose that ROCK is a necessary component in a mechanism that allows the cells in the 
nephron to pattern themselves according to their differentiation so that a segmented 
proximal-distal axis is produced.  
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If abnormal differentiation is a result of the failure of cells to segregate normally it could 
be experimentally tested. One way to test this hypothesis would be to produce a 
conditional transgenic model. The idea would be to drive a rather complex construct that 
excises a floxed endogenous cadherin-6, and activates a transgenically inserted GFP-
tagged E-cadherin driven under the endogenous cadherin-6 promoter. Cadherin-6 is 
normally only expressed in the proximal regions and E-cadherin only in the distal 
segments. This model would produce cells that are entirely proximal, apart from that 
they express E-cadherin instead of cadherin-6. This would demonstrate whether the 
proximal E-cadherin positive cells would adhere to distal E-cadherin positive cells and 
express genes for both proximal and distal lineages.  
 
The question remains whether the requirement for ROCK during nephrogenesis is a 
result of ROCK being necessary for a planar cell polarity pathway.  
 
 
4.3.3 ROCK through myosin and actin-myosin contraction. 
 
The demonstration that ROCK regulates nephrogenesis and maturation prompts the 
question about what mechanism it is that ROCK uses during these processes. I showed 
that the direct inhibition of myosin-ATPase, which is required for actin-myosin 
contraction, results in a strong blockage of nephron formation in whole kidney cultures, 
reminiscent of high concentrations of ROCK inhibitor. The ureteric bud was not affected 
in the same way as when ROCK is inhibited. The ureteric bud was not bloated, in fact it 
appeared to be smaller as if it had halted its development, as previously shown by 
Michael, Sweeney and Davies (Michael, Sweeney, and Davies 2005). Epitheliogenesis 
could be stimulated in spinal cord induced mesenchyme, again suggesting that nephron 
formation is more strongly induced in this system. The epithelial structures that did form 
in these cultures were structurally deformed, making it impossible to determine whether 
apicobasal polarity formation was affected. In experiments where the myosin-ATPase 
was added after 48hrs, when renal vesicles had formed, the nephrons displayed 
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structural malformations and the majority of nephrons displayed abnormal expression of 
E-cadherin. Similarly to the ROCK treated nephrons, the main portion of nephrons that 
were abnormal were in renal vesicle stage. I suggest that the effects of inhibiting 
myosin-ATPase in the kidney might be much more severe than inhibiting ROCK. 
Inhibition of ROCK will not completely stop actin-myosin contraction since myosin 
light chain can still be activated other mechanisms, for example myosin light chain 
kinase, discussed by Amano and colleagues (Amano et al 1996), see Diagram4.1. This 
means that inhibition of ROCK would only block ROCK regulation of actin-myosin 
contraction whereas other pathways might remain unaffected. This could account for the 
















The kidney develops via several intricate stages where the ureteric bud continuously 
branches and elongates as a result of positive and inhibitory signals from the 
metanephric mesenchyme, and as it does this it also induces nephrons to form in the 
virgin mesenchyme that it encounters. The mechanisms that contribute towards the 
development of the kidney very much represent a grey area of understanding and they 
require significantly more research. Rac1-GTPase (Rac1) and Rho-kinase (ROCK) were 
chosen as highly relevant proteins to investigate based on previously published 
experiments (from the Davies lab and from other research groups), and because they 
carry out mechanically interesting functions.  
 
Using kidney organ culture techniques and specific inhibitors, I targeted Rac1 and 
ROCK in vitro in order to determine what functions these proteins play during specific 
stages of kidney development. I have generated data which suggest that normal Rac1-
activity is necessary for normal proliferation rates in the kidney; a process I showed to 
be essential for normal branching morphogenesis. I showed that ROCK is necessary for 
several different stages of nephron development and the development of two sets of 
nephron polarities; the apicobasal and the proximal-distal. In fact, inhibition of ROCK 
blocks nephrogenesis, glomerular cleft formation and proximal-distal nephron axis 
development. These data are separately discussed below in light of published data and 
with suggestions for improvements and further experiments. 
  
Using in vitro cultures to model in vivo morphogenesis or the development of an organ 
requires appropriate consideration regarding the validity of such a model and the 
extrapolations and interpretations that can be made towards the in vivo situation. Here I 
have used two different systems; the spinal cord-induced mesenchyme to study nephron 
development and the whole-kidney culture system for a general approach to view the 
kidney as a whole. It is also possible to culture ureteric buds, isolated from metanephric 
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mesenchyme, and induce them to branch within three-dimensional gels consisting of 
collagen and basement membrane components (Qiao, Sakurai and Nigam 1999). 
Manipulations of a tissue for experimental purposes inherently results in the separation 
from the in vivo situation, yet these culturing techniques can provide valuable insights 
into the signalling within and between tissues. Arguably, the culturing of whole kidney-
rudiments provides a good model for in vivo kidney development as ureteric bud 
branching and nephron formation resembles that which occurs in vivo, in particularly 
when considering the early stages of kidney development (Saxen 1987). However, 
several aspects makes whole-kidney in vitro cultures a poor model for nephron 
development and ureteric bud branching and these are crucial to bear in mind when 
discussing the findings of this thesis. Firstly, the isolation of the kidney rudiments from 
the surrounding embryonic tissues results in the immediate disruption of tissue-to-tissue 
signalling and significantly the interruption of proper vascularisation. The disturbed 
vascularisation will have major impacts on the supply of growth factors and nutrients to 
the growing cells. Additionally, a crucial step of nephron formation is the development 
of the glomerulus, a structure contained within the renal corpuscle. The glomerulus is 
required for the supply of blood to the nephron, thus enabling blood filtration. The 
failure of vascularisation and the failure to form the glomerulus is a limiting factor for 
using in vitro kidney cultures as a method to understand in vivo development.  
 
This divergence between in vitro and in vivo development has recently become an 
increasingly interesting topic. The lack of a blood supply will result in a loss of urine 
production and normal fluid flow within the nephron and the ureteric bud. This might 
have impacts on the regulation of developmental signalling programs. As discussed in-
depth in the introduction, Wnt signalling is an important component of kidney 
development (Stark et al 1994; Park Valerius and McMahon 2007). It has been 
demonstrated that Wnt signalling can be controlled by cilia where the motion of cilia, 
stimulated by for example the flow of a fluid, regulates the activation of Wnt signalling, 
as reviewed in (Germino 2005). Epithelial tubes such as the tubules of the nephron and 
the collecting duct system are lined with cilia that through fluid flow could thus regulate 
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Wnt signalling, discussed in (Germino 2005). As previously mentioned, components of 
Wnt signalling pathways as well as of the Fat-protocadherin pathway have been found 
within both the ureteric bud and the nephrons (Marose et al 2008; Saburi et al 2008). 
Recently, it has been demonstrated that Wnt7b is capable of regulating the mitotic 
angles of cells in both nephron and the ureteric bud epithelia (Yu et al 2009), something 
that has also been shown to be coordinated by the Fat-protocadherin pathway (Saburi et 
al 2008). The possibility that the flow of fluids, through developing epithelial tubules, 
could regulate Wnt signalling in the kidney is an important point to consider not only 
from a general developmental biology perspective but especially when using in vitro 
culture systems to study kidney development.  
This potential difference between in vivo and in vitro kidney development is important 
to remember for the discussion of this thesis, however, as the stages of kidney 
development discussed herein are of an immature stage, it is arguable that potential 
differences formed by fluid flow would be minimal. 
 
 
5.1 Rac1 is necessary for proliferation: and something else? 
 
Normal Rac1 activity is necessary for kidney proliferation, as shown in Chapter 3. 
Inhibition of Rac1, using moderate concentrations of Rac1 inhibitor resulted in a 24-
34% reduction of cells progressing through DNA synthesis. This was not a surprising 
feature of Rac1 inhibition as Rac1 has been shown to be necessary for proliferation in 
other systems, such as in fibroblast, endothelial, and haematopoietic stem cells (Moore 
et al 1997; Mettouchi et al 2001; Gu et al 2003).  
Interestingly, I showed that the inhibition of Rac1 resulted in morphological defects in 
the kidney, mainly evident by the reduced ureteric bud branching and decreased overall 
growth. Michael and Davies showed that proliferation is a requirement for ureteric bud 
induction and that proliferating cells are more frequently detected in the ureteric bud tips 
compared to the ureteric bud stalk regions; the latter was sensitive to the activity of the 
known ramogen GDNF (Michael and Davies 2004). Regionalised high levels of 
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proliferation has also been shown in the mammary glands at the ends of ducts, and both 
proliferation and Rac1 were separately shown to be required for duct formation (Ewald 
et al 2008). In a different system, where nephron progenitor cells are cultured in a two 
dimensional system and induced by Wnt4, Rac1 has been shown to be important and the 
inhibition of Rac1 activity resulted in reduced culture sizes (Osafune et al 2006). Neither 
Osafune and colleagues, nor Ewald and colleagues attempted to determine by what 
mechanism it was that Rac1 functioned, nor did they connect Rac1 to the regulation of 
proliferation (Osafune et al 2006; Ewald et al 2008). I showed that the inhibition of Rac1 
in whole kidney cultures resulted in smaller kidneys with fewer branches and that these 
cultures had reduced numbers of BrdU positive cells.  
 
The effects of Rac1 inhibition on kidney development were investigated further in order 
to determine whether the reduced branching and growth was a result of the decreased 
proliferation. If the reduced branching produced by inhibiting Rac1 were to be caused 
solely by tissue-wide decreased proliferation, then it should be possible to mimic this by 
directly decreasing proliferation. If it could not be mimicked that would mean that Rac1 
might play additional roles during kidney development. I found that direct inhibition of 
proliferation resulted in decreased branching and growth. Interestingly, when the 
proliferation was reduced by a similar proportion to that caused by Rac1 inhibition, the 
decrease in branching was greater by direct inhibition of proliferation. If the data are 
interpreted in a straightforward manner, it would mean that Rac1 activity must normally 
negatively affect ureteric bud branching as well as regulating proliferation. The 
inhibition of Rac1 would result in a dual effect since the branching is released from the 
Rac1-controlled negative regulation as well as being subjected to decreasing 
proliferation rates.   
 
I think that the next logical experiment would be to produce a model where Rac1 
activity can be specifically regulated in the ureteric bud tips. The ureteric bud branches 
at the tips 94% of the time (Watanabe and Costantini 2004) and the tips display 
significantly higher levels of proliferation compared to stalk regions (Michael and 
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Davies 2004). This suggests that, if Rac1 is necessary for regulating proliferation and if 
this is a mechanism for controlling branching, then it would be expected that a specific 
reduction of Rac1 activity in the ureteric bud tips would decrease branching. It would be 
essential to confirm this by, also in a tip-specific manner, blocking cell cycling via a 
different mechanism. This could be achieved by expressing a cell cycling inhibiting 
protein (e.g. p27Kip1), under the control of a tip-specific gene (e.g. Wnt11) (Kispert et 
al 1996; Goukassian et al 2001). It is still possible that Rac1 performs other functions in 
the ureteric bud tips and we will therefore generate the same data as from the organ-wide 
inhibition of Rac1 and proliferation. To determine whether this is the case, it would be 
necessary to start elucidating what downstream regulators it is that Rac1 activates in the 
kidney and from there investigate how these, individually, contribute to kidney 
development. It is also possible that the inhibition of Rac1 does not reflect a true direct 
pathway between Rac1 and proliferation; it might equally well reveal a general necessity 
for Rac1 activity for cell viability. The same argument is applicable for the effects of 
Rac1 inhibition on ureteric bud branching. I find these explanations unlikely since 
relatively small differences in Rac1 inhibitor concentrations could affect branching to a 
significantly different extents.  
  
Apart from the branching, proliferation and overall growth, there were no other detected 
effects from inhibiting Rac1. Osafune and colleagues showed that inhibition of JNK1 or 
JNK2 lead to a failure of the nephron progenitor cells to differentiate and express genes 
that indicate nephron maturation (Osafune et al 2006). Rac1 can act upstream of JNK in 
the planar cell polarity pathway (Habas, Dawid, and He 2003). I generated no data that 
suggested that Rac1 is a regulator of nephron differentiation. On the contrary I found 
that the nephrons appeared morphologically normal and displayed markers of typical 
differentiation.  
  
Osafune and colleagues proposed that a planar cell polarity pathway regulates not only 
the size of their nephron progenitor cell cultures, but also the differentiation of these 
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cells towards different nephron lineages (Osafune et al 2006). I showed that Rac1 is 
unlikely to regulate nephron formation or subsequent differentiation.  
It cannot be ruled out that Rac1 is nevertheless a necessary component of nephron 
differentiation and that a general abundance of active Rac1 is present and that only very 
low levels of Rac1 are required and that I do not achieve such complete inhibition by 
using the Rac1 inhibitor. 
 
To further explore the possibility that Rac1 is regulated by a Wnt/planar cell polarity 
pathway I would devise a similar experiment as that explained in Chapter 4. There I 
proposed the disruption of Dishevelled, and the simultaneous rescue of β-catenin 
signalling as an approach to determine whether ROCK is downstream of a Wnt/planar 
cell polarity pathway although in this case, Rac1 activity would be assayed instead of 
ROCK.  
 
One mechanism of morphogenesis so far not mentioned, which is highly relevant when 
considering Rac1 and proliferation, is that of programmed cell death. A substantial 
number of cells, up to 3%, display apoptotic features and as the cells degrade at  a 
relatively rapid rate, 1-2hrs, this could indicate that perhaps as many as 50% of cells that 
form in the kidney die by apoptosis (Coles, Burn and Raff 1993). The majority of 
apoptotic cells are detected in the metanephric mesenchyme and in particular those 
regions that surround the nephrons, although strikingly, apoptotic cells were also found 
within nephrons (Coles, Burn and Raff 1993). The importance of cell death for kidney 
morphogenesis was convincingly demonstrated through the inhibition of apoptosis in the 
kidney (Araki et al 1999). Inhibition of caspase activity resulted in abnormal branching 
morphogenesis of the ureteric bud as well as reduced nephrogenesis (Araki et al 1999). 
A particularly interesting aspect that supports the possibility that apoptosis is important 
for kidney morphogenesis was the detection of apoptotic cells in the lower portion of the 
s-shaped body; that portion of the nephron which eventually gives rise to the proximal 
parts of the nephron (Coles, Burn and Raff 1993). Apoptotic nuclei were frequently 
detected in this nephron segment (Cole, Burn and Raff 1993). This finding is of interest 
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because there is a lack of models explaining the mechanisms of morphogenesis that 
regulate the formation of the s-shaped body including the development of the glomerular 
cleft and the flattened parietal epithelium. As discussed in the introduction, the 
mechanisms involved in the morphogenesis of the nephron are largely unknown. 
Specific locations of apoptosis could clearly play an important part in shaping the 
structure of the nephron epithelium and should as such be considered as a possible 
mechanism of nephron morphogenesis.  
 
In connection with Rac1, if cell death is a mechanism of nephron morphogenesis, then 
one could argue that cellular proliferation would likely be under a similar level of 
control in order to produce morphologically normal nephrons and ureteric buds. It would 
be of interest to study the precise location and orientation of dividing cells as well as 
apoptotic cells within the renal vesicle, through to the s-shaped body, in order to 
determine whether a replicable pattern is detected. 
 
  
5.2 Rho-kinase and nephrogenesis 
 
In this thesis I demonstrated that Rho-kinase (ROCK) was important for renal vesicle 
formation, glomerular cleft development and for the patterning of cells along the 
proximal-distal axis of the nephron. Previous findings have shown that ROCK plays an 
important part during kidney development (Michael and Davies 2004; Meyer et al 
2006). Inhibition of Rho-kinase in kidney cultures resulted in kidneys that had visibly 
bloated ureteric buds (Michael, Sweeney, and Davies 2005) and that had actually also 
increased in overall size, probably as a result of higher proliferation rates (Meyer et al 
2006). Planar cell polarity pathways acting via a RhoA-dependent planar cell polarity 
pathway (Osafune et al 2006) and a Wnt-independent, protocadherin-dependent planar 
cell polarity pathway (Saburi et al 2008) have been suggested to be acting in the kidney. 
The findings of Osafune and colleagues show that if active RhoA or ROCK were 
reduced/inhibited in nephron progenitor cell cultures, this led to larger cultures 
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compared to controls (Osafune et al 2006). The mechanism for this was not investigated 
but it is possible that increased proliferation, as seen in whole kidneys when ROCK was 
inhibited (Meyer et al 2006), could at least in part account for the size difference. 
Inhibition of ROCK did not affect the differentiation of these cells towards expressing 
nephron segment markers (Osafune et al 2006).  
 
I have shown that ROCK was important during renal vesicle formation. Inhibition of 
ROCK at high inhibitor concentrations almost completely blocked renal vesicle 
formation, and at lower concentrations there was still a large decrease. These effects 
were shown to be independent of the ureteric bud deformities caused by the inhibitor. A 
possibility is that ROCK was required during apicobasal polarity formation, and if that 
was the case, this could explain why very few renal vesicles were formed and why 
laminin was being deposited on the luminal epithelial surfaces when ROCK was 
inhibited. Interestingly, the inhibition of ROCK did not disturb the apicobasal polarity in 
nephrons with a properly established polarity, suggesting that the necessity for ROCK 
reflects a developmental and not a maintenance process. This correlates well with Yu’s 
suggestion that the knockdown of ROCK could only rescue inverted MDCK cell cysts in 
the first few days and vice versa; inverted polarity could only be induced before the 
cysts developed a stable apicobasal polarity (Yu et al 2008).  In the introduction to 
Chapter 4 I described other systems where ROCK has been implicated to regulate 
apicobasal polarity. Perhaps most notably of the examples, is the requirement of ROCK 
to stabilise the apicobasal polarity of mammary gland ducts (Ewald et al 2008). It is 
important to point out that this process differs from the mesenchymal-to-epithelial 
transition that produces the nephrons. The nephrons form via bona fide epitheliogenesis 
whereas the mammary gland ducts develop by a process that more closely resembles the 
sprouting of cells from an already existing epithelium as seen during MDCK cell 
tubulogenesis (Pollack, Runyan, and Mostov 1998; Ewald et al 2008). It is difficult to 
determine at what level parallels can be drawn between these two systems.  
Ideally, if nephron progenitor cells could be harvested and induced to form nephrons in a 
three dimensional matrix, without the presence of a large number of other cells, this 
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could provide the basis of a high-resolution study, similar to those carried out on MDCK 
cells, where it would be possible to properly define the need of ROCK during apicobasal 
polarity formation. There is a range of experiments that could further elucidate the role 
of ROCK during renal vesicle formation. Firstly, a new system has been developed 
where kidney cells are dissociated to a single cell suspension and then reaggregated to 
form ureteric bud structures and mesenchyme capable of normal growth and induction 
(Unbekandt and Davies, unpublished). The strength of this system comes from that the 
single-cell suspension stage is highly accessible for transfection with either siRNAs or 
whole plasmids. The kidney has otherwise proven to be highly resistant to in vitro 
transfection. This system would immediately open up the possibility to specifically 
knock down ROCK-I and ROCK-II separately, as well as to target a large array of 
different ROCK effectors. It would also allow for the transfection of constructs carrying 
inducible constitutively active forms of ROCK or ROCK effectors, immune to the 
effects of the ROCK inhibitor, thus providing a possible mechanism to rescue nephrons 
from ROCK inhibition.  
 
One of the interesting aspects of this thesis is that ROCK is needed for several different 
processes during nephrogenesis. The second mechanism that was disrupted in ROCK 
inhibitor nephrons was the formation of the glomerular cleft. Initially, I considered the 
possibility that this effect could be secondary to the abnormal renal vesicle formation. 
However, adding the ROCK inhibitor at a stage where renal vesicles had already 
developed, lead to the same abnormalities being detected. This indicated that the 
abnormal glomerular clefts formed by ROCK inhibition were not a result of disturbed 
renal vesicle development. Instead, this could reflect another ROCK-dependent process. 
It could of course still be the same mechanism that was regulated by ROCK and that this 
mechanism was used for different purposes at separate time points. The abnormal 
positioning of the WT1-positive cells in nephrons forming in ROCK inhibitor conditions 
suggested that there was a failure of the development of the presumptive renal corpuscle. 
Since the WT1-positive cells were located on the outside of the nephron, this might 
indicate that another polarity-based process was interrupted by the ROCK inhibition. 
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Nephrons without a renal corpuscle would most probably interact poorly, if at all, with 
the blood vessels. 
 
The third stage of nephron development that is affected by the inhibition of ROCK is 
during the development of the proximal-distal axis. Knockouts of Notch2 and Irx3 have 
shown that single genes can affect a whole nephron segment and either result in a loss of 
the whole segment structure or an expansion of neighbouring segment identities (Cheng 
et al 2007; Reggiani et al 2007). In fact, it is now known that a population of Six2-
expressing cells are capable of producing all the segments of the nephron (Kobayashi 
2008), something that was also suggested by Osafune et al (2006) using their in vitro 
cell culture system of Salll1-positive cells. These findings really demonstrated the 
plasticity of nephron progenitor cell populations. I show that by inhibiting ROCK, 
nephrons failed to properly define their proximal-distal axis. The abnormally patterned 
nephrons were not simply showing cells of different segment types that were intimately 
mingling. Cells were shown to ectopically express markers for more than one nephron 
structure. This suggested that cells were differentiating abnormally as a result of ROCK 
inhibition. However, by monitoring the gene expression of several nephron segment-
specific genes, in kidneys treated with ROCK inhibitor, I demonstrated that the 
inhibition of ROCK did not result in the loss of expression of these genes. This indicated 
that, although ROCK inhibition affected the final patterning of differentiation, it might 
not be a significant regulator of the induction of gene expression. This prompted the 
hypothesis that cells in a nephron might require a mechanism whereby they are 
appropriately patterned along the proximal-distal axis and that this patterning is also 
important for the cells’ normal differentiation. I suggest that the inhibition of ROCK 
disrupts the physical patterning of cells and this leads to cells being located in the wrong 
place and acquiring ectopic gene expression.  
 
What mechanism is resulting in the abnormal segregation of cells along the proximal-
distal axis? One possibility was presented in Chapter 4 where I suggested that cell 
sorting, by differential adhesion or another mechanism, might be blocked by ROCK 
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inhibition. ROCK has been shown to be able to negatively affect adherens junctions 
(Sahai and Marshall 2002), see Diagram4.2 in Chapter 4. Here I inhibited ROCK and as 
a result, possibly increasing adherens junctions stability, thus restricting cell-sorting. It is 
unlikely that the proximal-distal patterning functions via only this system but it is an 
important line of investigation. The abnormally patterned nephrons also displayed 
several morphological defects. A portion of nephrons fused to the ureteric bud at more 
than one site. This would suggest that the ability to fuse, which is normally occurring in 
the distal portion of the nephron, was expanded to other regions of the nephron. Whether 
this was a consequence of the abnormal patterning, remains to be shown. One interesting 
effect is of course the expansion of E-cadherin from the distal domains to proximal 
domains. It has not been formally demonstrated whether E-cadherin plays a role during 
nephron-ureteric bud fusion. It is interesting that the expression of E-cadherin is initially 
restricted to the region of the nephron that will fuse to the, also E-cadherin positive, 
ureteric bud. One possibility is that Wnt signalling is affecting the patterning of 
cadherins in the nephrons since, in MDCK cells, Wnt-signalling results in lower levels 
of cadherin-6 (Stewart, Barth, and Nelson 2000). This might have a mechanical 
importance since cadherin-6 is normally detected in the proximal regions of the renal 
vesicle and not in the distal regions that are near to the Wnt expressing ureteric bud (Cho 
et al 1998). The experiment stipulated to investigate whether cell-adhesion is important 
for proximal-distal nephron patterning (see Chapter 4 Discussion), might also answer 
what role E-cadherin has for nephron fusion to the ureteric bud since E-cadherin would 
be ectopically expressed in proximal nephron segments.  
 
Another morphological defect in the ROCK inhibitor cultures was the development of 
cyst-like nephrons. Cystogenesis in nephrons has previously been demonstrated to be the 
result of disrupted planar cell polarity. The proto-cadherin dependent planar cell polarity 
pathway has been shown to be involved in the regulation of the mitotic axis in nephrons 
(Saburi et al 2008). Knockouts of Fat4, an integral component of this pathway, resulted 
in cystic nephrons that resembled those found in polycystic kidneys (Saburi et al 2008). 
The regulation of the mitotic axis has actually been directly linked to polycystic kidney 
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disease (Fischer et al 2006). Polycystic kidney disease has also been linked to 
microtubule stability (Woo et al 1994). Since ROCK is a regulator of both the 
cytoskeleton and the proliferation rates in the kidney, these could be important directions 
to investigate to better understand polycystic kidney disease. I suggest that it would be 
important to demonstrate whether the inhibition of ROCK also affects mitotic axis.  
 
The finding that ROCK is necessary for nephron development spurs questions about 
what mechanism it is that ROCK uses for the different processes. To answer this 
question, I attempted to block the activity of one of ROCK’s downstream effectors. 
Diagram4.1 in Chapter 4 shows some of the important components that ROCK uses to 
regulate the formation and contraction of actin-myosin. I blocked myosin ATPase and 
found that this produced nephrons that shared similarities with the ones generated in 
ROCK inhibitor conditions. Inhibition of myosin ATPase disrupted renal vesicle 
formation. This suggests that ROCK might be important for renal vesicle formation 
through a pathway that regulates the formation and contraction of stress fibres. 
Secondly, when myosin ATPase was blocked after renal vesicle formation, the nephrons 
that developed also showed abnormal patterning along the proximal-distal axis. This 
indicated that the ROCK-dependent mechanism, that is important for proximal-distal 
patterning, might be dependent on actin-myosin contraction. If this is the case, this 
would show that some form of mechanical force is needed for normal patterning. As 
mentioned, the there were also differences in the effects produced by inhibiting ROCK 
and myosin ATPase. Most notable of the differences was the almost complete block of 
nephron maturation past renal vesicle stage. I propose that the differences between 
inhibiting ROCK and myosin ATPase was that, when ROCK was inactivated, other 
pathways were still capable of stimulating actin-myosin contraction (see Diagram4.1 in 
Chapter 4. When myosin ATPase was inhibited, actin-myosin contraction would have 
been more directly affected. If actin-myosin contraction and stress fibre formation is 
important for nephron development, these processes would be much more severely 
inhibited by the direct targeting of myosin ATPase compared to targeting ROCK. It is 
also possible that the differences between inhibiting myosin ATPase and ROCK could 
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result from that ROCK can also affect other pathways that could be important for 
nephrogenesis. This requires further research to determine if this is the case.  
 
There is another possible mechanism that is only briefly mentioned in this thesis. 
Although the Wnt/β-catenin signalling pathway has been shown to be essential for 
nephron induction, little has been discussed regarding the pool of β-catenin which is 
located in the adherens junctions. It should not be ruled out that ROCK might indirectly 
affect β-catenin signalling via its control on adherens junctions. The expansion of E-
cadherin expression could lead to effects on β-catenin signalling as a large proportion of 
β-catenin could be directed towards the adherens junctions.  It is arguable to what extent 
this might affect β-catenin signalling as a whole, but it would be unwise to rule out this 





There is a need to better understand the relationship between the genetic and the 
morphogenetic processes that operate during kidney development. Elucidating the roles 
of Rac1 and ROCK represents the early steps that provide a bridge between the 
molecular elements and the mechanical forces that are necessary in order to regulate, for 
example, the branching of the ureteric bud or the development of the nephron. In this 
thesis I presented Rac1 and ROCK as important proteins for several of the events that 
take place in the embryonic kidney. Proliferation and the contraction of stress-fibres 
were suggested as their respective mechanism, which they act through to contribute to 
the ureteric bud branching and growth, and for several stages of nephrogenesis. The next 
step is to connect Rac1 and ROCK, proteins that are quite far down the ladder, with 
those that are at the top. How is the activity of Rac1 or ROCK turned on or turned off? 
Is there a connection with genetic pathways that have already been identified as being 
important? By answering these questions we will achieve a much improved perspective 
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on how some fundamental processes are regulated during kidney development, and 
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Branching morphogenesis of epithelia is a common event in
mammalian organogenesis. The process forms the airways of the
lung, the milk ducts of the mammary glands, the exocrine ducts of
the pancreas, the urine collecting ducts of the kidney, the
seminiferous ducts of the prostate, and the ducts of salivary, lacrymal
and uterine glands (Davies, 2005). Generally, these systems develop
by dipodial branching, in which the ends of existing branches
bifurcate and separate from one another as the tubule elongates.
Although branching morphogenesis has been studied intensively for
several years, significant gaps in our knowledge remain. One of the
most important unanswered questions is whether the ability to
initiate new branches is confined only to certain cells in a branching
epithelium, for example those at the tip of an existing branch, or
whether all parts of the epithelium can do it. The answer will have
important implications for our basic understanding of how branched
systems organize themselves and may also have implications for
regenerative medicine. This report addresses this question in one of
the most-studied branching epithelia, the renal collecting duct
system.
The renal urinary collecting duct system arises from an initially
unbranched epithelium, the ureteric bud, which invades the
metanephric mesenchyme half way through mouse gestation and
branches within it to produce approximately 1600 branches over
approximately 10-11 rounds of bifurcation (Cebrian et al., 2004).
Although much work has been done on this system, it is still not
clear whether the ability to branch is confined to just a subset of cells
or whether it is spread generally throughout the system: there is
circumstantial evidence on both sides of the argument.
The main arguments that the ability to produce new branches is
restricted to the tip concern the normal pattern of branching, the
normal pattern of cell differentiation, and a close correlation
between the two. Detailed time-lapse observations of renal
branching morphogenesis have shown that most branching events
(94%) take place by bifurcation at the ends of existing branches
(Watanabe and Costantini, 2004). Cells in the terminal 70 μm of
branches (‘tips’) are the main zone of cell proliferation (Michael and
Davies, 2004) and show patterns of gene expression that differ from
those in the regions behind them (‘stalks’). Tip-specific markers
include Wnt11 and Sox9, while stalk-specific markers include
collagen XVIII, Wnt9b and a glycoprotein that binds Dolichos
biflorus agglutinin (DBA) (Lin et al., 2001; Michael et al., 2007;
Kent et al., 1996; Carroll et al., 2005; Kispert et al., 1996). Careful
measurements suggest that the zone of proliferation, the zone of
Wnt11 expression, and the zone of absence of DBA and collagen
XVIII seem to respect a common boundary (Table 1). The fact that
most branching takes place in the tip zone, which shows different
gene expression to the stalks, suggests that there may be a tip state
of differentiation that makes cells capable of initiating branches.
One of the most persuasive arguments against the ability to form
new tips being restricted to existing tips is the fact that new tips
appear to form from stalk regions, albeit at very low frequency and
accounting for only 6% of branch events (Watanabe and Costantini,
2004). The low frequency of these events makes their interpretation
difficult. It is known from careful analyses of mosaic organs, a few
cells of which express green fluorescent protein (GFP), that some
cells get ‘left behind’ by the tips to contribute to the stalk (Shakya et
al., 2005). It is therefore possible that the very infrequent lateral
branches actually arise from small groups of such tip cells that have
not yet differentiated into stalks. A second, circumstantial, argument,
comes from the fact that cell lines from renal collecting ducts can
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produce branching tubules in three-dimensional culture systems
without – as far as is known – requiring branch-producing cells to
be in a separate state of differentiation (Santos and Nigam, 1993). A
third argument is that various physical models of branching
morphogenesis, such as viscous fingering, have no need for the
ability to initiate branches to be restricted to specific cells (Fleury
and Watanabe, 2002; Fleury et al., 2004). A fourth possible
argument is that the Wolffian duct, from which the ureteric bud
normally emerges as a single side branch, can be induced to produce
supernumerary side branches by the focal application of ramogens,
such as GDNF (Sainio et al., 1997; Davies et al., 1999). The problem
with this argument is that the production of a side branch is an
essential property of the amniote Wolffian duct, so extra side-
branching from it does not necessarily imply that side-branching is
a normal ability of the ureteric bud itself.
Establishing whether the ability to initiate branching is restricted
or distributed within the ureteric bud/collecting duct system is
important, because it carries major implications for understading
patterning mechanisms and for creating strategies to promote
regeneration. We have therefore directly tested the ability of stalk
regions to generate new branching tips. Our results support a model
in which the ability to initiate branches is distributed widely, and not
restricted to cells that already express genetic markers characteristic
of branch tips.
MATERIALS AND METHODS
Dissection and organ culture
Metanephric rudiments were dissected from E11.5-E17.5 CD1 mouse
embryos, the ureteric bud being cut close to its junction with the Wolffian
duct/bladder. Ureteric ‘stalks’ were removed from tip regions by cutting just
below the ‘T’ junction of E11.5 kidneys, and the remaining tip regions were
retained for staining for Wnt11 or with Dolichos biflorus agglutinin (DBA).
Deliberate injuries to ureteric bud stalks or mesenchyme, for the experiments
that needed them, were achieved by stabbing with 0.516-mm needles.
Where surrounding stroma had to be removed from ureters (see main text),
this was achieved by trypsinization in 2 trypsin-EDTA for two minutes
followed by manual separation of the stroma and stalk. Organs were cultured
on Isopore filters (Millipore) on Trowell-type grids in 35-mm petri dishes in
MEM (Sigma M5650), with 10% fetal calf serum and penicillin-
streptomycin solution in 5% CO2 at 37°C.
RT-PCR for Wnt 11
For determination of the maximum possible extent of contamination of
stalk numbers by tip cells, we used conventional end-point PCR to detect
Wnt11 in various dilutions of kidney cDNA that represented known
numbers of tip cells. In this way, we established that we could detect Wnt11
cDNA derived from as few as 0.81±0.1 tip cells clearly (and very faintly
from reactions from smaller numbers of cells). At the same time, we used
the same PCR technique (described below) to attempt to detect Wnt11 from
stalk-derived cDNA without dilution, and showed the signal in a reaction
representing cDNA from 0.44 stalks (see below) to be barely detectable.
This was used to conclude that 0.44 stalks included fewer than 0.81
contaminating tip cells, or that a stalk contained fewer than two
contaminating tip cells.
In detail, total RNA was isolated from 28 whole kidneys, or from 35
stalks-plus-surrounding mesenchyme, using the SV total RNA isolation
kit (Promega), and 200 ng of each type of RNA was used to make cDNA
using the MLV-RT kit (Promega). One twentieth of the cDNA was then
used for each normal PCR reaction. The actual volumes and dilutions of
each stage were recorded accurately for subsequent calculations of the
number of tip cells and stalks represented in PCR reactions (these
calculations also used the fact that each tip consists of 117±18 cells, the
measurement of which is described in the immunofluorescence section
below). Tracking the dilutions of the samples as they were processed
indicated that each PCR reaction from stalk cDNA represented the RNA
of about 0.44 stalks and that each normal PCR reaction from kidney
included RNA from a mean of 81±12 tip cells (together with many non-tip
cells). Primers for β-actin were used in the normal PCR reactions to
provide a further check that the dilutions used to create the normal stalk
and kidney PCRs were correct and represented the same total number of
cells. In addition to standard PCR reactions, reactions were also performed
in which the kidney cDNA from the reverse transcription (RT) step was
diluted 1/10, 1/100, 1/500, 1/1000 and 1/5000: these therefore represented
RNA from 8.1, 0.81, 0.16, 0.081 and 0.016 tip cells. This dilution series
was run in lanes adjacent to the normal PCRs from kidney and stalk to
establish a threshold of clear detection.
For detection of Wnt11 expression in tips growing from ureteric bud
stalks, total RNA was isolated from four stalks that had been allowed to
generate new tips by surrounding them with fresh E11.5 mesenchyme, and
cDNA was synthesized using the same techniques and concentrations as are
described above.
Fixation and immuno/lectin-fluorescence
Kidneys/recombinants intended for immuno- or lectin-fluorescence were
fixed in methanol, washed in PBS with 4% milk powder and incubated in
1/100 mouse anti-calbindin-D28k (Abcam) and/or 1/200 rabbit anti-laminin
(Sigma) in PBS overnight at 4°C. They were then washed in PBS, and
transferred to donkey anti-mouse IgG-Texas Red (Abcam) diluted 1:100 and
lectin from Dolichos biflorus (horse gram)-FITC (Sigma) diluted 10 ng/ml
(1:100 of 1 mg/ml PBS stock) or 1/100 FITC anti-rabbit (Sigma) in 4% milk
powder in PBS overnight at 4°C. A final wash for 30 minutes was carried
out in PBS at room temperature while agitating gently. For determination of
the mean number of cells in a tip, staining with Dolichos biflorus lectin was
used to define (negatively) the tip, as described by Michael et al. (Michael
et al., 2007), and confocal microscopy was used to measure the mean
volume of the cellular part of a tip (4.8104±6103 μm3) and the mean
volume of tip cells (413±37 μm3). The ratio was used to determine the mean
number of cells per tip (117±18).
Culture of stalks in Matrigel
Culture in Matrigel was performed according to the methods of Sakurai et
al. and Qiao et al. (Sakurai et al., 2001; Qiao et al., 1999). Briefly, stalks were
isolated and cultured in a 1:1 mix of Growth Factor Reduced Matrigel (BD
Biosciences) and kidney culture medium with 125 ng/ml recombinant
human GDNF (Promega), 250 ng/ml recombinant human FGF1 (R&D
Systems) and 625 ng/ml recombinant human pleiotrophin (R&D Systems).
The stalks were cultured for 144 hours, fixed for two hours in 4%
paraformaldehyde in PBS (pH 7.0), washed in 1% Triton X-100 in PBS for
30 minutes, stained overnight in FITC-phalloidin (Sigma P5282) at 4°C and
washed in PBS for 1 hour at room temperature.
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Table 1. Evidence that tip and stalk markers described to date respect a common boundary
Marker* Expressed in Boundary position Source of information
DBA binding Stalk 67 μm (σ=18 μm) Michael et al., 2006
Collagen XVIII Stalk 70 μm (σ=25 μm) Our measurements from figure 1F,H of Lin et al., 2001
Wnt11 Tip 71 μm (σ=18 μm) Michael et al., 2006
Sox9 Tip 89 μm (σ=38 μm) Our measurements from figure 6A of Kent et al. 1996
High proliferation Tip Within the first 100 μm Michael and Davies, 2004 
(low spatial resolution data)












The plasmid used to generate Wnt11 probes for in situ hybridization has been
used elsewhere (Kispert et al., 1996) and was kindly donated by S. Vainio.
It consisted of a 2.1 kb cDNA of Wnt11 in pSKII. Antisense DIG-labelled
probes were generated by cutting the plasmid with XhoI and using T3 RNA
polymerase; sense ‘probes’ were generated by cutting the plasmid with XbaI
and using T7 polymerase. Cultures were first fixed in cold methanol to
enhance their adhesion to their filters, then fixed overnight in 4%
paraformaldehyde in PBS, incubated in 0.1% Tween 20 in PBS (‘PBT’) for
10 minutes, treated with 10 μg/ml proteinase K in PBT for 15 minutes at
room temperature, washed for 35 minutes in PBT and post-fixed for 40
minutes in 4% formaldehyde in PBT. They were then incubated for 2-4
hours at 65°C in 50% deionized formamide, 25% 20SSC, 2% Roche
blocking powder, 0.1% Tween 20, 0.5% CHAPS, 1 mg/ml yeast tRNA, 0.5
M EDTA and 0.05% heparin. Probe, pre-heated to 80°C for 3 minutes, was
added at 250 ng/ml and left overnight at 60oC. Samples were then washed
in post-hybridization solution (50% formamide, 25% 20SSC, 0.1% Tween
20, 0.5% CHAPS) for 210 minutes, then in 75% post-hybridization
solution (2SSC), then in 50%, then in 25%, each for 10 minutes. They
were then washed in 2SSC, 0.1% CHAPS for 230 minutes, and
0.2SSC, 0.1% CHAPS for the same amount of time. They were then
blocked in TBST with 10% sheep serum, incubated overnight in 1:200
alkaline phosphatase-conjugated anti-DIG (Roche) and developed the next
day with NBT/BCIP solution. All buffer solutions used for in situ
hybridization were treated with diethyl pyrocarbonate, and ProtectRNA
(Sigma) was used in all solutions after proteinse K digestion. Sense controls
were performed to support antisense experiments, and were negative.
RESULTS AND DISCUSSION
De-tipped ureteric bud stalks regenerate tips and
undergo branching
In principle, ureteric bud stalks may refrain from producing new tips
because they are intrinsically incapable of doing so, because they are
inhibited by existing tips, or because the mesenchyme surrounding
them has been rendered unsupportive of branching by the previous
passage of the tip. To test the intrinsic ability of stalks to produce
new tips, we removed them from the influence of existing tips, by
amputating those tips, and we provided fresh mesenchyme (Fig.
1A). To confirm that the entire tip region had been removed, each
amputated tip region was stained either for Wnt11 mRNA or with
fluorescent DBA, to ensure that it contained the tip-stalk boundary
(Fig. 1B-D). These are the same markers that we have previously
used to study stalk/tip boundaries (Michael et al., 2007), and they
define the tip with much more precision than other alleged tip
markers, such as Ret and Ros, as explained by Michael et al.
(Michael et al., 2007). In any (rare) case that complete removal of
the tip could not be confirmed, the corresponding stalk was
discarded. To ensure that the fresh mesenchymes did not contain
ureteric tips, they were used only if a complete ureteric bud could be
recovered from the donor kidney. As an additional check on the
efficiency of dissection, samples of mesenchyme were also stained
with anti-calbindin-D28K, a marker for ureteric buds (Davies, 1994);
they were negative, as expected.
As an additional check that stalks meeting the above criteria for
purity really were free of contaminating cells, a dilution-series
RT-PCR was performed to set an upper limit on the possible
number of tip cells that could be present in an allegedly pure stalk
sample. The details of the RT-PCR and the calculations made
from it are explained in the Materials and methods. It showed that
Wnt11 in as few as 0.81±0.12 tip cells, represented by the 1/100
dilution of kidney cDNA in Fig. 1E, could be detected clearly. The
Wnt11 in a PCR reaction representing the undiluted cDNA from
0.44 stalks shows a barely detectable band (Fig. 1E). Therefore,
each stalk was contaminated by fewer than 0.81/0.44=1.8 tip
cells. This is far fewer than those needed to make even one tip
(117±18 cells), even after a few cell cycles. These PCR data
2507RESEARCH REPORTTip regeneration in the ureteric bud
Fig. 1. Dissections and recombinations.
(A) Diagram of the tissue manipulations used
for these experiments. The top arrows
indicate separation of tips and stalk, and the
culture of the amputated stalk with fresh
mesenchyme, the middle arrows indicate
injury to mesenchyme (mes) alone, or to stalk
(ub) and mesenchyme, and the bottom
arrows indicate culture of the ‘wrong’ end of
the stalk with fresh mesenchyme.
(B-D) Discarded portions stained with an in
situ probe show the complete Wnt11-
expressing tip regions (B), in addition to short
regions of Wnt11-negative stalks; those
stained with the stalk-specific stain DBA
again show that the tips and a short length
of stalk are present in the discarded region
(C). Staining the same specimen with
calbindin-D28K, which stains both tips and
stalks (D), shows where the tips are. Scale
bar: 100 μm. (E) Dilution PCR analysis of
Wnt11 expression in kidneys, including tips,
and in de-tipped stalks. The numbers below
the dilutions are the number of tip cells
represented in the PCR. The signal in de-
tipped stalks is far dimmer than the 1/100
dilution of kidney (with 0.81 tip cells). The
actin bands demonstrate that the undiluted
samples of kidney and stalk cDNA represent












therefore support the in situ hybridization and immunostaining
data in the paragraph above, and suggest that the stalks are not
significantly contaminated by tip cells.
The majority (71%) of de-tipped stalks provided with fresh
mesenchyme produced branched epithelial trees of an appearance
broadly similar to those of a normal ureteric bud, albeit smaller (Fig.
2A). This fraction is approximately twice the number of stalks that
could have contained even one contaminating tip cell, as calculated
in the paragraph above, so cannot be due to contamination by tip
cells. The other 29% simply expanded in a cyst-like manner,
probably because they were damaged during handling. The branches
produced in the 71% of cultures that produced trees terminated in
ampulla-shaped tips that were indistinguishable from those of
normal kidneys. What is more, in situ hybridization and RT-PCR for
Wnt11 showed that this tip marker was expressed at the tips of the
branches generated by the stalk (Fig. 2C,G), and DBA lectin staining
showed that this stalk marker was reduced in or absent from most
new tips (Fig. 2B). The de-tipped stalks were therefore capable of
regenerating tips that had normal marker expression, as well as
normal morphology. The proportion in which this occurred, just over
70%, is much higher than the 6% of branches that seem to arise
laterally from stalks in normal renal development (Watanabe and
Costantini, 2004), and it is not reasonable to assume that these could
have arisen from ‘lost’ clusters of tip cells left behind: if there were
that many ‘lost’ tip cells, we and others would have seen them in
Wnt11 in situ stains.
Branching and tip formation can be induced even
from the wrong end of the ureteric bud
To determine whether the ability to initiate branches was still present
even in the most distal regions of the ureteric bud stalk, we left the
existing tips of ureteric buds alone and instead packed fresh
mesenchyme around the distal end of the ureter that was severed
when the kidney was isolated from the embryo (Fig. 1A). Forty
percent of the E11.5 kidneys so treated showed prolific branching
from the severed ureter to produce ‘double-ended’ trees (Fig. 2D).
These tips lost DBA-binding activity (Fig. 2E,F) and also induced
the formation of nephrons in the surrounding mesenchyme (Fig.
3C,D). This ability is retained by ureters from both E11.5 and E12.5
kidneys (Fig. 3A).
These results demonstrate that the ability of the ureteric bud to
initiate new branch tips is not restricted to existing tips but is instead
distributed widely, at least for the first few days of the bud’s
existence. This possibility has been suspected recently from time-
lapse studies of ureteric branching (Shakya et al., 2005; Watanabe
and Costantini, 2004), but, as pointed out in the recent review of
Costantini and Shakya, it has not been directly examined before
(Costantini and Shakya, 2006). The finding also implies that the
specialized state of gene expression at the tips (Wnt11-positive,
DBA-negative, etc) might be required for the proper organization of
branching morphogenesis, but it cannot be needed for cells to make
their first response to ramogenic signals. If it were, the Wnt11–,
DBA+ stalks could not have responded. Expression of molecules
such as Wnt11 must therefore be secondary to the events that first
induce new branches to form.
Although the distal ends of ureters of E11.5 and E12.5 kidneys
could produce new branches when provided with fresh
mesenchyme, those of E13.5, E14.5 and E15.5 kidneys failed to
do so. These epithelia are surrounded by a sleeve of stroma that
might, conceivably, inhibit tip formation. To address this
possibility, we removed the stroma enzymatically before
applying fresh E11.5 mesenchyme to the ureter epithelium. It
was possible to remove 100% of stromal cells from ureters up to
and including E13.5, but from E14.5 only about 90% of the cells
could be removed (leaving significant uncovered areas of
epithelium); further extending the enzymatic incubations resulted
in the tissue losing structure completely. The E13.5 ureters freed
completely from stroma were able to produce new tips when
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Fig. 2. Regeneration of new branching
epithelia from E11.5 ureteric bud stalks.
(A,B) New branching tree generated from an
isolated E11.5 stalk surrounded by fresh
mesenchyme, stained with (A) anti-calbindin-D28K
and (B) the stalk marker DBA. Comparison of the
images reveals that at least some of the new tips
are DBA negative (arrowheads). (C) Another
example, stained for Wnt11 by in situ hybridization;
the new tips have acquired Wnt11 expression.
(D-F) Generation of a new ureteric bud tree from
the ‘wrong end’ of the ureteric bud. (D) Low-power
view of a ‘double-ended’ kidney formed by
branching from the cut end of the ureteric bud.
(E,F) Higher-power view of the ‘wrong end’ tree,
stained with anti-calbindin-D28K (E) and DBA (F): a
significant number of tips (outlined in F) have
greatly reduced DBA expression compared with
stalk (arrowhead). (G) These stalk-derived tips (Reg)
express the tip marker Wnt11 by RT-PCR at levels
similar to those in whole kidneys (kid), whereas the
stalks not allowed to generate new tips (Slk) do not











provided with fresh E11.5 mesenchyme, and these tips went on
to induce nephrons in that mesenchyme, suggesting that the
failure of E13.5 ureters surrounded by stroma to produce new
tips was due to an inhibitory influence of the stroma. Later
ureters that could be freed substantially but not completely from
stroma still failed to form tips. A simple mechanical influence of
stroma, for example that it forms a diffusion barrier to molecules
such as GDNF from the fresh mesenchyme outside it, is unlikely
to explain this effect, as even the older enzyme-treated ureters
had lost enough stroma to make the epithelium accessible. Bmps
such as Bmp4 and Bmp5 are expressed strongly in this stroma
(Dudley and Robertson, 1997), and are known to be inhibitors of
branching (Hartwig et al., 2008; Gupta et al., 1999; Miyazaki et
al., 2000; Michos et al., 2007). Gremlin 1 is a powerful
antagonist of Bmps, particularly Bmp2 and Bmp4, and treatment
of cultured kidney rudiments with exogenous gremlin 1 is
sufficient to antagonize Bmp activity and alter ureteric branching
in intact kidneys (Michos et al., 2007). To test whether the
secretion of Bmps by the remaining peri-ureteric stroma might
account for the repression of tip formation in our system, we
applied the Bmp antagonist gremlin 1 at 5 μg/ml to the cultures.
This concentration was the same as that used by Michos et al.,
and, in our hands, it had a modest effect on increasing the amount
of branching in E11.5 kidneys, by 14% (P=0.073), suggesting
that the molecule was active. It failed, however, to induce tip
formation from the enzyme-treated E14.5 ureter/ fresh
mesenchyme combinations. This suggests that the stroma
secretes an inhibitor other than Bmps, or that the ability to
produce new tips is lost as the epithelium itself matures.
New tip formation is a response to fresh
mesenchyme, not to tissue injury
The process of setting up the cultures described above necessarily
involved cutting mesenchymal and epithelial tissues. It was
therefore possible that the production of new branches was simply
a response to injury. To test this, two types of cutting experiment
were performed without any transplantation of mesenchyme. In the
first, a syringe needle was used to cut a slit in the mesenchyme
adjacent to one side of the ureteric bud stalk but with no injury to the
stalk itself and in the second, the cut passed through the stalk itself,
as well as the surrounding mesenchyme (Fig. 1A). The injured
kidney rudiments were then incubated for 6 days, uninjured kidneys
being used as controls. None of the kidneys in either control or cut
groups showed any evidence of branching from the stalk.
Conversely, when mesenchyme was removed from the side of the
stalk of the ureteric bud, without injuring the bud itself, and replaced
by a clump of fresh metanephric mesenchyme, 75% of kidneys
demonstrated emission of new branches from the side of the stalk.
Injury alone was not therefore a sufficient trigger for production of
new tips; fresh mesenchyme was required.
De-tipped stalks branch when placed in a three-
dimensional matrix
Intact ureteric buds will grow and branch when placed in a three-
dimensional gel matrix, consisting of Matrigel supplemented with
GDNF, FGF1 and pleiotrophin (Sakurai et al., 2001). Isolated, de-
tipped stalks transferred to this culture system, grow and branch in
a manner similar to that of intact ureteric buds (Fig. 3B). This
demonstrates that ramogenic factors already characterized in normal
mesenchyme (GDNF, FGF1 and pleiotrophin) are sufficient to
promote the regeneration of tips. It is notable that the density of tips
is much higher in this system than in normal kidneys.
Ureteric stalks, then, are capable of forming new tips if provided
with fresh mesenchyme or with a Matrigel artificially loaded with
ramogens, such as GDNF and FGF1, known to be manufactured by
fresh mesenchyme (Sainio et al., 1997; Sakurai et al., 2001). It is
known that GDNF is not expressed by mesenchyme cells after they
have been induced, by contact with the ureteric bud, to form
neprhons and stroma (Sainio et al., 1997). FGF1 persists a little
longer, but is still lost as nephrons mature beyond the ‘S’-shaped
stage (Cancilla et al., 1999). Indeed, not only do maturing nephrons
and stroma cease to produce ramogens, they also begin to secrete
anti-ramogenic factors, such as Bmp2 and Tgfβ (Lyons et al., 1995;
Ritvos et al., 1995; Davies and Fisher, 2002; Dudley and Robertson,
1997; Bush et al., 2004; Gupta et al., 1999; Piscione et al., 1997).
This suggests a model in which stalks are normally prevented from
branching because the mesenchyme that surrrounds them has
already ceased to express ramogens. The likely importance of the
mesenchyme in modulating the production of tips by the stalks is
supported by the behaviour of stalks in ramogen-enriched Matrigel.
The density of tips formed by the stalk is much higher than that seen
in normal kidney development, suggesting that in the normal organ
the mesenchyme surrounding the stalk must be non-permissive for
tip formation. Indeed, it is the source of factors, such as heregulin α
(neuregulin 1 – Mouse Genome Informatics), that support growth
and maturation of the bud without inducing branching (Sakurai et
al., 2005).
This system described above would, under normal circumstances,
tend to restrict branching to the existing tips because these are the
only cells that meet uninduced mesenchyme. Only if mesenchymal
cell mixing, and/or inefficient branching of the bud throughout the
mesenchyme, brought a population of uninduced mesenchyme cells
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Fig. 3. Generation of branched ureteric systems from the
‘wrong end’ of the ureters of more mature kidneys. (A) A cut
ureteric stalk of an E12.5 kidney capped with E11.5 metanephric
mesenchyme ramified through the mesenchyme to generate a
branched collecting duct system (circled). (B) Branching
morphogenesis of an E11.5 de-tipped stalk transferred to matrigel
with GDNF, FGF1 and pleiotrophin, incubated for 144 hours and
stained with FITC-phalloidin to reveal its anatomy. It is interesting to
note that the phalloidin stain is particularly strong in the apical
regions of cells at the branch tips, as described for normal ureteric
buds developing in whole kidneys (Michael et al., 2005). (C,D) Tips
formed from the ‘wrong end’ of the ureter, as in A, induce the
formation of nephrons in the surrounding mesenchyme. These are
not detectable in the ureteric bud-specific anti-calbindin stain (C) but












near to a stalk would production of a new tip by the stalk occur. A
system organized according to these principles would be robust
against errors, because any zones of the kidney ‘missed out’ by the
branching of the tree would be able to induce secondary branches
from stalks until they were adequately served. This presumably
accounts for the very low, but non-zero (6%), frequency with which
lateral branches have been observed to occur in culture (Watanabe
and Costantini, 2004).
Understanding that the whole of the ureteric bud is capable of
producing a branching tree, at least until it has matured too far, may
have implications beyond the need to revise models for the control
of pattern formation in this system. There is increasing interest in
using the techniques of stem cell biology and tissue engineering to
repair kidneys made defective by congenital disease or infection
(Hayashi, 2006; Rookmaaker et al., 2004). Most current effort is
aimed at using transplanted progenitor cells to create areas of kidney
in which new nephrons, free of genetic defects, develop. The
absence, in a fully formed kidney, of active ureteric bud tips to
provide these areas with a collecting duct system has been seen as a
potential problem of the technique. If, however, the stalks of the
cortical bud/collecting duct system can generate new tips anyway,
either at once or as a result of minor treatment, the entire enterprise
becomes much more hopeful. For this reason, our observation that
stalks can regenerate tips may have implications for regenerative
medicine, as well as for basic developmental biology.
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Fig.A2.1 Localisation of ROCK-II in cultured kidneys 
 
Fig.A2.1 shows kidneys that were cultured in CKCM for 72hrs prior to fixation in methanol. Cultures 
were stained for ROCK using mouse anti-ROCK-II. This was detected using anti-mouse-FITC. 
Antibody controls were performed using primary antibodies only (C) or secondary antibodies only 
(D). (A) and (B) show cultures stained with both primary and secondary antibodies; these cultures 


































Fig.A2.2 The effects ROCK inhibition on nephron formation as viewed using WT1-
GFP  
 
Fig.A2.2 shows MM from a mouse strain heterozygously carrying a knock in of GFP into the 







cord. Cultures were placed in CKCM without (A) or with (B) 20µM Y27632. Cultures were kept for 
72hrs prior direct visualisation of the WT1-GFP protein.  
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Odd no. and even no. 
lanes contain data from 







































96hrs Control and Experimental Conditions  
These lanes display the 
expression of cdh-6 in control 
and experimental conditions 





































72hrs Control and Experimental Conditions  
The Cdh-6 data is shown in lanes 17 and 18 on 
the gel displaying the expression profiles for 




































24hrs and 48hrs Control Conditions  
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Fig.A2.3 Original gel-images for data presented in Chapter 4: Fig.4.11. 
 
Fig.A2.3 shows original gel images for “144hrs Control and Experimental Conditions” “96hrs Control 
and Experimental Conditions”, “72hrs Control and Experimental Conditions” and “24hrs and 48hrs 
Control Conditions”. All lanes at each time-point are as specified for the “144hrs Control and 
Experimental Conditions” images, unless specified otherwise. Odd and even numbered lanes contain 
cDNA produced from control and experimental data, respectively. For “24hrs and 48hrs Control 
Conditions”, odd and even numbered lanes contain cDNA produced from kidneys cultured for 24hrs 
and 48hrs, respectively. 
 
 
